cancer.type	eQTL.type	tagSNP	LD	SNP.ID	SNP.position.hg19	Gene.symbol	Gene.position.hg19	Beta	t-stat	P-value	GWAS-Traits	
THYM	cis	1	rs10005733	chr4:292001	ZNF718	chr4:53272-156488:+	0.54	6.46	4.44E-9	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs10006789	chr4:1330333	CRIPAK	chr4:1385340-1389782:+	0.76	6.54	3.04E-9	Systolic blood pressure	
THYM	cis	1	rs10008757	chr4:76903036	NAAA	chr4:76831809-76862166:-	-0.46	-4.92	3.56E-6	Longevity	
THYM	cis	1	rs10021364	chr4:310691	ZNF718	chr4:53272-156488:+	-0.66	-6.89	6.07E-10	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs10023335	chr4:77358987	STBD1	chr4:77172853-77232282:+	-0.48	-4.23	5.35E-5	Creatinine levels	
THYM	cis	1	rs10027325	chr4:282608	ZNF718	chr4:53272-156488:+	0.52	5.94	4.59E-8	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs10028351	chr4:71295971	AMTN	chr4:71384298-71398459:+	0.42	4.59	1.36E-5	Alcoholism (heaviness of drinking)	
THYM	cis	1	rs10051747	chr5:56083289	C5orf35	chr5:56205103-56213010:+	0.74	8.92	3.44E-14	Type 2 diabetes	
THYM	cis	1	rs1005224	chr14:76173860	TTLL5	chr14:76127621-76421421:+	0.33	4.35	3.48E-5	Large artery stroke	
THYM	cis	1	rs10078	chr5:438102	C5orf55	chr5:441645-443258:-	0.37	4.77	6.74E-6	Fat distribution (HIV)	
THYM	cis	1	rs1009242	chr9:131916832	CRAT	chr9:131857075-131873070:-	0.38	4.61	1.24E-5	Blood metabolite ratios	
THYM	cis	1	rs1010117	chr20:23608421	CST9	chr20:23583049-23586610:-	-0.51	-4.73	7.71E-6	Chronic kidney disease	
THYM	cis	1	rs10117059	chr9:123653477	LOC253039	chr9:123605320-123616644:+	-0.62	-5.56	2.51E-7	Rheumatoid arthritis	
THYM	cis	1	rs10140433	chr14:74659989	LIN52	chr14:74551656-74667117:+	-0.39	-7.22	1.25E-10	Common traits (Other)	
THYM	cis	1	rs10144220	chr14:74647904	LIN52	chr14:74551656-74667117:+	-0.39	-7.16	1.73E-10	Common traits (Other)	
THYM	cis	1	rs10150201	chr14:74649157	LIN52	chr14:74551656-74667117:+	-0.39	-7.16	1.73E-10	Common traits (Other)	
THYM	cis	1	rs10157597	chr1:45990278	CCDC163P	chr1:45960581-45965646:-	-0.85	-14.31	1.95E-25	Homocysteine levels	
THYM	cis	1	rs1016669	chr3:41894440	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs10167422	chr2:227777554	RHBDD1	chr2:227700773-227861591:+	-0.31	-4.54	1.67E-5	Pulmonary function	
THYM	cis	1	rs10169714	chr2:73808773	ALMS1P	chr2:73872046-73912692:+	0.59	4.53	1.69E-5	Metabolite levels	
THYM	cis	1	rs10175180	chr2:73673123	ALMS1P	chr2:73872046-73912692:+	0.58	4.72	8.0E-6	Metabolite levels	
THYM	cis	1	rs10178409	chr2:73855507	ALMS1P	chr2:73872046-73912692:+	0.66	4.97	2.93E-6	Urinary metabolites	
THYM	cis	1	rs10179134	chr2:73637519	ALMS1P	chr2:73872046-73912692:+	0.58	4.3	4.1E-5	Metabolite levels	
THYM	cis	1	rs1018184	chr6:86648475	SNHG5	chr6:86386726-86388451:-	0.57	6.85	7.2E-10	Response to antipsychotic treatment	
THYM	cis	1	rs10184268	chr2:73627044	ALMS1P	chr2:73872046-73912692:+	0.57	4.51	1.85E-5	Metabolite levels	
THYM	cis	1	rs10186501	chr2:73697844	ALMS1P	chr2:73872046-73912692:+	0.58	4.72	8.0E-6	Metabolite levels	
THYM	cis	1	rs10187192	chr2:73713500	ALMS1P	chr2:73872046-73912692:+	0.63	4.71	8.5E-6	Metabolite levels	
THYM	cis	1	rs10187416	chr2:73713741	ALMS1P	chr2:73872046-73912692:+	0.57	4.73	7.87E-6	Metabolite levels	
THYM	cis	1	rs10189574	chr2:73698518	ALMS1P	chr2:73872046-73912692:+	0.58	4.72	8.0E-6	Metabolite levels	
THYM	cis	1	rs10190219	chr2:73658331	ALMS1P	chr2:73872046-73912692:+	0.63	4.71	8.5E-6	Metabolite levels	
THYM	cis	1	rs10193316	chr2:227777650	RHBDD1	chr2:227700773-227861591:+	-0.31	-4.54	1.67E-5	Pulmonary function	
THYM	cis	1	rs10193373	chr2:281886	SH3YL1	chr2:218138-264810:-	-0.34	-4.91	3.83E-6	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs10193404	chr2:227777757	RHBDD1	chr2:227700773-227861591:+	-0.31	-4.51	1.82E-5	Pulmonary function	
THYM	cis	1	rs10193972	chr2:73717656	ALMS1P	chr2:73872046-73912692:+	0.58	4.75	7.12E-6	Metabolite levels	
THYM	cis	1	rs10194962	chr2:101418410	PDCL3	chr2:101179418-101193201:+	0.55	4.47	2.15E-5	Creutzfeldt-Jakob disease (variant)	
THYM	cis	1	rs10197757	chr2:227763244	RHBDD1	chr2:227700773-227861591:+	-0.32	-4.77	6.67E-6	Pulmonary function	
THYM	cis	1	rs10204368	chr2:227774244	RHBDD1	chr2:227700773-227861591:+	-0.31	-4.56	1.54E-5	Pulmonary function	
THYM	cis	1	rs10207220	chr2:73785046	ALMS1P	chr2:73872046-73912692:+	0.59	4.53	1.69E-5	Metabolite levels	
THYM	cis	1	rs10210763	chr2:227776029	RHBDD1	chr2:227700773-227861591:+	-0.31	-4.56	1.54E-5	Pulmonary function	
THYM	cis	1	rs10212536	chr3:41827026	ULK4	chr3:41288091-42003660:-	1	10.48	1.54E-17	Diastolic blood pressure	
THYM	cis	1	rs10216533	chr8:143763690	PSCA	chr8:143761875-143764142:+	0.43	4.29	4.22E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs10218795	chr1:145416056	NOTCH2NL	chr1:145209111-145295525:+	0.88	5.72	1.21E-7	Coronary heart disease	
THYM	cis	1	rs10234309	chr7:135311167	PL-5283	chr7:135347221-135378160:+	0.36	5.03	2.33E-6	Paget's disease	
THYM	cis	1	rs10247443	chr7:50620586	FIGNL1	chr7:50511834-50518088:-	-0.3	-4.59	1.33E-5	Malaria	
THYM	cis	1	rs10247526	chr7:65780696	CCT6P1	chr7:65216092-65228661:+	-0.64	-5.23	1.0E-6	Diabetic kidney disease	
THYM	cis	1	rs10250513	chr7:50621488	FIGNL1	chr7:50511834-50518088:-	-0.3	-4.64	1.09E-5	Malaria	
THYM	cis	1	rs1025646	chr3:41754422	ULK4	chr3:41288091-42003660:-	0.99	10.12	9.3E-17	Diastolic blood pressure	
THYM	cis	1	rs1028449	chr14:35512995	KIAA0391	chr14:35591776-35786673:+	0.32	4.18	6.43E-5	Atopic dermatitis	
THYM	cis	1	rs1028449	chr14:35512995	PPP2R3C	chr14:35554679-35591679:-	0.27	5.03	2.32E-6	Atopic dermatitis	
THYM	cis	1	rs10416218	chr19:33599127	GPATCH1	chr19:33571786-33621318:+	0.37	4.33	3.69E-5	Bone properties (heel)	
THYM	cis	1	rs10416265	chr19:33605300	GPATCH1	chr19:33571786-33621318:+	0.37	4.23	5.33E-5	Bone properties (heel)	
THYM	cis	1	rs10423531	chr19:33600140	GPATCH1	chr19:33571786-33621318:+	0.37	4.33	3.69E-5	Bone properties (heel)	
THYM	cis	1	rs1042658	chr17:38173902	GSDMA	chr17:38119226-38134019:+	-0.87	-9.32	4.71E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THYM	cis	1	rs10431505	chr12:58178589	FAM119B	chr12:58166383-58176323:+	0.41	5.83	7.7E-8	Multiple sclerosis	
THYM	cis	1	rs10431505	chr12:58178589	TSFM	chr12:58176536-58191367:+	-0.28	-5.16	1.33E-6	Multiple sclerosis	
THYM	cis	1	rs10437514	chr10:45048646	ZNF22	chr10:45496273-45500776:+	0.58	5.21	1.1E-6	Estradiol plasma levels (breast cancer)	
THYM	cis	1	rs10437520	chr10:45047427	ZNF22	chr10:45496273-45500776:+	0.47	4.63	1.16E-5	Estradiol plasma levels (breast cancer)	
THYM	cis	1	rs10439607	chr20:30258541	MYLK2	chr20:30407178-30422500:+	0.41	4.14	7.63E-5	Subcortical brain region volumes	
THYM	cis	1	rs10445300	chr17:2114587	SRR	chr17:2207248-2228553:+	-0.53	-5.47	3.67E-7	Esophageal cancer (squamous cell)	
THYM	cis	1	rs1044717	chr1:45976587	CCDC163P	chr1:45960581-45965646:-	-0.86	-14.78	2.3E-26	Homocysteine levels	
THYM	cis	1	rs10455158	chr6:86672825	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs1045531	chr8:143763547	PSCA	chr8:143761875-143764142:+	0.43	4.29	4.22E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs10455449	chr6:86592226	SNHG5	chr6:86386726-86388451:-	-0.61	-7.35	6.78E-11	Response to antipsychotic treatment	
THYM	cis	1	rs10455455	chr6:86670214	SNHG5	chr6:86386726-86388451:-	-0.6	-7.24	1.15E-10	Response to antipsychotic treatment	
THYM	cis	1	rs10455456	chr6:86670322	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs1045547	chr8:143763757	PSCA	chr8:143761875-143764142:+	0.43	4.29	4.22E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs1045574	chr8:143763958	PSCA	chr8:143761875-143764142:+	0.43	4.29	4.22E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs1045605	chr8:143764101	PSCA	chr8:143761875-143764142:+	0.43	4.29	4.22E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs10456622	chr6:49396453	CENPQ	chr6:49431096-49460820:+	-0.23	-4.18	6.44E-5	Folate pathway vitamin levels	
THYM	cis	1	rs10456622	chr6:49396453	MUT	chr6:49398994-49431031:-	0.28	4.34	3.5E-5	Folate pathway vitamin levels	
THYM	cis	1	rs10461617	chr5:56104308	C5orf35	chr5:56205103-56213010:+	0.73	8.85	4.68E-14	Type 2 diabetes	
THYM	cis	1	rs10470686	chr3:48449956	TREX1	chr3:48501186-48509043:+	-0.29	-4.43	2.49E-5	Longevity	
THYM	cis	1	rs10489249	chr1:171714521	VAMP4	chr1:171669298-171711214:-	0.32	4.18	6.49E-5	Hippocampal atrophy	
THYM	cis	1	rs10489251	chr1:171717534	VAMP4	chr1:171669298-171711214:-	0.33	4.16	7.1E-5	Hippocampal atrophy	
THYM	cis	1	rs10490958	chr10:17233450	CUBN	chr10:16865966-17171816:-	-0.31	-4.71	8.37E-6	Homocysteine levels	
THYM	cis	1	rs10496191	chr2:73673798	ALMS1P	chr2:73872046-73912692:+	0.58	4.72	8.0E-6	Metabolite levels	
THYM	cis	1	rs10496193	chr2:73773503	ALMS1P	chr2:73872046-73912692:+	0.57	4.64	1.09E-5	Metabolite levels	
THYM	cis	1	rs10498958	chr6:86649705	SNHG5	chr6:86386726-86388451:-	0.6	7.24	1.15E-10	Response to antipsychotic treatment	
THYM	cis	1	rs10506317	chr12:54164066	COPZ1	chr12:54718911-54745633:+	-0.3	-4.54	1.64E-5	Tanning	
THYM	cis	1	rs10509741	chr10:101917366	BLOC1S2	chr10:102033713-102046439:-	-0.5	-5.35	6.1E-7	Schizophrenia	
THYM	cis	1	rs1052501	chr3:41925398	ULK4	chr3:41288091-42003660:-	-1	-11.02	1.12E-18	Diastolic blood pressure	
THYM	cis	1	rs1064039	chr20:23618427	CST9	chr20:23583049-23586610:-	-0.48	-4.46	2.25E-5	Chronic kidney disease	
THYM	cis	1	rs10736426	chr1:45984353	CCDC163P	chr1:45960581-45965646:-	0.8	13.18	3.67E-23	Homocysteine levels	
THYM	cis	1	rs10739388	chr9:115977175	CDC26	chr9:116029290-116037869:-	-0.36	-5.71	1.26E-7	Hematology traits	
THYM	cis	1	rs10744482	chr12:131298195	STX2	chr12:131274149-131323811:-	0.33	5.6	2.1E-7	Plasma plasminogen activator levels	
THYM	cis	1	rs10747783	chr12:58176614	FAM119B	chr12:58166383-58176323:+	0.41	5.83	7.7E-8	Multiple sclerosis	
THYM	cis	1	rs10747783	chr12:58176614	TSFM	chr12:58176536-58191367:+	-0.28	-5.16	1.33E-6	Multiple sclerosis	
THYM	cis	1	rs10749860	chr1:46328210	CCDC163P	chr1:45960581-45965646:-	-0.51	-6.14	1.91E-8	Body mass index	
THYM	cis	1	rs10759636	chr9:116018777	CDC26	chr9:116029290-116037869:-	-0.36	-5.77	9.96E-8	Hematology traits	
THYM	cis	1	rs10760118	chr9:123641616	LOC253039	chr9:123605320-123616644:+	-0.59	-5.33	6.59E-7	Rheumatoid arthritis	
THYM	cis	1	rs10760121	chr9:123647915	LOC253039	chr9:123605320-123616644:+	-0.62	-5.56	2.51E-7	Rheumatoid arthritis	
THYM	cis	1	rs10760589	chr9:131906293	CRAT	chr9:131857075-131873070:-	0.38	4.61	1.24E-5	Blood metabolite ratios	
THYM	cis	1	rs10773819	chr12:131279022	STX2	chr12:131274149-131323811:-	0.35	5.91	5.25E-8	Plasma plasminogen activator levels	
THYM	cis	1	rs10773822	chr12:131289107	STX2	chr12:131274149-131323811:-	0.35	5.89	5.79E-8	Plasma plasminogen activator levels	
THYM	cis	1	rs10783847	chr12:58196447	FAM119B	chr12:58166383-58176323:+	0.41	5.83	7.7E-8	Multiple sclerosis	
THYM	cis	1	rs10783847	chr12:58196447	TSFM	chr12:58176536-58191367:+	-0.28	-5.16	1.33E-6	Multiple sclerosis	
THYM	cis	1	rs10783848	chr12:58196528	FAM119B	chr12:58166383-58176323:+	0.41	5.83	7.7E-8	Multiple sclerosis	
THYM	cis	1	rs10783848	chr12:58196528	TSFM	chr12:58176536-58191367:+	-0.28	-5.16	1.33E-6	Multiple sclerosis	
THYM	cis	1	rs10789475	chr1:46304177	CCDC163P	chr1:45960581-45965646:-	-0.48	-5.58	2.24E-7	Body mass index	
THYM	cis	1	rs10789481	chr1:46383583	CCDC163P	chr1:45960581-45965646:-	-0.48	-5.73	1.2E-7	Body mass index	
THYM	cis	1	rs10789487	chr1:46420221	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs1078968	chr3:53123486	RFT1	chr3:53122503-53164470:-	-0.44	-4.93	3.42E-6	Height	
THYM	cis	1	rs10791830	chr11:65661291	CTSW	chr11:65647284-65651212:+	-0.56	-5.87	6.24E-8	Crohn's disease	
THYM	cis	1	rs10791830	chr11:65661291	SNX32	chr11:65601410-65621170:+	0.59	5.1	1.75E-6	Crohn's disease	
THYM	cis	1	rs10799428	chr1:227798565	DUSP5P	chr1:228780657-228788159:+	-0.77	-4.8	5.93E-6	Height	
THYM	cis	1	rs10800501	chr1:170128903	SCYL3	chr1:169821804-169863076:-	-0.23	-4.17	6.81E-5	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
THYM	cis	1	rs10804632	chr3:134294501	ANAPC13	chr3:134196547-134204865:-	0.55	7.52	3.08E-11	Height	
THYM	cis	1	rs10804632	chr3:134294501	CEP63	chr3:134204575-134293852:+	0.42	6.29	9.47E-9	Height	
THYM	cis	1	rs10807701	chr7:65724686	CCT6P1	chr7:65216092-65228661:+	-0.64	-5.29	7.77E-7	Diabetic kidney disease	
THYM	cis	1	rs10807702	chr7:65767843	CCT6P1	chr7:65216092-65228661:+	0.68	5.66	1.6E-7	Diabetic kidney disease	
THYM	cis	1	rs10818480	chr9:123643170	LOC253039	chr9:123605320-123616644:+	-0.62	-5.62	1.91E-7	Rheumatoid arthritis	
THYM	cis	1	rs10819464	chr9:131876277	CRAT	chr9:131857075-131873070:-	0.38	4.61	1.24E-5	Blood metabolite ratios	
THYM	cis	1	rs10819466	chr9:131881492	CRAT	chr9:131857075-131873070:-	0.38	4.61	1.24E-5	Blood metabolite ratios	
THYM	cis	1	rs10819469	chr9:131882067	CRAT	chr9:131857075-131873070:-	0.42	4.98	2.82E-6	Blood metabolite ratios	
THYM	cis	1	rs10819471	chr9:131896325	CRAT	chr9:131857075-131873070:-	0.37	4.37	3.22E-5	Blood metabolite ratios	
THYM	cis	1	rs10848205	chr12:131280714	STX2	chr12:131274149-131323811:-	0.33	5.6	2.1E-7	Plasma plasminogen activator levels	
THYM	cis	1	rs1085243	chr1:46544768	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs1085244	chr1:46563680	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs10857712	chr10:135225666	MTG1	chr10:135207621-135234173:+	0.32	5.4	4.87E-7	Systemic lupus erythematosus	
THYM	cis	1	rs10865914	chr3:41919499	ULK4	chr3:41288091-42003660:-	-1	-11.02	1.12E-18	Diastolic blood pressure	
THYM	cis	1	rs10877012	chr12:58162085	FAM119B	chr12:58166383-58176323:+	0.42	5.62	1.9E-7	Multiple sclerosis	
THYM	cis	1	rs10877012	chr12:58162085	TSFM	chr12:58176536-58191367:+	-0.27	-4.75	7.08E-6	Multiple sclerosis	
THYM	cis	1	rs10877013	chr12:58165085	FAM119B	chr12:58166383-58176323:+	0.42	5.82	8.05E-8	Multiple sclerosis	
THYM	cis	1	rs10877013	chr12:58165085	TSFM	chr12:58176536-58191367:+	-0.28	-5.1	1.74E-6	Multiple sclerosis	
THYM	cis	1	rs10877014	chr12:58167661	FAM119B	chr12:58166383-58176323:+	0.41	5.83	7.7E-8	Multiple sclerosis	
THYM	cis	1	rs10877014	chr12:58167661	TSFM	chr12:58176536-58191367:+	-0.28	-5.16	1.33E-6	Multiple sclerosis	
THYM	cis	1	rs10877015	chr12:58167788	FAM119B	chr12:58166383-58176323:+	0.42	5.72	1.22E-7	Multiple sclerosis	
THYM	cis	1	rs10877015	chr12:58167788	TSFM	chr12:58176536-58191367:+	-0.29	-5.12	1.6E-6	Multiple sclerosis	
THYM	cis	1	rs10877019	chr12:58172929	FAM119B	chr12:58166383-58176323:+	-0.42	-5.72	1.22E-7	Multiple sclerosis	
THYM	cis	1	rs10877019	chr12:58172929	TSFM	chr12:58176536-58191367:+	0.29	5.12	1.6E-6	Multiple sclerosis	
THYM	cis	1	rs10890352	chr1:46283628	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	6.8E-8	Body mass index	
THYM	cis	1	rs10890354	chr1:46305347	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	6.8E-8	Body mass index	
THYM	cis	1	rs10890361	chr1:46346234	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	6.8E-8	Body mass index	
THYM	cis	1	rs10890363	chr1:46356148	CCDC163P	chr1:45960581-45965646:-	0.49	6	3.55E-8	Body mass index	
THYM	cis	1	rs10890383	chr1:46588503	CCDC163P	chr1:45960581-45965646:-	-0.46	-5.33	6.71E-7	Body mass index	
THYM	cis	1	rs10896043	chr11:65543827	SNX32	chr11:65601410-65621170:+	-0.41	-4.48	2.05E-5	Systemic lupus erythematosus	
THYM	cis	1	rs10897274	chr11:62200369	ASRGL1	chr11:62104774-62160885:+	0.31	4.44	2.45E-5	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs10900062	chr10:45039599	ZNF22	chr10:45496273-45500776:+	0.47	4.63	1.16E-5	Estradiol plasma levels (breast cancer)	
THYM	cis	1	rs10900063	chr10:45045250	ZNF22	chr10:45496273-45500776:+	0.58	5.21	1.1E-6	Estradiol plasma levels (breast cancer)	
THYM	cis	1	rs10900064	chr10:45057471	ZNF22	chr10:45496273-45500776:+	0.57	5.19	1.21E-6	Estradiol plasma levels (breast cancer)	
THYM	cis	1	rs10902728	chr1:26598281	CD52	chr1:26644411-26647013:+	0.21	4.28	4.51E-5	Obesity-related traits	
THYM	cis	1	rs10908498	chr1:156278175	CCT3	chr1:156278752-156308195:-	-0.18	-4.17	6.84E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THYM	cis	1	rs10908499	chr1:156279176	CCT3	chr1:156278752-156308195:-	-0.18	-4.17	6.84E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THYM	cis	1	rs10908500	chr1:156280671	CCT3	chr1:156278752-156308195:-	-0.18	-4.17	6.84E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THYM	cis	1	rs10916199	chr1:227902472	DUSP5P	chr1:228780657-228788159:+	-0.61	-4.7	8.8E-6	Height	
THYM	cis	1	rs10935120	chr3:134233092	ANAPC13	chr3:134196547-134204865:-	-0.56	-7.61	1.94E-11	Height	
THYM	cis	1	rs10935120	chr3:134233092	CEP63	chr3:134204575-134293852:+	-0.41	-6	3.54E-8	Height	
THYM	cis	1	rs10937158	chr3:183708439	ABCC5	chr3:183637726-183735727:-	0.48	4.28	4.53E-5	Anterior chamber depth	
THYM	cis	1	rs10944161	chr6:86630376	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs10944163	chr6:86658693	SNHG5	chr6:86386726-86388451:-	-0.61	-7.35	6.78E-11	Response to antipsychotic treatment	
THYM	cis	1	rs10944169	chr6:86683036	SNHG5	chr6:86386726-86388451:-	-0.58	-7.1	2.24E-10	Response to antipsychotic treatment	
THYM	cis	1	rs10944170	chr6:86685469	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs10946198	chr6:167404432	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs10946199	chr6:167404492	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs10950032	chr7:65738591	CCT6P1	chr7:65216092-65228661:+	-0.64	-5.29	7.77E-7	Diabetic kidney disease	
THYM	cis	1	rs10988125	chr9:131572903	ENDOG	chr9:131580779-131584954:+	0.24	5.01	2.46E-6	Blood metabolite levels	
THYM	cis	1	rs10988214	chr9:131883752	CRAT	chr9:131857075-131873070:-	0.38	4.61	1.24E-5	Blood metabolite ratios	
THYM	cis	1	rs10988223	chr9:131903021	CRAT	chr9:131857075-131873070:-	0.42	4.98	2.82E-6	Blood metabolite ratios	
THYM	cis	1	rs10988224	chr9:131903334	CRAT	chr9:131857075-131873070:-	0.38	4.64	1.12E-5	Blood metabolite ratios	
THYM	cis	1	rs10988232	chr9:131915348	CRAT	chr9:131857075-131873070:-	0.38	4.61	1.24E-5	Blood metabolite ratios	
THYM	cis	1	rs1106369	chr12:131300095	STX2	chr12:131274149-131323811:-	0.35	5.89	5.79E-8	Plasma plasminogen activator levels	
THYM	cis	1	rs1107328	chr9:131917534	CRAT	chr9:131857075-131873070:-	-0.47	-5.4	4.92E-7	Blood metabolite ratios	
THYM	cis	1	rs11079508	chr17:61750066	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.41	2.72E-5	Body mass index	
THYM	cis	1	rs1109227	chr3:48479207	TREX1	chr3:48501186-48509043:+	-0.28	-4.23	5.28E-5	Longevity	
THYM	cis	1	rs11119885	chr1:212400998	NEK2	chr1:211836115-211848967:-	-0.16	-4.14	7.53E-5	Intelligence (childhood)	
THYM	cis	1	rs11123170	chr2:113978940	LOC654433	chr2:113993107-114024579:+	-0.87	-6.86	6.85E-10	Renal function-related traits (BUN)	
THYM	cis	1	rs11123170	chr2:113978940	PAX8	chr2:113973575-114036498:-	-0.8	-6.93	5.01E-10	Renal function-related traits (BUN)	
THYM	cis	1	rs11124575	chr2:37500435	CEBPZ	chr2:37428778-37458740:-	-0.42	-4.15	7.35E-5	Chronic lymphocytic leukemia	
THYM	cis	1	rs11130170	chr3:48449897	TREX1	chr3:48501186-48509043:+	-0.29	-4.43	2.49E-5	Longevity	
THYM	cis	1	rs11130171	chr3:48462461	TREX1	chr3:48501186-48509043:+	-0.29	-4.26	4.8E-5	Longevity	
THYM	cis	1	rs11130338	chr3:53120924	RFT1	chr3:53122503-53164470:-	-0.44	-4.99	2.68E-6	Height	
THYM	cis	1	rs111315781	chr2:201738724	CFLAR	chr2:201980816-202029001:+	-0.38	-4.55	1.59E-5	Triptolide cytotoxicity	
THYM	cis	1	rs111315781	chr2:201738724	PPIL3	chr2:201735680-201753999:-	-0.94	-8.25	9.01E-13	Triptolide cytotoxicity	
THYM	cis	1	rs11132254	chr4:185611592	CCDC111	chr4:185570767-185616112:+	0.33	4.2	6.0E-5	Kawasaki disease	
THYM	cis	1	rs11132254	chr4:185611592	MLF1IP	chr4:185615220-185655286:-	-0.34	-7.71	1.2E-11	Kawasaki disease	
THYM	cis	1	rs111344533	chr16:4654144	NMRAL1	chr16:4511696-4526307:-	-0.5	-5.61	1.96E-7	Obesity-related traits	
THYM	cis	1	rs11137463	chr9:91556822	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs1114380	chr2:73804708	ALMS1P	chr2:73872046-73912692:+	0.59	4.53	1.69E-5	Metabolite levels	
THYM	cis	1	rs11148252	chr13:53009048	CKAP2	chr13:53029495-53050763:+	-0.35	-5.4	4.97E-7	Lewy body disease	
THYM	cis	1	rs11156875	chr14:35619816	KIAA0391	chr14:35591776-35786673:+	0.31	4.16	7.09E-5	Atopic dermatitis	
THYM	cis	1	rs11156875	chr14:35619816	PPP2R3C	chr14:35554679-35591679:-	0.25	4.71	8.36E-6	Atopic dermatitis	
THYM	cis	1	rs11157696	chr14:50105746	RPL36AL	chr14:50085407-50087349:-	-0.26	-4.26	4.89E-5	Carotid intima media thickness	
THYM	cis	1	rs11159067	chr14:74637444	LIN52	chr14:74551656-74667117:+	0.39	7.16	1.73E-10	Common traits (Other)	
THYM	cis	1	rs11161511	chr1:76210477	ACADM	chr1:76190043-76229353:+	-0.3	-4.16	6.9E-5	Blood metabolite levels;Acylcarnitine levels	
THYM	cis	1	rs11170680	chr12:54161378	COPZ1	chr12:54718911-54745633:+	-0.3	-4.8	5.87E-6	Tanning	
THYM	cis	1	rs11170681	chr12:54165013	COPZ1	chr12:54718911-54745633:+	-0.3	-4.74	7.49E-6	Tanning	
THYM	cis	1	rs11171803	chr12:56718422	RPS26	chr12:56435686-56438005:+	-0.83	-4.32	3.91E-5	Psoriasis vulgaris	
THYM	cis	1	rs11172333	chr12:58170335	FAM119B	chr12:58166383-58176323:+	0.42	5.72	1.22E-7	Multiple sclerosis	
THYM	cis	1	rs11172333	chr12:58170335	TSFM	chr12:58176536-58191367:+	-0.29	-5.12	1.6E-6	Multiple sclerosis	
THYM	cis	1	rs11172335	chr12:58175201	FAM119B	chr12:58166383-58176323:+	0.42	5.72	1.22E-7	Multiple sclerosis	
THYM	cis	1	rs11172335	chr12:58175201	TSFM	chr12:58176536-58191367:+	-0.29	-5.12	1.6E-6	Multiple sclerosis	
THYM	cis	1	rs11172342	chr12:58187758	FAM119B	chr12:58166383-58176323:+	0.42	5.72	1.22E-7	Multiple sclerosis	
THYM	cis	1	rs11172342	chr12:58187758	TSFM	chr12:58176536-58191367:+	-0.29	-5.12	1.6E-6	Multiple sclerosis	
THYM	cis	1	rs11172343	chr12:58188157	FAM119B	chr12:58166383-58176323:+	0.42	5.72	1.22E-7	Multiple sclerosis	
THYM	cis	1	rs11172343	chr12:58188157	TSFM	chr12:58176536-58191367:+	-0.29	-5.12	1.6E-6	Multiple sclerosis	
THYM	cis	1	rs11172344	chr12:58193448	FAM119B	chr12:58166383-58176323:+	0.41	5.83	7.7E-8	Multiple sclerosis	
THYM	cis	1	rs11172344	chr12:58193448	TSFM	chr12:58176536-58191367:+	-0.28	-5.16	1.33E-6	Multiple sclerosis	
THYM	cis	1	rs11172349	chr12:58212528	FAM119B	chr12:58166383-58176323:+	0.42	5.74	1.15E-7	Multiple sclerosis	
THYM	cis	1	rs11172349	chr12:58212528	TSFM	chr12:58176536-58191367:+	-0.29	-5.08	1.9E-6	Multiple sclerosis	
THYM	cis	1	rs11172351	chr12:58213485	FAM119B	chr12:58166383-58176323:+	0.42	5.77	9.91E-8	Multiple sclerosis	
THYM	cis	1	rs11172351	chr12:58213485	TSFM	chr12:58176536-58191367:+	-0.29	-5.04	2.21E-6	Multiple sclerosis	
THYM	cis	1	rs11191419	chr10:104612335	AS3MT	chr10:104613967-104661653:+	-0.47	-6.56	2.86E-9	Schizophrenia	
THYM	cis	1	rs11191425	chr10:104625970	SFXN2	chr10:104474298-104498946:+	-0.53	-4.4	2.85E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THYM	cis	1	rs11201312	chr10:81795778	LOC219347	chr10:81805991-81838949:-	0.65	4.43	2.48E-5	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs11211132	chr1:45990516	CCDC163P	chr1:45960581-45965646:-	-0.85	-14.31	1.95E-25	Homocysteine levels	
THYM	cis	1	rs11211199	chr1:46287869	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	6.8E-8	Body mass index	
THYM	cis	1	rs11211208	chr1:46334256	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	6.8E-8	Body mass index	
THYM	cis	1	rs11211230	chr1:46406767	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs11211234	chr1:46438787	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs11211241	chr1:46452683	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs11227284	chr11:65503224	SNX32	chr11:65601410-65621170:+	0.43	4.57	1.48E-5	Systemic lupus erythematosus	
THYM	cis	1	rs11227288	chr11:65516588	SNX32	chr11:65601410-65621170:+	0.41	4.48	2.05E-5	Systemic lupus erythematosus	
THYM	cis	1	rs112293138	chr1:171714002	VAMP4	chr1:171669298-171711214:-	0.34	4.39	2.94E-5	Hippocampal atrophy	
THYM	cis	1	rs11231050	chr11:62131660	ASRGL1	chr11:62104774-62160885:+	-0.51	-5.37	5.53E-7	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs112326077	chr12:54158264	COPZ1	chr12:54718911-54745633:+	-0.3	-4.54	1.64E-5	Tanning	
THYM	cis	1	rs11239102	chr10:45009625	ZNF22	chr10:45496273-45500776:+	0.45	4.58	1.43E-5	Estradiol plasma levels (breast cancer)	
THYM	cis	1	rs11239105	chr10:45013614	ZNF22	chr10:45496273-45500776:+	0.57	5.19	1.21E-6	Estradiol plasma levels (breast cancer)	
THYM	cis	1	rs11239106	chr10:45013624	ZNF22	chr10:45496273-45500776:+	0.47	4.61	1.27E-5	Estradiol plasma levels (breast cancer)	
THYM	cis	1	rs11239111	chr10:45016980	ZNF22	chr10:45496273-45500776:+	0.47	4.63	1.16E-5	Estradiol plasma levels (breast cancer)	
THYM	cis	1	rs11239120	chr10:45034301	ZNF22	chr10:45496273-45500776:+	0.47	4.61	1.27E-5	Estradiol plasma levels (breast cancer)	
THYM	cis	1	rs11239124	chr10:45042411	ZNF22	chr10:45496273-45500776:+	0.47	4.63	1.16E-5	Estradiol plasma levels (breast cancer)	
THYM	cis	1	rs11239132	chr10:45055615	ZNF22	chr10:45496273-45500776:+	0.57	5.19	1.21E-6	Estradiol plasma levels (breast cancer)	
THYM	cis	1	rs11242	chr3:53125922	RFT1	chr3:53122503-53164470:-	0.44	4.91	3.78E-6	Height	
THYM	cis	1	rs11248009	chr4:220149	ZNF718	chr4:53272-156488:+	0.68	7.3	8.88E-11	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs11248013	chr4:311425	ZNF718	chr4:53272-156488:+	0.66	6.89	6.07E-10	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs1125203	chr3:41760895	ULK4	chr3:41288091-42003660:-	1.03	11.64	5.41E-20	Diastolic blood pressure	
THYM	cis	1	rs11265260	chr1:159700039	NHLH1	chr1:160336861-160342638:+	0.71	4.23	5.43E-5	C-reactive protein	
THYM	cis	1	rs113333037	chr17:2200106	SRR	chr17:2207248-2228553:+	-0.55	-5.52	2.92E-7	Esophageal cancer (squamous cell)	
THYM	cis	1	rs113528355	chr12:54154515	COPZ1	chr12:54718911-54745633:+	-0.29	-4.39	2.97E-5	Tanning	
THYM	cis	1	rs1138273	chr3:134261437	ANAPC13	chr3:134196547-134204865:-	0.58	8.05	2.33E-12	Height	
THYM	cis	1	rs1138273	chr3:134261437	CEP63	chr3:134204575-134293852:+	0.4	5.81	8.19E-8	Height	
THYM	cis	1	rs1141321	chr6:49412433	CENPQ	chr6:49431096-49460820:+	-0.23	-4.18	6.53E-5	Folate pathway vitamin levels	
THYM	cis	1	rs1141321	chr6:49412433	MUT	chr6:49398994-49431031:-	0.28	4.37	3.17E-5	Folate pathway vitamin levels	
THYM	cis	1	rs114200987	chr14:35586916	KIAA0391	chr14:35591776-35786673:+	0.32	4.14	7.59E-5	Atopic dermatitis	
THYM	cis	1	rs114200987	chr14:35586916	PPP2R3C	chr14:35554679-35591679:-	0.27	4.99	2.76E-6	Atopic dermatitis	
THYM	cis	1	rs1142345	chr6:18130918	NHLRC1	chr6:18120718-18122851:-	-1.1	-4.37	3.12E-5	Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines	
THYM	cis	1	rs114914341	chr16:4617621	NMRAL1	chr16:4511696-4526307:-	-0.5	-5.61	1.96E-7	Obesity-related traits	
THYM	cis	1	rs114960066	chr3:41882323	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs114976176	chr2:264621	SH3YL1	chr2:218138-264810:-	-0.38	-5.65	1.64E-7	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs11525966	chr9:91561936	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs11538349	chr7:65421871	CCT6P1	chr7:65216092-65228661:+	0.62	5.07	1.95E-6	Diabetic kidney disease	
THYM	cis	1	rs115395195	chr11:62100353	ASRGL1	chr11:62104774-62160885:+	-0.63	-6.18	1.62E-8	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs11541642	chr15:40683702	C15orf23	chr15:40674922-40686488:+	0.41	4.29	4.24E-5	Heschl's gyrus morphology	
THYM	cis	1	rs11542436	chr17:61778689	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.33	3.66E-5	Body mass index	
THYM	cis	1	rs11553746	chr2:272203	SH3YL1	chr2:218138-264810:-	-0.33	-4.86	4.59E-6	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs11577745	chr1:171720909	VAMP4	chr1:171669298-171711214:-	0.32	4.18	6.49E-5	Hippocampal atrophy	
THYM	cis	1	rs11578699	chr1:171719769	VAMP4	chr1:171669298-171711214:-	0.33	4.16	7.1E-5	Hippocampal atrophy	
THYM	cis	1	rs11579634	chr1:46466391	CCDC163P	chr1:45960581-45965646:-	0.5	6.08	2.51E-8	Body mass index	
THYM	cis	1	rs11580522	chr1:171720978	VAMP4	chr1:171669298-171711214:-	-0.34	-4.38	3.06E-5	Hippocampal atrophy	
THYM	cis	1	rs1158282	chr14:76172916	TTLL5	chr14:76127621-76421421:+	0.36	4.96	3.04E-6	Large artery stroke	
THYM	cis	1	rs11589562	chr1:46466721	CCDC163P	chr1:45960581-45965646:-	0.49	5.84	7.3E-8	Body mass index	
THYM	cis	1	rs11590714	chr1:171716779	VAMP4	chr1:171669298-171711214:-	0.35	4.43	2.48E-5	Hippocampal atrophy	
THYM	cis	1	rs11628710	chr14:74649280	LIN52	chr14:74551656-74667117:+	0.39	7.16	1.73E-10	Common traits (Other)	
THYM	cis	1	rs11651264	chr17:79576394	TSPAN10	chr17:79609349-79615778:+	-0.63	-6.68	1.61E-9	Eye color traits	
THYM	cis	1	rs11652797	chr17:79574124	TSPAN10	chr17:79609349-79615778:+	0.63	6.68	1.61E-9	Eye color traits	
THYM	cis	1	rs116551361	chr6:24483512	ALDH5A1	chr6:24495197-24537434:+	0.33	4.16	7.04E-5	Hematological and biochemical traits	
THYM	cis	1	rs116551361	chr6:24483512	GPLD1	chr6:24428405-24489850:-	0.56	5.51	3.04E-7	Hematological and biochemical traits	
THYM	cis	1	rs11658329	chr17:61763031	TCAM1P	chr17:61934376-61941738:+	0.54	4.5	1.96E-5	Body mass index	
THYM	cis	1	rs11658555	chr17:18817486	FAM18B	chr17:18684582-18710026:+	0.26	4.53	1.73E-5	Pancreatic cancer	
THYM	cis	1	rs11658740	chr17:61751069	TCAM1P	chr17:61934376-61941738:+	-0.53	-4.29	4.35E-5	Body mass index	
THYM	cis	1	rs11673344	chr19:37684966	ZNF781	chr19:38158650-38183216:-	-0.38	-4.44	2.43E-5	Obesity-related traits	
THYM	cis	1	rs11674602	chr2:73723185	ALMS1P	chr2:73872046-73912692:+	0.61	4.89	4.16E-6	Metabolite levels	
THYM	cis	1	rs1167613	chr7:65487439	CCT6P1	chr7:65216092-65228661:+	0.61	5.07	1.93E-6	Diabetic kidney disease	
THYM	cis	1	rs1167827	chr7:75163169	PMS2L3	chr7:75137070-75157418:-	-0.46	-5.48	3.52E-7	Body mass index	
THYM	cis	1	rs1167827	chr7:75163169	STAG3L1	chr7:74988447-75026250:+	-0.36	-4.23	5.31E-5	Body mass index	
THYM	cis	1	rs11681497	chr2:242344333	SEPT2	chr2:242254723-242293439:+	0.45	6.11	2.15E-8	Chronic lymphocytic leukemia	
THYM	cis	1	rs11686072	chr2:227777493	RHBDD1	chr2:227700773-227861591:+	-0.31	-4.54	1.67E-5	Pulmonary function	
THYM	cis	1	rs11688129	chr2:28952581	TRMT61B	chr2:29072690-29093175:-	0.5	4.16	6.98E-5	Body mass index	
THYM	cis	1	rs11689392	chr2:73622026	ALMS1P	chr2:73872046-73912692:+	0.57	4.51	1.85E-5	Metabolite levels	
THYM	cis	1	rs11692572	chr2:227774503	RHBDD1	chr2:227700773-227861591:+	-0.31	-4.5	1.93E-5	Pulmonary function	
THYM	cis	1	rs11702374	chr21:43829758	TMPRSS3	chr21:43791996-43816200:-	0.47	4.48	2.07E-5	Type 1 diabetes	
THYM	cis	1	rs11706117	chr3:134212526	ANAPC13	chr3:134196547-134204865:-	0.59	8.13	1.58E-12	Height	
THYM	cis	1	rs11706117	chr3:134212526	CEP63	chr3:134204575-134293852:+	0.41	5.87	6.33E-8	Height	
THYM	cis	1	rs11708531	chr3:134224902	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs11708531	chr3:134224902	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs11712561	chr3:48435272	TREX1	chr3:48501186-48509043:+	-0.28	-4.31	4.04E-5	Longevity	
THYM	cis	1	rs11714406	chr3:121372513	IQCB1	chr3:121488610-121553926:-	0.48	4.4	2.85E-5	Cognitive performance	
THYM	cis	1	rs11719458	chr3:121382005	IQCB1	chr3:121488610-121553926:-	0.46	4.27	4.63E-5	Cognitive performance	
THYM	cis	1	rs11721318	chr3:121429485	IQCB1	chr3:121488610-121553926:-	0.45	4.25	5.03E-5	Cognitive performance	
THYM	cis	1	rs11722197	chr4:281707	ZNF718	chr4:53272-156488:+	0.65	7.31	8.46E-11	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs11722521	chr4:276765	ZNF718	chr4:53272-156488:+	0.65	7.31	8.46E-11	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs11723261	chr4:282499	ZNF718	chr4:53272-156488:+	0.65	7.31	8.46E-11	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs11723615	chr4:276983	ZNF718	chr4:53272-156488:+	0.65	7.31	8.46E-11	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs11723803	chr4:292369	ZNF718	chr4:53272-156488:+	0.51	6.85	7.46E-10	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs11724176	chr4:224901	ZNF718	chr4:53272-156488:+	0.68	7.3	8.88E-11	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs11724417	chr4:223352	ZNF718	chr4:53272-156488:+	0.68	7.3	8.88E-11	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs11726829	chr4:224948	ZNF718	chr4:53272-156488:+	0.54	6.17	1.69E-8	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs11729365	chr4:272524	ZNF718	chr4:53272-156488:+	0.65	7.31	8.46E-11	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs11730202	chr4:210096	ZNF718	chr4:53272-156488:+	0.68	7.3	8.88E-11	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs11737268	chr4:224452	ZNF718	chr4:53272-156488:+	0.54	6.17	1.69E-8	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs11739344	chr5:56111087	C5orf35	chr5:56205103-56213010:+	0.74	8.92	3.44E-14	Type 2 diabetes	
THYM	cis	1	rs11758849	chr6:86708262	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs11759855	chr6:86610841	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs117779516	chr12:56750872	RPS26	chr12:56435686-56438005:+	-0.92	-4.35	3.48E-5	Psoriasis vulgaris	
THYM	cis	1	rs11790735	chr9:91563536	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs117907570	chr6:86601283	SNHG5	chr6:86386726-86388451:-	-0.59	-7.85	6.36E-12	Response to antipsychotic treatment	
THYM	cis	1	rs11792354	chr9:91563592	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs11792366	chr9:91563653	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs118049526	chr11:62107508	ASRGL1	chr11:62104774-62160885:+	-0.63	-6.19	1.55E-8	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs11810993	chr1:46478793	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs11813099	chr10:17183451	CUBN	chr10:16865966-17171816:-	0.3	4.6	1.29E-5	Homocysteine levels	
THYM	cis	1	rs11856184	chr15:43919162	ADAL	chr15:43622872-43646094:+	-0.51	-4.38	3.06E-5	Tumor biomarkers	
THYM	cis	1	rs11862083	chr16:4649720	NMRAL1	chr16:4511696-4526307:-	-0.36	-4.17	6.75E-5	Obesity-related traits	
THYM	cis	1	rs11871767	chr17:61698723	TCAM1P	chr17:61934376-61941738:+	-0.51	-4.14	7.54E-5	Body mass index	
THYM	cis	1	rs11879853	chr19:23029434	ZNF492	chr19:22817126-22850472:+	0.5	5.66	1.61E-7	Bronchopulmonary dysplasia	
THYM	cis	1	rs11882144	chr19:42072602	CEACAM21	chr19:42055886-42093196:+	0.69	8.89	3.89E-14	Schizophrenia	
THYM	cis	1	rs11882498	chr19:23060012	ZNF492	chr19:22817126-22850472:+	-0.52	-5.7	1.32E-7	Bronchopulmonary dysplasia	
THYM	cis	1	rs11886530	chr2:101426084	PDCL3	chr2:101179418-101193201:+	0.51	4.17	6.67E-5	Creutzfeldt-Jakob disease (variant)	
THYM	cis	1	rs11893881	chr2:73824373	ALMS1P	chr2:73872046-73912692:+	0.61	4.95	3.2E-6	Metabolite levels	
THYM	cis	1	rs11899740	chr2:73631212	ALMS1P	chr2:73872046-73912692:+	0.66	4.79	6.16E-6	Metabolite levels	
THYM	cis	1	rs11899902	chr2:73631564	ALMS1P	chr2:73872046-73912692:+	0.62	4.72	8.01E-6	Metabolite levels	
THYM	cis	1	rs11901272	chr2:73720444	ALMS1P	chr2:73872046-73912692:+	0.58	4.75	7.12E-6	Metabolite levels	
THYM	cis	1	rs11903916	chr2:73815328	ALMS1P	chr2:73872046-73912692:+	0.58	4.7	8.77E-6	Metabolite levels	
THYM	cis	1	rs11919350	chr3:134235970	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs11919350	chr3:134235970	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs11923562	chr3:41760331	ULK4	chr3:41288091-42003660:-	0.93	8.8	6.19E-14	Diastolic blood pressure	
THYM	cis	1	rs11927068	chr3:134266321	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs11927068	chr3:134266321	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs11928499	chr3:134232350	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs11928499	chr3:134232350	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs11928580	chr3:41885722	ULK4	chr3:41288091-42003660:-	0.97	10.79	3.37E-18	Diastolic blood pressure	
THYM	cis	1	rs11962469	chr6:24482421	ALDH5A1	chr6:24495197-24537434:+	0.33	4.17	6.75E-5	Hematological and biochemical traits	
THYM	cis	1	rs11962469	chr6:24482421	GPLD1	chr6:24428405-24489850:-	0.57	5.56	2.44E-7	Hematological and biochemical traits	
THYM	cis	1	rs11964408	chr6:18145907	NHLRC1	chr6:18120718-18122851:-	1.04	4.57	1.45E-5	Thiopurine S-methyltransferase activity	
THYM	cis	1	rs11966998	chr6:18145733	NHLRC1	chr6:18120718-18122851:-	-1.04	-4.57	1.45E-5	Thiopurine S-methyltransferase activity	
THYM	cis	1	rs11967496	chr6:18145750	NHLRC1	chr6:18120718-18122851:-	-1.01	-4.34	3.6E-5	Thiopurine S-methyltransferase activity	
THYM	cis	1	rs11971779	chr7:139040258	C7orf55	chr7:139025897-139030539:+	0.21	4.35	3.44E-5	Diisocyanate-induced asthma	
THYM	cis	1	rs11976020	chr7:72247800	TYW1B	chr7:72023729-72298813:-	1.04	12.74	2.85E-22	Educational attainment (years of education)	
THYM	cis	1	rs12021587	chr1:46472759	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs1203156	chr6:88079694	C6orf164	chr6:88032306-88109459:+	-0.49	-5.01	2.47E-6	Depressive episodes in bipolar disorder	
THYM	cis	1	rs12041164	chr1:156279811	CCT3	chr1:156278752-156308195:-	-0.18	-4.17	6.84E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THYM	cis	1	rs12049588	chr1:46472422	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs12091564	chr1:145395604	NOTCH2NL	chr1:145209111-145295525:+	-0.88	-5.72	1.21E-7	Coronary heart disease	
THYM	cis	1	rs12091720	chr1:76186949	ACADM	chr1:76190043-76229353:+	0.3	4.24	5.21E-5	Blood metabolite levels;Acylcarnitine levels	
THYM	cis	1	rs12120182	chr1:227814332	DUSP5P	chr1:228780657-228788159:+	-0.81	-5.13	1.51E-6	Height	
THYM	cis	1	rs12123977	chr1:76209754	ACADM	chr1:76190043-76229353:+	-0.36	-4.56	1.53E-5	Blood metabolite levels;Acylcarnitine levels	
THYM	cis	1	rs12126607	chr1:76217097	ACADM	chr1:76190043-76229353:+	0.3	4.24	5.21E-5	Blood metabolite levels;Acylcarnitine levels	
THYM	cis	1	rs12127402	chr1:76205643	ACADM	chr1:76190043-76229353:+	0.3	4.24	5.21E-5	Blood metabolite levels;Acylcarnitine levels	
THYM	cis	1	rs12132794	chr1:156281020	CCT3	chr1:156278752-156308195:-	0.18	4.28	4.4E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THYM	cis	1	rs12139630	chr1:46350935	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	7.1E-8	Body mass index	
THYM	cis	1	rs12144263	chr1:46352446	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	7.1E-8	Body mass index	
THYM	cis	1	rs12154056	chr6:86634094	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12185102	chr15:75352201	PPCDC	chr15:75315927-75343066:+	0.27	4.81	5.68E-6	Blood trace element (Zn levels)	
THYM	cis	1	rs12190598	chr6:86686074	SNHG5	chr6:86386726-86388451:-	-0.57	-6.83	7.85E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12190604	chr6:86716215	SNHG5	chr6:86386726-86388451:-	-0.58	-6.9	5.71E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12192992	chr6:86609915	SNHG5	chr6:86386726-86388451:-	-0.57	-6.96	4.28E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12196037	chr6:86694631	SNHG5	chr6:86386726-86388451:-	-0.61	-7.35	6.78E-11	Response to antipsychotic treatment	
THYM	cis	1	rs12196411	chr6:86779762	SNHG5	chr6:86386726-86388451:-	-0.63	-7.57	2.43E-11	Response to antipsychotic treatment	
THYM	cis	1	rs12196937	chr6:49382808	CENPQ	chr6:49431096-49460820:+	-0.24	-4.37	3.16E-5	Folate pathway vitamin levels	
THYM	cis	1	rs12196937	chr6:49382808	MUT	chr6:49398994-49431031:-	0.27	4.32	3.89E-5	Folate pathway vitamin levels	
THYM	cis	1	rs12197114	chr6:109735498	MICAL1	chr6:109765268-109787171:-	-0.17	-4.41	2.69E-5	Height	
THYM	cis	1	rs12199516	chr6:86726221	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12199784	chr6:86726808	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12200330	chr6:86656653	SNHG5	chr6:86386726-86388451:-	-0.57	-6.96	4.28E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12201571	chr6:86609750	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12201735	chr6:86656939	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12201741	chr6:86602619	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12201880	chr6:86627007	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12202075	chr6:49427655	CENPQ	chr6:49431096-49460820:+	-0.25	-4.33	3.64E-5	Folate pathway vitamin levels	
THYM	cis	1	rs12202075	chr6:49427655	MUT	chr6:49398994-49431031:-	0.28	4.21	5.84E-5	Folate pathway vitamin levels	
THYM	cis	1	rs12203493	chr6:86758642	SNHG5	chr6:86386726-86388451:-	-0.59	-7.17	1.63E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12203924	chr6:86776412	SNHG5	chr6:86386726-86388451:-	-0.59	-7.17	1.63E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12204015	chr6:86598334	SNHG5	chr6:86386726-86388451:-	-0.57	-7.62	1.9E-11	Response to antipsychotic treatment	
THYM	cis	1	rs12204365	chr6:86700532	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12205336	chr6:86722367	SNHG5	chr6:86386726-86388451:-	-0.57	-6.96	4.28E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12205548	chr6:86759770	SNHG5	chr6:86386726-86388451:-	-0.62	-7.46	4.09E-11	Response to antipsychotic treatment	
THYM	cis	1	rs12207305	chr6:86723502	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12207610	chr6:86688016	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12208493	chr6:86662267	SNHG5	chr6:86386726-86388451:-	-0.57	-6.96	4.28E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12209127	chr6:86724427	SNHG5	chr6:86386726-86388451:-	-0.57	-6.96	4.28E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12212733	chr6:86726013	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12213149	chr6:86668644	SNHG5	chr6:86386726-86388451:-	-0.57	-6.96	4.28E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12213740	chr6:86656733	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12215037	chr6:86727631	SNHG5	chr6:86386726-86388451:-	-0.6	-7.24	1.15E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12215903	chr6:86675028	SNHG5	chr6:86386726-86388451:-	-0.57	-6.7	1.49E-9	Response to antipsychotic treatment	
THYM	cis	1	rs12216203	chr6:86675301	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12216328	chr6:86703418	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12279819	chr11:62137245	ASRGL1	chr11:62104774-62160885:+	-0.55	-5.39	5.18E-7	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs12287832	chr11:65553492	SNX32	chr11:65601410-65621170:+	0.56	5.74	1.12E-7	Systemic lupus erythematosus	
THYM	cis	1	rs12309485	chr12:54162461	COPZ1	chr12:54718911-54745633:+	-0.29	-4.68	9.47E-6	Tanning	
THYM	cis	1	rs12325866	chr17:61755974	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.41	2.72E-5	Body mass index	
THYM	cis	1	rs12359952	chr10:45032962	ZNF22	chr10:45496273-45500776:+	0.47	4.63	1.16E-5	Estradiol plasma levels (breast cancer)	
THYM	cis	1	rs12402397	chr1:212395944	NEK2	chr1:211836115-211848967:-	-0.17	-4.33	3.71E-5	Intelligence (childhood)	
THYM	cis	1	rs12405451	chr1:46384326	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs12409773	chr1:46358831	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	7.1E-8	Body mass index	
THYM	cis	1	rs12410071	chr1:46358886	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.84	7.39E-8	Body mass index	
THYM	cis	1	rs12411269	chr1:46271052	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	6.8E-8	Body mass index	
THYM	cis	1	rs12416687	chr10:104629011	AS3MT	chr10:104613967-104661653:+	-0.4	-4.38	3.11E-5	Arsenic metabolism	
THYM	cis	1	rs12473740	chr2:88527647	THNSL2	chr2:88469835-88486145:+	-0.5	-4.18	6.38E-5	Plasma clusterin levels	
THYM	cis	1	rs12487542	chr3:48426076	TREX1	chr3:48501186-48509043:+	-0.28	-4.38	3.02E-5	Longevity	
THYM	cis	1	rs12488768	chr3:53086234	ITIH4	chr3:52847007-52866554:-	0.27	4.18	6.51E-5	Ulcerative colitis	
THYM	cis	1	rs12490835	chr3:134223730	ANAPC13	chr3:134196547-134204865:-	0.58	8.05	2.33E-12	Height	
THYM	cis	1	rs12490835	chr3:134223730	CEP63	chr3:134204575-134293852:+	0.4	5.81	8.19E-8	Height	
THYM	cis	1	rs12505835	chr4:297525	ZNF718	chr4:53272-156488:+	0.63	6.87	6.5E-10	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs12561806	chr1:46396776	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs12564541	chr1:46380237	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs12577464	chr11:43662440	HSD17B12	chr11:43702143-43878160:+	-0.58	-5.99	3.71E-8	Forced vital capacity	
THYM	cis	1	rs12600855	chr17:28279591	EFCAB5	chr17:28256874-28435469:+	0.31	4.26	4.79E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs12600993	chr17:28291222	EFCAB5	chr17:28256874-28435469:+	0.31	4.26	4.79E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs12615988	chr2:227769000	RHBDD1	chr2:227700773-227861591:+	-0.31	-4.56	1.54E-5	Pulmonary function	
THYM	cis	1	rs12637751	chr3:134266124	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs12637751	chr3:134266124	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs12639255	chr3:41861738	ULK4	chr3:41288091-42003660:-	1	10.81	3.16E-18	Diastolic blood pressure	
THYM	cis	1	rs12661204	chr6:86678586	SNHG5	chr6:86386726-86388451:-	-0.61	-7.35	6.78E-11	Response to antipsychotic treatment	
THYM	cis	1	rs12663651	chr6:86701655	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12663690	chr6:86640162	SNHG5	chr6:86386726-86388451:-	0.57	6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs12664335	chr6:86597774	SNHG5	chr6:86386726-86388451:-	0.56	6.66	1.79E-9	Response to antipsychotic treatment	
THYM	cis	1	rs12665321	chr6:86769289	SNHG5	chr6:86386726-86388451:-	-0.62	-7.46	4.09E-11	Response to antipsychotic treatment	
THYM	cis	1	rs1267817	chr7:66110040	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Gout	
THYM	cis	1	rs1267818	chr7:66107024	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Gout	
THYM	cis	1	rs1267820	chr7:66050295	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Diabetic kidney disease	
THYM	cis	1	rs12698509	chr7:65418876	CCT6P1	chr7:65216092-65228661:+	0.62	5.13	1.51E-6	Diabetic kidney disease	
THYM	cis	1	rs1275538	chr2:27441397	KCNK3	chr2:26915581-26954066:+	-0.51	-4.44	2.45E-5	Blood metabolite levels	
THYM	cis	1	rs12760175	chr1:46447840	CCDC163P	chr1:45960581-45965646:-	-0.46	-5.37	5.48E-7	Body mass index	
THYM	cis	1	rs12771477	chr10:17209464	CUBN	chr10:16865966-17171816:-	0.31	4.8	5.85E-6	Homocysteine levels	
THYM	cis	1	rs12772275	chr10:17204542	CUBN	chr10:16865966-17171816:-	0.3	4.68	9.61E-6	Homocysteine levels	
THYM	cis	1	rs12773642	chr10:17196055	CUBN	chr10:16865966-17171816:-	0.31	4.8	5.85E-6	Homocysteine levels	
THYM	cis	1	rs12780845	chr10:17223244	CUBN	chr10:16865966-17171816:-	0.32	5.02	2.41E-6	Homocysteine levels	
THYM	cis	1	rs12782687	chr10:17223368	CUBN	chr10:16865966-17171816:-	0.32	5.06	2.02E-6	Homocysteine levels	
THYM	cis	1	rs12783490	chr10:17223716	CUBN	chr10:16865966-17171816:-	0.32	4.95	3.16E-6	Homocysteine levels	
THYM	cis	1	rs12806	chr10:101911142	BLOC1S2	chr10:102033713-102046439:-	-0.49	-5.32	6.95E-7	Schizophrenia	
THYM	cis	1	rs12898259	chr15:75369780	PPCDC	chr15:75315927-75343066:+	0.26	4.7	8.93E-6	Blood trace element (Zn levels)	
THYM	cis	1	rs12901243	chr15:75374233	PPCDC	chr15:75315927-75343066:+	0.26	4.7	8.93E-6	Blood trace element (Zn levels)	
THYM	cis	1	rs12903201	chr15:75370776	PPCDC	chr15:75315927-75343066:+	0.26	4.7	8.93E-6	Blood trace element (Zn levels)	
THYM	cis	1	rs12910992	chr15:90372465	AP3S2	chr15:90373832-90456222:-	-0.42	-4.68	9.6E-6	Type 2 diabetes	
THYM	cis	1	rs12948099	chr17:79600799	TSPAN10	chr17:79609349-79615778:+	0.63	6.54	3.14E-9	Eye color traits	
THYM	cis	1	rs12980225	chr19:23026745	ZNF492	chr19:22817126-22850472:+	-0.5	-5.66	1.61E-7	Bronchopulmonary dysplasia	
THYM	cis	1	rs12983770	chr19:23023614	ZNF492	chr19:22817126-22850472:+	-0.5	-5.66	1.61E-7	Bronchopulmonary dysplasia	
THYM	cis	1	rs1299548	chr7:7302293	C1GALT1	chr7:7222246-7283979:+	-0.29	-4.17	6.79E-5	Visceral adipose tissue adjusted for BMI	
THYM	cis	1	rs13003464	chr2:61186829	C2orf74	chr2:61372243-61391964:+	0.39	4.35	3.4E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THYM	cis	1	rs13026475	chr2:239178455	LOC151174	chr2:239133754-239140318:-	0.93	4.57	1.47E-5	Irritable bowel syndrome	
THYM	cis	1	rs13033501	chr2:239181860	LOC151174	chr2:239133754-239140318:-	0.89	4.51	1.84E-5	Irritable bowel syndrome	
THYM	cis	1	rs13038305	chr20:23610262	CST9	chr20:23583049-23586610:-	-0.51	-4.73	7.71E-6	Chronic kidney disease	
THYM	cis	1	rs13039536	chr20:23612305	CST9	chr20:23583049-23586610:-	-0.51	-4.71	8.44E-6	Chronic kidney disease	
THYM	cis	1	rs13041070	chr20:23614261	CST9	chr20:23583049-23586610:-	-0.51	-4.71	8.44E-6	Chronic kidney disease	
THYM	cis	1	rs13059720	chr3:134242021	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs13059720	chr3:134242021	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs13069724	chr3:48478039	TREX1	chr3:48501186-48509043:+	-0.28	-4.14	7.54E-5	Longevity	
THYM	cis	1	rs13071337	chr3:48438189	TREX1	chr3:48501186-48509043:+	-0.28	-4.38	3.02E-5	Longevity	
THYM	cis	1	rs13071551	chr3:134310867	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.1	1.9E-12	Height	
THYM	cis	1	rs13071551	chr3:134310867	CEP63	chr3:134204575-134293852:+	-0.41	-5.93	4.96E-8	Height	
THYM	cis	1	rs13073838	chr3:74627703	CNTN3	chr3:74311722-74570343:-	0.47	4.82	5.5E-6	Economic and political preferences	
THYM	cis	1	rs13076033	chr3:52898427	ITIH4	chr3:52847007-52866554:-	-0.52	-4.62	1.21E-5	Immune reponse to smallpox (secreted IL-2)	
THYM	cis	1	rs13076076	chr3:48479039	TREX1	chr3:48501186-48509043:+	-0.29	-4.26	4.8E-5	Longevity	
THYM	cis	1	rs13081177	chr3:134289860	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs13081177	chr3:134289860	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs13081688	chr3:134259954	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs13081688	chr3:134259954	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs13083794	chr3:121464928	IQCB1	chr3:121488610-121553926:-	0.45	4.25	5.03E-5	Cognitive performance	
THYM	cis	1	rs13087578	chr3:121369207	IQCB1	chr3:121488610-121553926:-	0.48	4.39	2.98E-5	Cognitive performance	
THYM	cis	1	rs13087719	chr3:41951576	ULK4	chr3:41288091-42003660:-	-1.02	-11.47	1.23E-19	Diastolic blood pressure	
THYM	cis	1	rs13087875	chr3:134261123	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs13087875	chr3:134261123	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs13088455	chr3:53087482	ITIH4	chr3:52847007-52866554:-	0.27	4.18	6.51E-5	Ulcerative colitis	
THYM	cis	1	rs13089966	chr3:134279197	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs13089966	chr3:134279197	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs13090969	chr3:134307257	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.1	1.9E-12	Height	
THYM	cis	1	rs13090969	chr3:134307257	CEP63	chr3:134204575-134293852:+	-0.41	-5.93	4.96E-8	Height	
THYM	cis	1	rs13091785	chr3:48494098	TREX1	chr3:48501186-48509043:+	-0.28	-4.22	5.51E-5	Longevity	
THYM	cis	1	rs13096604	chr3:134250099	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs13096604	chr3:134250099	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs13168670	chr5:140146899	WDR55	chr5:140044384-140050551:+	-0.35	-4.23	5.34E-5	Schizophrenia	
THYM	cis	1	rs13194429	chr6:86646705	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs13196930	chr6:86652245	SNHG5	chr6:86386726-86388451:-	-0.6	-7.24	1.15E-10	Response to antipsychotic treatment	
THYM	cis	1	rs13199006	chr6:86608708	SNHG5	chr6:86386726-86388451:-	-0.57	-7.62	1.9E-11	Response to antipsychotic treatment	
THYM	cis	1	rs13217384	chr6:86720000	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs13220979	chr7:65363204	CCT6P1	chr7:65216092-65228661:+	0.64	4.78	6.3E-6	Diabetic kidney disease	
THYM	cis	1	rs13235972	chr7:65883605	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Diabetic kidney disease	
THYM	cis	1	rs13237037	chr7:65997882	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Diabetic kidney disease	
THYM	cis	1	rs13247184	chr7:65358928	CCT6P1	chr7:65216092-65228661:+	0.68	5.01	2.55E-6	Diabetic kidney disease	
THYM	cis	1	rs1325195	chr1:179071756	ABL2	chr1:179068463-179198819:-	-0.32	-4.23	5.44E-5	IgE grass sensitization	
THYM	cis	1	rs13252719	chr8:71734569	XKR9	chr8:71581600-71648176:+	0.84	10.7	5.33E-18	Bone mineral density	
THYM	cis	1	rs13253842	chr8:71625503	XKR9	chr8:71581600-71648176:+	0.84	10.55	1.11E-17	Bone mineral density	
THYM	cis	1	rs13262685	chr8:120226145	MAL2	chr8:120220610-120257911:+	0.42	4.42	2.6E-5	Hippocampal atrophy	
THYM	cis	1	rs13310597	chr7:65598540	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs13314659	chr3:48449149	TREX1	chr3:48501186-48509043:+	0.29	4.43	2.49E-5	Longevity	
THYM	cis	1	rs13322305	chr3:134310791	ANAPC13	chr3:134196547-134204865:-	0.55	7.48	3.7E-11	Height	
THYM	cis	1	rs13322305	chr3:134310791	CEP63	chr3:134204575-134293852:+	0.43	6.36	7.09E-9	Height	
THYM	cis	1	rs13325965	chr3:41914942	ULK4	chr3:41288091-42003660:-	0.95	9.28	5.58E-15	Diastolic blood pressure	
THYM	cis	1	rs13335998	chr16:4651921	NMRAL1	chr16:4511696-4526307:-	-0.5	-5.61	1.96E-7	Obesity-related traits	
THYM	cis	1	rs1337844	chr6:86677273	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs1337850	chr6:86729103	SNHG5	chr6:86386726-86388451:-	-0.57	-6.96	4.28E-10	Response to antipsychotic treatment	
THYM	cis	1	rs13380863	chr17:61780793	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.13	7.81E-5	Body mass index	
THYM	cis	1	rs13383871	chr2:73631779	ALMS1P	chr2:73872046-73912692:+	0.63	4.58	1.4E-5	Metabolite levels	
THYM	cis	1	rs13385191	chr2:20888265	C2orf43	chr2:20883803-21022827:-	-0.63	-7.64	1.72E-11	Prostate cancer	
THYM	cis	1	rs13398956	chr2:73720258	ALMS1P	chr2:73872046-73912692:+	0.59	4.59	1.34E-5	Metabolite levels	
THYM	cis	1	rs13421462	chr2:73719875	ALMS1P	chr2:73872046-73912692:+	0.62	4.72	8.24E-6	Metabolite levels	
THYM	cis	1	rs13428235	chr2:73633430	ALMS1P	chr2:73872046-73912692:+	0.62	4.72	8.01E-6	Metabolite levels	
THYM	cis	1	rs13431267	chr2:73782200	ALMS1P	chr2:73872046-73912692:+	0.59	4.53	1.69E-5	Metabolite levels	
THYM	cis	1	rs13432605	chr2:73810981	ALMS1P	chr2:73872046-73912692:+	0.59	4.56	1.53E-5	Metabolite levels	
THYM	cis	1	rs1346618	chr2:227771988	RHBDD1	chr2:227700773-227861591:+	0.31	4.56	1.54E-5	Pulmonary function	
THYM	cis	1	rs134869	chr22:42652074	CYP2D6	chr22:42522502-42526883:-	-0.69	-7.37	6.15E-11	Cognitive function	
THYM	cis	1	rs134873	chr22:42657566	CYP2D6	chr22:42522502-42526883:-	-0.68	-7.31	8.39E-11	Cognitive function	
THYM	cis	1	rs134882	chr22:42670965	CYP2D6	chr22:42522502-42526883:-	-0.71	-7.7	1.28E-11	Cognitive function	
THYM	cis	1	rs134900	chr22:42683343	CYP2D6	chr22:42522502-42526883:-	-0.68	-7.23	1.2E-10	Cognitive function	
THYM	cis	1	rs134902	chr22:42683997	CYP2D6	chr22:42522502-42526883:-	-0.67	-7.14	1.89E-10	Cognitive function	
THYM	cis	1	rs1357762	chr3:134264859	ANAPC13	chr3:134196547-134204865:-	0.56	7.61	1.94E-11	Height	
THYM	cis	1	rs1357762	chr3:134264859	CEP63	chr3:134204575-134293852:+	0.41	6	3.54E-8	Height	
THYM	cis	1	rs1360172	chr9:131907980	CRAT	chr9:131857075-131873070:-	0.38	4.61	1.24E-5	Blood metabolite ratios	
THYM	cis	1	rs1371135	chr15:90391270	AP3S2	chr15:90373832-90456222:-	-0.39	-4.48	2.08E-5	Type 2 diabetes	
THYM	cis	1	rs1389369	chr1:212400536	NEK2	chr1:211836115-211848967:-	-0.17	-4.53	1.74E-5	Intelligence (childhood)	
THYM	cis	1	rs1389370	chr1:212400617	NEK2	chr1:211836115-211848967:-	-0.17	-4.53	1.74E-5	Intelligence (childhood)	
THYM	cis	1	rs1392104	chr7:65759107	CCT6P1	chr7:65216092-65228661:+	-0.64	-5.29	7.77E-7	Diabetic kidney disease	
THYM	cis	1	rs1400321	chr2:112670046	MERTK	chr2:112656191-112786945:+	0.25	4.15	7.36E-5	Multiple sclerosis	
THYM	cis	1	rs1402003	chr3:183642879	ABCC5	chr3:183637726-183735727:-	0.48	4.21	5.7E-5	Anterior chamber depth	
THYM	cis	1	rs1403284	chr2:73726662	ALMS1P	chr2:73872046-73912692:+	-0.62	-4.41	2.71E-5	Metabolite levels	
THYM	cis	1	rs1404147	chr7:65264524	CCT6P1	chr7:65216092-65228661:+	0.7	5.35	6.04E-7	Diabetic kidney disease	
THYM	cis	1	rs1406384	chr11:62083530	ASRGL1	chr11:62104774-62160885:+	-0.56	-5.68	1.44E-7	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs1415753	chr6:86753074	SNHG5	chr6:86386726-86388451:-	-0.59	-7.1	2.21E-10	Response to antipsychotic treatment	
THYM	cis	1	rs1423620	chr5:56100996	C5orf35	chr5:56205103-56213010:+	0.74	9.25	6.53E-15	Type 2 diabetes	
THYM	cis	1	rs1423621	chr5:56101035	C5orf35	chr5:56205103-56213010:+	0.74	9.25	6.53E-15	Type 2 diabetes	
THYM	cis	1	rs1435509	chr2:101419792	PDCL3	chr2:101179418-101193201:+	0.55	4.47	2.15E-5	Creutzfeldt-Jakob disease (variant)	
THYM	cis	1	rs1451374	chr7:50622653	FIGNL1	chr7:50511834-50518088:-	-0.3	-4.64	1.09E-5	Malaria	
THYM	cis	1	rs1451375	chr7:50622712	FIGNL1	chr7:50511834-50518088:-	0.3	4.64	1.09E-5	Malaria	
THYM	cis	1	rs1451707	chr6:56801877	BEND6	chr6:56819773-56892138:+	-0.49	-4.54	1.66E-5	Menarche (age at onset)	
THYM	cis	1	rs1451708	chr6:56802201	BEND6	chr6:56819773-56892138:+	-0.49	-4.54	1.66E-5	Menarche (age at onset)	
THYM	cis	1	rs1459242	chr3:48413537	TREX1	chr3:48501186-48509043:+	0.28	4.42	2.61E-5	Longevity	
THYM	cis	1	rs1466389	chr17:2096384	SRR	chr17:2207248-2228553:+	-0.48	-5.18	1.22E-6	Esophageal cancer (squamous cell)	
THYM	cis	1	rs1498312	chr1:76177849	ACADM	chr1:76190043-76229353:+	0.3	4.24	5.21E-5	Blood metabolite levels;Acylcarnitine levels	
THYM	cis	1	rs1498315	chr1:76159225	ACADM	chr1:76190043-76229353:+	0.3	4.24	5.21E-5	Blood metabolite levels;Acylcarnitine levels	
THYM	cis	1	rs1498718	chr3:134205920	ANAPC13	chr3:134196547-134204865:-	0.57	7.72	1.16E-11	Height	
THYM	cis	1	rs1498718	chr3:134205920	CEP63	chr3:134204575-134293852:+	0.41	5.95	4.4E-8	Height	
THYM	cis	1	rs1499613	chr7:65730860	CCT6P1	chr7:65216092-65228661:+	-0.64	-5.29	7.77E-7	Diabetic kidney disease	
THYM	cis	1	rs1499614	chr7:65730798	CCT6P1	chr7:65216092-65228661:+	0.64	5.29	7.77E-7	Diabetic kidney disease	
THYM	cis	1	rs1502696	chr9:91545220	C9orf47	chr9:91605778-91611055:+	-0.26	-4.7	8.7E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs1502697	chr9:91545316	C9orf47	chr9:91605778-91611055:+	-0.26	-4.7	8.7E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs1534025	chr3:134313304	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.1	1.9E-12	Height	
THYM	cis	1	rs1534025	chr3:134313304	CEP63	chr3:134204575-134293852:+	-0.41	-5.93	4.96E-8	Height	
THYM	cis	1	rs1534026	chr3:134284767	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs1534026	chr3:134284767	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs1534471	chr2:73647508	ALMS1P	chr2:73872046-73912692:+	0.58	4.7	8.77E-6	Metabolite levels	
THYM	cis	1	rs1535500	chr6:39284050	KCNK17	chr6:39266778-39282237:-	-0.47	-4.8	6.01E-6	Type 2 diabetes	
THYM	cis	1	rs1546059	chr7:65654709	CCT6P1	chr7:65216092-65228661:+	-0.67	-5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs1553174	chr7:65731194	CCT6P1	chr7:65216092-65228661:+	-0.64	-5.29	7.77E-7	Diabetic kidney disease	
THYM	cis	1	rs1555569	chr17:2149425	SRR	chr17:2207248-2228553:+	-0.55	-5.8	8.62E-8	Esophageal cancer (squamous cell)	
THYM	cis	1	rs1559282	chr5:56099375	C5orf35	chr5:56205103-56213010:+	0.74	9.25	6.53E-15	Type 2 diabetes	
THYM	cis	1	rs1563736	chr3:48436794	TREX1	chr3:48501186-48509043:+	-0.28	-4.38	3.02E-5	Longevity	
THYM	cis	1	rs15637	chr17:61772050	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.47	2.2E-5	Body mass index	
THYM	cis	1	rs1564716	chr3:41862613	ULK4	chr3:41288091-42003660:-	1	10.81	3.16E-18	Diastolic blood pressure	
THYM	cis	1	rs15676	chr9:131572027	ENDOG	chr9:131580779-131584954:+	-0.24	-4.96	3.05E-6	Blood metabolite levels	
THYM	cis	1	rs1571229	chr9:131913711	CRAT	chr9:131857075-131873070:-	0.38	4.61	1.24E-5	Blood metabolite ratios	
THYM	cis	1	rs1577917	chr6:86691940	SNHG5	chr6:86386726-86388451:-	-0.61	-7.35	6.78E-11	Response to antipsychotic treatment	
THYM	cis	1	rs1577919	chr6:86757296	SNHG5	chr6:86386726-86388451:-	-0.59	-7.1	2.21E-10	Response to antipsychotic treatment	
THYM	cis	1	rs1599932	chr12:58177943	FAM119B	chr12:58166383-58176323:+	0.42	5.72	1.22E-7	Multiple sclerosis	
THYM	cis	1	rs1599932	chr12:58177943	TSFM	chr12:58176536-58191367:+	-0.29	-5.12	1.6E-6	Multiple sclerosis	
THYM	cis	1	rs160633	chr7:65528228	CCT6P1	chr7:65216092-65228661:+	0.65	5.41	4.64E-7	Diabetic kidney disease	
THYM	cis	1	rs160634	chr7:65528664	CCT6P1	chr7:65216092-65228661:+	-0.64	-5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs160637	chr7:65584318	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs160639	chr7:65579987	CCT6P1	chr7:65216092-65228661:+	0.63	5.27	8.65E-7	Diabetic kidney disease	
THYM	cis	1	rs160642	chr7:65558373	CCT6P1	chr7:65216092-65228661:+	0.65	5.41	4.64E-7	Diabetic kidney disease	
THYM	cis	1	rs160643	chr7:65558222	CCT6P1	chr7:65216092-65228661:+	0.67	5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs160644	chr7:65558186	CCT6P1	chr7:65216092-65228661:+	0.65	5.41	4.64E-7	Diabetic kidney disease	
THYM	cis	1	rs160646	chr7:65556280	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.15E-7	Diabetic kidney disease	
THYM	cis	1	rs160648	chr7:65543384	CCT6P1	chr7:65216092-65228661:+	0.64	5.47	3.66E-7	Diabetic kidney disease	
THYM	cis	1	rs160652	chr7:65538431	CCT6P1	chr7:65216092-65228661:+	0.65	5.41	4.64E-7	Diabetic kidney disease	
THYM	cis	1	rs160655	chr7:65533214	CCT6P1	chr7:65216092-65228661:+	0.64	5.47	3.66E-7	Diabetic kidney disease	
THYM	cis	1	rs1607908	chr3:41905196	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs1609810	chr9:123642351	LOC253039	chr9:123605320-123616644:+	-0.62	-5.59	2.21E-7	Rheumatoid arthritis	
THYM	cis	1	rs1609985	chr12:131320170	STX2	chr12:131274149-131323811:-	0.36	6.02	3.27E-8	Plasma plasminogen activator levels	
THYM	cis	1	rs1612124	chr3:41967893	ULK4	chr3:41288091-42003660:-	-0.96	-10.38	2.59E-17	Diastolic blood pressure	
THYM	cis	1	rs1613759	chr3:41906183	ULK4	chr3:41288091-42003660:-	1	11.02	1.12E-18	Diastolic blood pressure	
THYM	cis	1	rs1615243	chr3:41965234	ULK4	chr3:41288091-42003660:-	-1.02	-11.59	6.88E-20	Diastolic blood pressure	
THYM	cis	1	rs1615543	chr3:41906404	ULK4	chr3:41288091-42003660:-	1	11.02	1.12E-18	Diastolic blood pressure	
THYM	cis	1	rs1618893	chr7:66096119	CCT6P1	chr7:65216092-65228661:+	0.59	4.84	5.03E-6	Diabetic kidney disease	
THYM	cis	1	rs1628874	chr3:41955714	ULK4	chr3:41288091-42003660:-	-1.02	-11.47	1.23E-19	Diastolic blood pressure	
THYM	cis	1	rs1629460	chr3:41927449	ULK4	chr3:41288091-42003660:-	-1	-11.02	1.12E-18	Diastolic blood pressure	
THYM	cis	1	rs1633360	chr12:58108052	TSFM	chr12:58176536-58191367:+	0.22	4.16	7.08E-5	Rheumatoid arthritis	
THYM	cis	1	rs1638731	chr7:66144679	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Gout	
THYM	cis	1	rs1638734	chr7:66097539	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Diabetic kidney disease	
THYM	cis	1	rs16876529	chr6:86591202	SNHG5	chr6:86386726-86388451:-	-0.57	-7.62	1.9E-11	Response to antipsychotic treatment	
THYM	cis	1	rs16947005	chr17:61702989	TCAM1P	chr17:61934376-61941738:+	0.54	4.54	1.65E-5	Body mass index	
THYM	cis	1	rs16947014	chr17:61719032	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.33	3.63E-5	Body mass index	
THYM	cis	1	rs16947042	chr17:61766457	TCAM1P	chr17:61934376-61941738:+	-0.52	-4.32	3.77E-5	Body mass index	
THYM	cis	1	rs16952009	chr17:2102437	SRR	chr17:2207248-2228553:+	-0.45	-4.91	3.8E-6	Esophageal cancer (squamous cell)	
THYM	cis	1	rs1701750	chr7:65467145	CCT6P1	chr7:65216092-65228661:+	0.6	4.98	2.86E-6	Diabetic kidney disease	
THYM	cis	1	rs1701758	chr7:65470201	CCT6P1	chr7:65216092-65228661:+	0.6	4.98	2.86E-6	Diabetic kidney disease	
THYM	cis	1	rs17024770	chr2:101421316	PDCL3	chr2:101179418-101193201:+	0.55	4.47	2.15E-5	Creutzfeldt-Jakob disease (variant)	
THYM	cis	1	rs17061431	chr3:41792655	ULK4	chr3:41288091-42003660:-	1	10.61	8.33E-18	Diastolic blood pressure	
THYM	cis	1	rs17062109	chr3:41810364	ULK4	chr3:41288091-42003660:-	0.99	10.93	1.72E-18	Diastolic blood pressure	
THYM	cis	1	rs17063584	chr3:41861463	ULK4	chr3:41288091-42003660:-	1	10.81	3.16E-18	Diastolic blood pressure	
THYM	cis	1	rs17063599	chr3:41861676	ULK4	chr3:41288091-42003660:-	1	10.81	3.16E-18	Diastolic blood pressure	
THYM	cis	1	rs17063649	chr3:41863406	ULK4	chr3:41288091-42003660:-	1	10.81	3.16E-18	Diastolic blood pressure	
THYM	cis	1	rs17064124	chr3:41890803	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs1707304	chr1:46598269	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.76	1.02E-7	Body mass index	
THYM	cis	1	rs1707321	chr1:46505309	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs1707335	chr1:46571921	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs1707336	chr1:46493460	CCDC163P	chr1:45960581-45965646:-	-0.48	-6.01	3.45E-8	Body mass index	
THYM	cis	1	rs1707340	chr1:46514942	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs17096228	chr14:74558669	LIN52	chr14:74551656-74667117:+	0.39	7.16	1.73E-10	Common traits (Other)	
THYM	cis	1	rs17105547	chr14:77698358	NGB	chr14:77731834-77737655:-	-0.41	-4.16	7.04E-5	Obsessive-compulsive symptoms	
THYM	cis	1	rs17118439	chr12:56667604	RPS26	chr12:56435686-56438005:+	0.79	4.16	6.91E-5	Psoriasis vulgaris	
THYM	cis	1	rs17140062	chr10:17202840	CUBN	chr10:16865966-17171816:-	0.31	4.8	5.85E-6	Homocysteine levels	
THYM	cis	1	rs17145874	chr11:62195344	ASRGL1	chr11:62104774-62160885:+	-0.29	-4.41	2.74E-5	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs1715235	chr7:65488394	CCT6P1	chr7:65216092-65228661:+	0.65	5.41	4.64E-7	Diabetic kidney disease	
THYM	cis	1	rs17164747	chr4:260587	ZNF718	chr4:53272-156488:+	0.65	7.31	8.46E-11	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs17164851	chr7:130003487	CPA5	chr7:129984630-130008571:+	0.92	8.55	2.09E-13	Age-related hearing impairment (interaction)	
THYM	cis	1	rs1716642	chr3:41965865	ULK4	chr3:41288091-42003660:-	-1.02	-11.59	6.88E-20	Diastolic blood pressure	
THYM	cis	1	rs1716644	chr3:41968028	ULK4	chr3:41288091-42003660:-	-0.96	-10.38	2.59E-17	Diastolic blood pressure	
THYM	cis	1	rs1716651	chr3:41975099	ULK4	chr3:41288091-42003660:-	-1.02	-11.59	6.88E-20	Diastolic blood pressure	
THYM	cis	1	rs1716657	chr3:41918456	ULK4	chr3:41288091-42003660:-	-1	-11.02	1.12E-18	Diastolic blood pressure	
THYM	cis	1	rs1716660	chr3:41929960	ULK4	chr3:41288091-42003660:-	-1.02	-11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs1716661	chr3:41962818	ULK4	chr3:41288091-42003660:-	-1.02	-11.47	1.26E-19	Diastolic blood pressure	
THYM	cis	1	rs1716664	chr3:41948378	ULK4	chr3:41288091-42003660:-	-1	-11.02	1.12E-18	Diastolic blood pressure	
THYM	cis	1	rs1716668	chr3:41907850	ULK4	chr3:41288091-42003660:-	1	11.02	1.12E-18	Diastolic blood pressure	
THYM	cis	1	rs1716669	chr3:41908681	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs1716676	chr3:41903208	ULK4	chr3:41288091-42003660:-	1	11.02	1.12E-18	Diastolic blood pressure	
THYM	cis	1	rs1716683	chr3:41923074	ULK4	chr3:41288091-42003660:-	-1	-11.02	1.12E-18	Diastolic blood pressure	
THYM	cis	1	rs1716685	chr3:41925301	ULK4	chr3:41288091-42003660:-	1	11.13	6.37E-19	Diastolic blood pressure	
THYM	cis	1	rs1716688	chr3:41926546	ULK4	chr3:41288091-42003660:-	-1	-11.02	1.12E-18	Diastolic blood pressure	
THYM	cis	1	rs1716690	chr3:41922102	ULK4	chr3:41288091-42003660:-	-1	-11.02	1.12E-18	Diastolic blood pressure	
THYM	cis	1	rs1716692	chr3:41983786	ULK4	chr3:41288091-42003660:-	-1.02	-11.59	6.88E-20	Diastolic blood pressure	
THYM	cis	1	rs1716693	chr3:41985600	ULK4	chr3:41288091-42003660:-	-1.01	-11.41	1.64E-19	Diastolic blood pressure	
THYM	cis	1	rs1716696	chr3:41935811	ULK4	chr3:41288091-42003660:-	-1.02	-11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs1716984	chr3:41965532	ULK4	chr3:41288091-42003660:-	-1.02	-11.59	6.88E-20	Diastolic blood pressure	
THYM	cis	1	rs1716987	chr3:41970516	ULK4	chr3:41288091-42003660:-	-0.99	-10.55	1.1E-17	Diastolic blood pressure	
THYM	cis	1	rs1716993	chr3:41974556	ULK4	chr3:41288091-42003660:-	-0.96	-10.38	2.59E-17	Diastolic blood pressure	
THYM	cis	1	rs1716997	chr3:41924333	ULK4	chr3:41288091-42003660:-	-1	-11.02	1.12E-18	Diastolic blood pressure	
THYM	cis	1	rs1716999	chr3:41930041	ULK4	chr3:41288091-42003660:-	-1.02	-11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs1717000	chr3:41930219	ULK4	chr3:41288091-42003660:-	-1.02	-11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs1717001	chr3:41934949	ULK4	chr3:41288091-42003660:-	-1	-11.02	1.12E-18	Diastolic blood pressure	
THYM	cis	1	rs1717006	chr3:41940448	ULK4	chr3:41288091-42003660:-	1	11.13	6.37E-19	Diastolic blood pressure	
THYM	cis	1	rs1717009	chr3:41946308	ULK4	chr3:41288091-42003660:-	-1.02	-11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs1717011	chr3:41980199	ULK4	chr3:41288091-42003660:-	-1.02	-11.59	6.88E-20	Diastolic blood pressure	
THYM	cis	1	rs1717014	chr3:41917395	ULK4	chr3:41288091-42003660:-	1	11.02	1.12E-18	Diastolic blood pressure	
THYM	cis	1	rs1717017	chr3:41915616	ULK4	chr3:41288091-42003660:-	1	11.02	1.12E-18	Diastolic blood pressure	
THYM	cis	1	rs1717020	chr3:41981490	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.26E-19	Diastolic blood pressure	
THYM	cis	1	rs1717021	chr3:41983860	ULK4	chr3:41288091-42003660:-	-1.02	-11.59	6.88E-20	Diastolic blood pressure	
THYM	cis	1	rs1717024	chr3:41984888	ULK4	chr3:41288091-42003660:-	-1.01	-11.41	1.64E-19	Diastolic blood pressure	
THYM	cis	1	rs1717027	chr3:41987920	ULK4	chr3:41288091-42003660:-	-1.01	-11.41	1.64E-19	Diastolic blood pressure	
THYM	cis	1	rs1717031	chr3:41905791	ULK4	chr3:41288091-42003660:-	1	11.02	1.12E-18	Diastolic blood pressure	
THYM	cis	1	rs1717033	chr3:41910216	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs1723267	chr7:65473314	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs1723269	chr7:65472786	CCT6P1	chr7:65216092-65228661:+	0.61	5.14	1.49E-6	Diabetic kidney disease	
THYM	cis	1	rs1723270	chr7:65469830	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs173334	chr6:88080223	C6orf164	chr6:88032306-88109459:+	-0.5	-5.01	2.47E-6	Depressive episodes in bipolar disorder	
THYM	cis	1	rs17433780	chr1:89474818	GBP3	chr1:89472367-89488549:-	0.71	8.32	6.45E-13	Carotid intima media thickness	
THYM	cis	1	rs17459044	chr9:131853624	CRAT	chr9:131857075-131873070:-	0.38	4.44	2.43E-5	Pelvic organ prolapse (moderate/severe)	
THYM	cis	1	rs17596617	chr11:43690717	HSD17B12	chr11:43702143-43878160:+	-0.63	-7.22	1.25E-10	Forced vital capacity	
THYM	cis	1	rs17608059	chr17:13910549	CDRT15P	chr17:13927815-13928915:+	-0.5	-4.95	3.18E-6	Temperament	
THYM	cis	1	rs17649068	chr1:171713893	VAMP4	chr1:171669298-171711214:-	0.32	4.18	6.49E-5	Hippocampal atrophy	
THYM	cis	1	rs17649250	chr1:171720586	VAMP4	chr1:171669298-171711214:-	0.32	4.18	6.49E-5	Hippocampal atrophy	
THYM	cis	1	rs1768803	chr1:46546208	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs1768816	chr1:46528599	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.99	3.67E-8	Body mass index	
THYM	cis	1	rs17691170	chr3:121357626	IQCB1	chr3:121488610-121553926:-	0.47	4.32	3.78E-5	Cognitive performance	
THYM	cis	1	rs17694011	chr3:134213981	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs17694011	chr3:134213981	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs17713396	chr2:227201	SH3YL1	chr2:218138-264810:-	-0.32	-4.5	1.95E-5	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs17713729	chr2:249092	SH3YL1	chr2:218138-264810:-	-0.33	-4.86	4.59E-6	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs17714252	chr2:285471	SH3YL1	chr2:218138-264810:-	-0.33	-4.86	4.7E-6	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs17761723	chr17:2107090	SRR	chr17:2207248-2228553:+	0.59	6.45	4.71E-9	Esophageal cancer (squamous cell)	
THYM	cis	1	rs17761864	chr17:2171637	SRR	chr17:2207248-2228553:+	-0.52	-5.52	2.94E-7	Esophageal cancer (squamous cell)	
THYM	cis	1	rs17834627	chr17:2198892	SRR	chr17:2207248-2228553:+	-0.55	-5.52	2.92E-7	Esophageal cancer (squamous cell)	
THYM	cis	1	rs17878846	chr10:104630412	SFXN2	chr10:104474298-104498946:+	-0.6	-4.71	8.59E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THYM	cis	1	rs1794693	chr6:167405670	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs1796220	chr7:66062100	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Diabetic kidney disease	
THYM	cis	1	rs1796228	chr7:66033084	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Diabetic kidney disease	
THYM	cis	1	rs1814336	chr3:134200823	ANAPC13	chr3:134196547-134204865:-	0.56	7.74	1.08E-11	Height	
THYM	cis	1	rs1814336	chr3:134200823	CEP63	chr3:134204575-134293852:+	0.39	5.72	1.23E-7	Height	
THYM	cis	1	rs1814337	chr3:134200682	ANAPC13	chr3:134196547-134204865:-	0.56	7.69	1.35E-11	Height	
THYM	cis	1	rs1814337	chr3:134200682	CEP63	chr3:134204575-134293852:+	0.41	5.94	4.66E-8	Height	
THYM	cis	1	rs1819333	chr6:167373547	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs1830074	chr7:6718674	PMS2CL	chr7:6749757-6793492:+	-0.5	-4.34	3.6E-5	Body mass index	
THYM	cis	1	rs1833896	chr5:56097669	C5orf35	chr5:56205103-56213010:+	0.74	9.25	6.53E-15	Type 2 diabetes	
THYM	cis	1	rs1835158	chr2:227763993	RHBDD1	chr2:227700773-227861591:+	-0.32	-4.73	7.77E-6	Pulmonary function	
THYM	cis	1	rs1857964	chr6:86635994	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs1857965	chr6:86630776	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs1862619	chr5:56098256	C5orf35	chr5:56205103-56213010:+	0.74	9.25	6.53E-15	Type 2 diabetes	
THYM	cis	1	rs186378	chr7:65582058	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs1863913	chr3:134200205	ANAPC13	chr3:134196547-134204865:-	0.53	7.15	1.78E-10	Height	
THYM	cis	1	rs1863913	chr3:134200205	CEP63	chr3:134204575-134293852:+	0.39	5.77	9.81E-8	Height	
THYM	cis	1	rs1864367	chr3:53111704	RFT1	chr3:53122503-53164470:-	-0.44	-4.99	2.68E-6	Height	
THYM	cis	1	rs1864395	chr10:43655697	CSGALNACT2	chr10:43633934-43680747:+	-0.34	-4.58	1.44E-5	Hirschsprung disease	
THYM	cis	1	rs1864399	chr10:43610455	CSGALNACT2	chr10:43633934-43680747:+	-0.34	-4.79	6.22E-6	Hirschsprung disease	
THYM	cis	1	rs1873494	chr7:65649899	CCT6P1	chr7:65216092-65228661:+	-0.67	-5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs1874883	chr3:134205071	ANAPC13	chr3:134196547-134204865:-	0.58	8.04	2.51E-12	Height	
THYM	cis	1	rs1874883	chr3:134205071	CEP63	chr3:134204575-134293852:+	0.4	5.88	6.17E-8	Height	
THYM	cis	1	rs1875124	chr12:58196802	FAM119B	chr12:58166383-58176323:+	0.42	5.72	1.22E-7	Multiple sclerosis	
THYM	cis	1	rs1875124	chr12:58196802	TSFM	chr12:58176536-58191367:+	-0.29	-5.12	1.6E-6	Multiple sclerosis	
THYM	cis	1	rs1875620	chr9:91540059	C9orf47	chr9:91605778-91611055:+	0.29	4.92	3.69E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs1877316	chr17:61766880	TCAM1P	chr17:61934376-61941738:+	-0.52	-4.17	6.75E-5	Body mass index	
THYM	cis	1	rs1880376	chr3:134270347	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs1880376	chr3:134270347	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs1880377	chr3:134270468	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs1880377	chr3:134270468	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs1881245	chr2:73649928	ALMS1P	chr2:73872046-73912692:+	0.57	4.75	7.32E-6	Metabolite levels	
THYM	cis	1	rs1881534	chr11:62085083	ASRGL1	chr11:62104774-62160885:+	0.55	5.3	7.38E-7	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs1882099	chr4:1352685	CRIPAK	chr4:1385340-1389782:+	0.76	6.47	4.27E-9	Systolic blood pressure	
THYM	cis	1	rs1882655	chr7:66147057	CCT6P1	chr7:65216092-65228661:+	-0.59	-4.86	4.58E-6	Gout	
THYM	cis	1	rs1885986	chr17:2203175	SRR	chr17:2207248-2228553:+	-0.54	-5.48	3.47E-7	Esophageal cancer (squamous cell)	
THYM	cis	1	rs190414	chr5:56116772	C5orf35	chr5:56205103-56213010:+	0.74	8.92	3.44E-14	Type 2 diabetes	
THYM	cis	1	rs1910272	chr9:91559042	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs1911552	chr6:86638024	SNHG5	chr6:86386726-86388451:-	-0.57	-7.62	1.9E-11	Response to antipsychotic treatment	
THYM	cis	1	rs1911553	chr6:86630892	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs1917130	chr3:134313773	ANAPC13	chr3:134196547-134204865:-	-0.57	-7.63	1.8E-11	Height	
THYM	cis	1	rs1917130	chr3:134313773	CEP63	chr3:134204575-134293852:+	-0.42	-6.1	2.28E-8	Height	
THYM	cis	1	rs1930961	chr22:25875265	CRYBB2	chr22:25615612-25627836:+	1.12	7.51	3.14E-11	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs1962716	chr6:86648436	SNHG5	chr6:86386726-86388451:-	-0.57	-6.96	4.28E-10	Response to antipsychotic treatment	
THYM	cis	1	rs1964555	chr17:16763555	TRPV2	chr17:16318888-16340315:+	0.23	4.14	7.43E-5	Response to platinum-based chemotherapy (cisplatin)	
THYM	cis	1	rs1964692	chr7:65454183	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs1966839	chr7:50627101	FIGNL1	chr7:50511834-50518088:-	-0.3	-4.66	1.03E-5	Malaria	
THYM	cis	1	rs1977447	chr9:131868196	CRAT	chr9:131857075-131873070:-	-0.47	-5.46	3.85E-7	Blood metabolite ratios	
THYM	cis	1	rs1979823	chr7:65704613	CCT6P1	chr7:65216092-65228661:+	-0.64	-5.29	7.77E-7	Diabetic kidney disease	
THYM	cis	1	rs1979	chr6:26377591	BTN3A2	chr6:26365398-26378546:+	-0.74	-5.26	8.76E-7	Schizophrenia	
THYM	cis	1	rs1981898	chr14:76175565	TTLL5	chr14:76127621-76421421:+	0.36	4.8	5.87E-6	Large artery stroke	
THYM	cis	1	rs1986557	chr4:283118	ZNF718	chr4:53272-156488:+	0.52	5.94	4.59E-8	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs1994157	chr3:41897482	ULK4	chr3:41288091-42003660:-	0.96	9.51	1.88E-15	Diastolic blood pressure	
THYM	cis	1	rs1995688	chr6:86632319	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs1999852	chr6:86705738	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs2001483	chr12:131318645	STX2	chr12:131274149-131323811:-	0.35	5.89	5.79E-8	Plasma plasminogen activator levels	
THYM	cis	1	rs2006751	chr11:43670501	HSD17B12	chr11:43702143-43878160:+	-0.58	-5.99	3.71E-8	Forced vital capacity	
THYM	cis	1	rs2010648	chr14:35604892	KIAA0391	chr14:35591776-35786673:+	0.35	4.67	9.73E-6	Atopic dermatitis	
THYM	cis	1	rs2010648	chr14:35604892	PPP2R3C	chr14:35554679-35591679:-	0.26	4.92	3.68E-6	Atopic dermatitis	
THYM	cis	1	rs2012917	chr1:212405771	NEK2	chr1:211836115-211848967:-	-0.16	-4.42	2.59E-5	Intelligence (childhood)	
THYM	cis	1	rs2013815	chr6:167373812	RNASET2	chr6:167343008-167412795:-	0.47	7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs2015246	chr11:62196312	ASRGL1	chr11:62104774-62160885:+	-0.29	-4.41	2.74E-5	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs2016161	chr20:23621174	CST9	chr20:23583049-23586610:-	0.48	4.46	2.27E-5	Chronic kidney disease	
THYM	cis	1	rs2028299	chr15:90374257	AP3S2	chr15:90373832-90456222:-	-0.42	-4.83	5.23E-6	Type 2 diabetes	
THYM	cis	1	rs2045554	chr3:48494542	TREX1	chr3:48501186-48509043:+	0.28	4.29	4.29E-5	Longevity	
THYM	cis	1	rs2056486	chr2:73717567	ALMS1P	chr2:73872046-73912692:+	0.58	4.75	7.12E-6	Metabolite levels	
THYM	cis	1	rs2056603	chr3:134312749	ANAPC13	chr3:134196547-134204865:-	0.57	7.57	2.35E-11	Height	
THYM	cis	1	rs2056603	chr3:134312749	CEP63	chr3:134204575-134293852:+	0.42	6.06	2.7E-8	Height	
THYM	cis	1	rs2056604	chr3:134312648	ANAPC13	chr3:134196547-134204865:-	0.55	7.48	3.7E-11	Height	
THYM	cis	1	rs2056604	chr3:134312648	CEP63	chr3:134204575-134293852:+	0.43	6.36	7.09E-9	Height	
THYM	cis	1	rs2058059	chr7:72311817	TYW1B	chr7:72023729-72298813:-	-0.53	-4.45	2.34E-5	Subcutaneous adipose tissue	
THYM	cis	1	rs2067852	chr10:45056521	ZNF22	chr10:45496273-45500776:+	0.64	5.71	1.28E-7	Estradiol plasma levels (breast cancer)	
THYM	cis	1	rs2069502	chr12:58144665	FAM119B	chr12:58166383-58176323:+	-0.37	-4.86	4.67E-6	Multiple sclerosis	
THYM	cis	1	rs2069502	chr12:58144665	TSFM	chr12:58176536-58191367:+	0.25	4.36	3.35E-5	Multiple sclerosis	
THYM	cis	1	rs2070180	chr3:121351338	IQCB1	chr3:121488610-121553926:-	-0.47	-4.4	2.82E-5	Cognitive performance	
THYM	cis	1	rs2072052	chr12:58146719	FAM119B	chr12:58166383-58176323:+	0.41	5.68	1.48E-7	Multiple sclerosis	
THYM	cis	1	rs2072052	chr12:58146719	TSFM	chr12:58176536-58191367:+	-0.26	-4.6	1.29E-5	Multiple sclerosis	
THYM	cis	1	rs2072293	chr14:74537885	LIN52	chr14:74551656-74667117:+	0.38	7.07	2.63E-10	Common traits (Other)	
THYM	cis	1	rs2074038	chr11:44087989	ACCS	chr11:44087475-44105569:+	1.06	8.64	1.32E-13	IgA nephropathy	
THYM	cis	1	rs2074771	chr2:242350944	SEPT2	chr2:242254723-242293439:+	0.44	5.87	6.46E-8	Chronic lymphocytic leukemia	
THYM	cis	1	rs2077224	chr11:62197427	ASRGL1	chr11:62104774-62160885:+	-0.29	-4.3	4.07E-5	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs2077808	chr1:45988115	CCDC163P	chr1:45960581-45965646:-	-0.86	-14.78	2.3E-26	Homocysteine levels	
THYM	cis	1	rs2083731	chr15:75368538	PPCDC	chr15:75315927-75343066:+	0.26	4.77	6.63E-6	Blood trace element (Zn levels)	
THYM	cis	1	rs2087946	chr1:212405396	NEK2	chr1:211836115-211848967:-	-0.16	-4.42	2.59E-5	Intelligence (childhood)	
THYM	cis	1	rs2093395	chr6:41155026	LOC221442	chr6:41068773-41108567:+	-0.36	-5.29	7.68E-7	Alzheimer's disease (late onset)	
THYM	cis	1	rs2093396	chr6:41155000	LOC221442	chr6:41068773-41108567:+	0.36	5.29	7.68E-7	Alzheimer's disease (late onset)	
THYM	cis	1	rs2112125	chr2:54348030	RTN4	chr2:55199329-55277734:-	-0.51	-4.25	4.97E-5	Sudden cardiac arrest	
THYM	cis	1	rs2113078	chr5:56087190	C5orf35	chr5:56205103-56213010:+	0.73	8.09	1.95E-12	Type 2 diabetes	
THYM	cis	1	rs2113079	chr5:56157951	C5orf35	chr5:56205103-56213010:+	0.74	8.92	3.3E-14	Type 2 diabetes	
THYM	cis	1	rs211718	chr1:76106675	ACADM	chr1:76190043-76229353:+	0.3	4.13	7.75E-5	Blood metabolite levels;Acylcarnitine levels	
THYM	cis	1	rs2120019	chr15:75334184	PPCDC	chr15:75315927-75343066:+	0.27	4.85	4.8E-6	Blood trace element (Zn levels)	
THYM	cis	1	rs2128834	chr3:41862645	ULK4	chr3:41288091-42003660:-	1	10.95	1.58E-18	Diastolic blood pressure	
THYM	cis	1	rs2128835	chr3:41862873	ULK4	chr3:41288091-42003660:-	1	10.81	3.16E-18	Diastolic blood pressure	
THYM	cis	1	rs2130392	chr4:185639169	CCDC111	chr4:185570767-185616112:+	0.33	4.27	4.71E-5	Kawasaki disease	
THYM	cis	1	rs2130392	chr4:185639169	MLF1IP	chr4:185615220-185655286:-	-0.33	-7.29	9.16E-11	Kawasaki disease	
THYM	cis	1	rs2140195	chr2:73702344	ALMS1P	chr2:73872046-73912692:+	0.57	4.75	7.32E-6	Metabolite levels	
THYM	cis	1	rs2141924	chr7:66186246	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Gout	
THYM	cis	1	rs2143950	chr14:35572357	KIAA0391	chr14:35591776-35786673:+	0.32	4.14	7.59E-5	Atopic dermatitis	
THYM	cis	1	rs2143950	chr14:35572357	PPP2R3C	chr14:35554679-35591679:-	0.27	4.99	2.76E-6	Atopic dermatitis	
THYM	cis	1	rs2149085	chr6:167371110	RNASET2	chr6:167343008-167412795:-	0.45	7.24	1.15E-10	Crohn's disease	
THYM	cis	1	rs2149090	chr6:167372764	RNASET2	chr6:167343008-167412795:-	0.47	7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs2149091	chr6:167372786	RNASET2	chr6:167343008-167412795:-	0.47	7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs2158100	chr17:18811479	FAM18B	chr17:18684582-18710026:+	0.27	4.63	1.16E-5	Pancreatic cancer	
THYM	cis	1	rs2163041	chr2:227772480	RHBDD1	chr2:227700773-227861591:+	-0.31	-4.56	1.54E-5	Pulmonary function	
THYM	cis	1	rs2163167	chr3:53131772	RFT1	chr3:53122503-53164470:-	-0.44	-4.8	5.86E-6	Height	
THYM	cis	1	rs2166663	chr6:86593896	SNHG5	chr6:86386726-86388451:-	-0.57	-7.62	1.9E-11	Response to antipsychotic treatment	
THYM	cis	1	rs2169748	chr2:28957753	TRMT61B	chr2:29072690-29093175:-	0.52	4.15	7.22E-5	Body mass index	
THYM	cis	1	rs2177601	chr3:134245434	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs2177601	chr3:134245434	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs2177703	chr7:65391717	CCT6P1	chr7:65216092-65228661:+	0.67	4.9	3.88E-6	Diabetic kidney disease	
THYM	cis	1	rs2181043	chr10:17217803	CUBN	chr10:16865966-17171816:-	0.31	4.9	4.0E-6	Homocysteine levels	
THYM	cis	1	rs2184768	chr10:45046562	ZNF22	chr10:45496273-45500776:+	0.47	4.63	1.16E-5	Estradiol plasma levels (breast cancer)	
THYM	cis	1	rs2184769	chr10:45050050	ZNF22	chr10:45496273-45500776:+	0.4	4.31	3.95E-5	Estradiol plasma levels (breast cancer)	
THYM	cis	1	rs2184770	chr10:45049680	ZNF22	chr10:45496273-45500776:+	0.46	4.66	1.04E-5	Estradiol plasma levels (breast cancer)	
THYM	cis	1	rs2227336	chr17:38174855	GSDMA	chr17:38119226-38134019:+	-0.87	-9.32	4.71E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THYM	cis	1	rs2229384	chr6:49425521	CENPQ	chr6:49431096-49460820:+	0.3	4.78	6.27E-6	Homocysteine levels	
THYM	cis	1	rs2239557	chr14:74551970	LIN52	chr14:74551656-74667117:+	0.38	7.1	2.22E-10	Common traits (Other)	
THYM	cis	1	rs2242150	chr3:48505964	TREX1	chr3:48501186-48509043:+	0.29	4.28	4.47E-5	Longevity	
THYM	cis	1	rs2242471	chr4:76878716	NAAA	chr4:76831809-76862166:-	0.46	4.92	3.56E-6	Longevity	
THYM	cis	1	rs2242473	chr4:76878956	NAAA	chr4:76831809-76862166:-	0.46	4.92	3.56E-6	Longevity	
THYM	cis	1	rs2242474	chr4:76878982	NAAA	chr4:76831809-76862166:-	0.46	4.92	3.56E-6	Longevity	
THYM	cis	1	rs2243480	chr7:65599196	CCT6P1	chr7:65216092-65228661:+	0.59	4.73	7.78E-6	Diabetic kidney disease	
THYM	cis	1	rs2245715	chr15:43818052	ADAL	chr15:43622872-43646094:+	-0.63	-5.3	7.39E-7	Tumor biomarkers	
THYM	cis	1	rs2246920	chr11:62104937	ASRGL1	chr11:62104774-62160885:+	0.56	5.84	7.18E-8	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs2247145	chr1:117470312	SLC22A15	chr1:116519119-116612672:+	-0.64	-4.7	8.76E-6	Erectile dysfunction and prostate cancer treatment	
THYM	cis	1	rs2249984	chr1:117469322	SLC22A15	chr1:116519119-116612672:+	-0.59	-4.39	2.96E-5	Erectile dysfunction and prostate cancer treatment	
THYM	cis	1	rs2250096	chr1:117468983	SLC22A15	chr1:116519119-116612672:+	-0.59	-4.39	2.96E-5	Erectile dysfunction and prostate cancer treatment	
THYM	cis	1	rs2250439	chr1:117466050	SLC22A15	chr1:116519119-116612672:+	-0.59	-4.39	2.96E-5	Erectile dysfunction and prostate cancer treatment	
THYM	cis	1	rs2250445	chr1:117465904	SLC22A15	chr1:116519119-116612672:+	-0.56	-4.27	4.6E-5	Erectile dysfunction and prostate cancer treatment	
THYM	cis	1	rs2250448	chr1:117465862	SLC22A15	chr1:116519119-116612672:+	-0.59	-4.39	2.96E-5	Erectile dysfunction and prostate cancer treatment	
THYM	cis	1	rs2251115	chr6:49446509	CENPQ	chr6:49431096-49460820:+	-0.27	-5.12	1.57E-6	Homocysteine levels	
THYM	cis	1	rs2251844	chr15:43836478	ADAL	chr15:43622872-43646094:+	-0.62	-5.23	1.01E-6	Tumor biomarkers	
THYM	cis	1	rs2253209	chr3:53115160	RFT1	chr3:53122503-53164470:-	-0.44	-4.99	2.68E-6	Height	
THYM	cis	1	rs2253656	chr3:53119099	RFT1	chr3:53122503-53164470:-	-0.44	-4.99	2.68E-6	Height	
THYM	cis	1	rs2253685	chr3:53119703	RFT1	chr3:53122503-53164470:-	-0.44	-4.99	2.68E-6	Height	
THYM	cis	1	rs2253796	chr3:53120098	RFT1	chr3:53122503-53164470:-	-0.44	-4.99	2.68E-6	Height	
THYM	cis	1	rs2254224	chr1:117457864	SLC22A15	chr1:116519119-116612672:+	-0.58	-4.55	1.58E-5	Erectile dysfunction and prostate cancer treatment	
THYM	cis	1	rs2254230	chr9:131905177	CRAT	chr9:131857075-131873070:-	-0.47	-5.4	4.92E-7	Blood metabolite ratios	
THYM	cis	1	rs2255042	chr15:43834318	ADAL	chr15:43622872-43646094:+	0.64	5.26	8.99E-7	Tumor biomarkers	
THYM	cis	1	rs2255051	chr15:43846161	ADAL	chr15:43622872-43646094:+	-0.64	-5.26	8.99E-7	Tumor biomarkers	
THYM	cis	1	rs2255440	chr15:43830467	ADAL	chr15:43622872-43646094:+	-0.62	-5.23	1.01E-6	Tumor biomarkers	
THYM	cis	1	rs2257790	chr7:65600450	CCT6P1	chr7:65216092-65228661:+	0.63	5.27	8.65E-7	Diabetic kidney disease	
THYM	cis	1	rs2260160	chr15:43895643	ADAL	chr15:43622872-43646094:+	-0.51	-4.41	2.75E-5	Tumor biomarkers	
THYM	cis	1	rs2260160	chr15:43895643	CATSPER2	chr15:43922774-43959900:-	-0.57	-4.35	3.47E-5	Tumor biomarkers	
THYM	cis	1	rs2272006	chr3:41997059	ULK4	chr3:41288091-42003660:-	-1.01	-11.41	1.64E-19	Diastolic blood pressure	
THYM	cis	1	rs2272007	chr3:41996136	ULK4	chr3:41288091-42003660:-	-1.01	-11.41	1.64E-19	Diastolic blood pressure	
THYM	cis	1	rs2273	chr4:76889388	NAAA	chr4:76831809-76862166:-	0.46	4.92	3.56E-6	Longevity	
THYM	cis	1	rs2275426	chr1:46487552	CCDC163P	chr1:45960581-45965646:-	-0.49	-6.02	3.21E-8	Body mass index	
THYM	cis	1	rs2279077	chr3:48474249	TREX1	chr3:48501186-48509043:+	-0.28	-4.23	5.28E-5	Longevity	
THYM	cis	1	rs2280141	chr10:124193181	PLEKHA1	chr10:124134220-124191866:+	-0.26	-4.17	6.69E-5	Height	
THYM	cis	1	rs2287679	chr19:33600764	GPATCH1	chr19:33571786-33621318:+	0.37	4.33	3.69E-5	Bone properties (heel)	
THYM	cis	1	rs2287680	chr19:33608566	GPATCH1	chr19:33571786-33621318:+	-0.37	-4.33	3.69E-5	Bone properties (heel)	
THYM	cis	1	rs2288073	chr2:24413298	LOC375190	chr2:24299728-24397519:+	0.34	4.83	5.25E-6	Venous thromboembolism (SNP x SNP interaction)	
THYM	cis	1	rs2289681	chr17:42989088	CCDC103	chr17:42977154-42982758:+	0.63	4.8	5.99E-6	Cognitive function	
THYM	cis	1	rs2290416	chr8:144657600	NAPRT1	chr8:144656956-144660513:-	-0.73	-4.76	6.88E-6	Attention deficit hyperactivity disorder	
THYM	cis	1	rs2290822	chr3:48473204	TREX1	chr3:48501186-48509043:+	-0.29	-4.26	4.8E-5	Longevity	
THYM	cis	1	rs2290911	chr2:224919	SH3YL1	chr2:218138-264810:-	-0.31	-4.56	1.52E-5	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs2292239	chr12:56482180	RPS26	chr12:56435686-56438005:+	0.86	9	2.29E-14	Cognitive function	
THYM	cis	1	rs2292342	chr19:49118371	SEC1	chr19:49141296-49185501:+	-0.84	-4.15	7.35E-5	Elevated serum carcinoembryonic antigen levels	
THYM	cis	1	rs2294008	chr8:143761931	PSCA	chr8:143761875-143764142:+	0.44	4.31	3.94E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs2294010	chr8:143762430	PSCA	chr8:143761875-143764142:+	0.43	4.29	4.22E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs2297112	chr9:131900180	CRAT	chr9:131857075-131873070:-	0.38	4.61	1.24E-5	Blood metabolite ratios	
THYM	cis	1	rs2303759	chr19:49869051	DKKL1	chr19:49867042-49878371:+	-0.34	-4.32	3.87E-5	Multiple sclerosis	
THYM	cis	1	rs2304668	chr2:239168448	LOC151174	chr2:239133754-239140318:-	1.03	4.7	8.82E-6	Irritable bowel syndrome	
THYM	cis	1	rs2316803	chr9:91551990	C9orf47	chr9:91605778-91611055:+	-0.27	-4.81	5.58E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs2316804	chr9:91551898	C9orf47	chr9:91605778-91611055:+	-0.26	-4.68	9.7E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs2324843	chr6:86617501	SNHG5	chr6:86386726-86388451:-	-0.6	-7.24	1.15E-10	Response to antipsychotic treatment	
THYM	cis	1	rs2326680	chr20:5942955	MCM8	chr20:5931298-5975829:+	-0.22	-4.5	1.96E-5	HIV-1 viral setpoint	
THYM	cis	1	rs2329340	chr7:50620229	FIGNL1	chr7:50511834-50518088:-	-0.3	-4.59	1.33E-5	Malaria	
THYM	cis	1	rs2329341	chr7:50620275	FIGNL1	chr7:50511834-50518088:-	-0.3	-4.59	1.33E-5	Malaria	
THYM	cis	1	rs2329342	chr7:50624971	FIGNL1	chr7:50511834-50518088:-	0.3	4.64	1.09E-5	Malaria	
THYM	cis	1	rs2336723	chr3:53106047	RFT1	chr3:53122503-53164470:-	-0.42	-4.8	5.83E-6	Height	
THYM	cis	1	rs2351706	chr15:90384115	AP3S2	chr15:90373832-90456222:-	-0.43	-4.89	4.09E-6	Type 2 diabetes	
THYM	cis	1	rs2351707	chr15:90384045	AP3S2	chr15:90373832-90456222:-	-0.43	-4.89	4.09E-6	Type 2 diabetes	
THYM	cis	1	rs2353605	chr4:219538	ZNF718	chr4:53272-156488:+	0.5	5.43	4.41E-7	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs2356559	chr1:45981512	CCDC163P	chr1:45960581-45965646:-	-0.84	-13.85	1.56E-24	Homocysteine levels	
THYM	cis	1	rs2356561	chr1:45980862	CCDC163P	chr1:45960581-45965646:-	-0.8	-13.18	3.67E-23	Homocysteine levels	
THYM	cis	1	rs2358628	chr14:74631757	LIN52	chr14:74551656-74667117:+	-0.41	-7.88	5.51E-12	Common traits (Other)	
THYM	cis	1	rs2358633	chr14:74647418	LIN52	chr14:74551656-74667117:+	-0.39	-7.16	1.73E-10	Common traits (Other)	
THYM	cis	1	rs236104	chr20:5958960	MCM8	chr20:5931298-5975829:+	-0.21	-4.4	2.79E-5	HIV-1 viral setpoint	
THYM	cis	1	rs236121	chr20:5972594	MCM8	chr20:5931298-5975829:+	-0.2	-4.21	5.84E-5	HIV-1 viral setpoint	
THYM	cis	1	rs2362450	chr3:48461313	TREX1	chr3:48501186-48509043:+	-0.28	-4.25	5.05E-5	Longevity	
THYM	cis	1	rs2362452	chr3:48418214	TREX1	chr3:48501186-48509043:+	0.28	4.43	2.52E-5	Longevity	
THYM	cis	1	rs2363731	chr2:88521793	THNSL2	chr2:88469835-88486145:+	-0.5	-4.23	5.34E-5	Plasma clusterin levels	
THYM	cis	1	rs2370578	chr3:134199612	ANAPC13	chr3:134196547-134204865:-	0.58	7.97	3.55E-12	Height	
THYM	cis	1	rs2370578	chr3:134199612	CEP63	chr3:134204575-134293852:+	0.4	5.69	1.38E-7	Height	
THYM	cis	1	rs2370641	chr3:134222161	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs2370641	chr3:134222161	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs2370642	chr3:134222136	ANAPC13	chr3:134196547-134204865:-	0.58	8.05	2.33E-12	Height	
THYM	cis	1	rs2370642	chr3:134222136	CEP63	chr3:134204575-134293852:+	0.4	5.81	8.19E-8	Height	
THYM	cis	1	rs2371623	chr3:41761083	ULK4	chr3:41288091-42003660:-	1.01	11.17	5.4E-19	Diastolic blood pressure	
THYM	cis	1	rs2371627	chr3:41839219	ULK4	chr3:41288091-42003660:-	1.02	10.9	1.98E-18	Diastolic blood pressure	
THYM	cis	1	rs2373865	chr3:134291556	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs2373865	chr3:134291556	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs2396433	chr2:227772502	RHBDD1	chr2:227700773-227861591:+	-0.31	-4.56	1.54E-5	Pulmonary function	
THYM	cis	1	rs239935	chr6:167411788	RNASET2	chr6:167343008-167412795:-	-0.44	-7.19	1.5E-10	Crohn's disease	
THYM	cis	1	rs2415255	chr15:75332412	PPCDC	chr15:75315927-75343066:+	0.27	4.85	4.8E-6	Blood trace element (Zn levels)	
THYM	cis	1	rs2420170	chr7:65656053	CCT6P1	chr7:65216092-65228661:+	-0.67	-5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs2420171	chr7:65637760	CCT6P1	chr7:65216092-65228661:+	-0.67	-5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs2421017	chr10:124148167	PLEKHA1	chr10:124134220-124191866:+	-0.26	-4.17	6.69E-5	Height	
THYM	cis	1	rs2421555	chr2:73816955	ALMS1P	chr2:73872046-73912692:+	0.58	4.7	8.77E-6	Metabolite levels	
THYM	cis	1	rs242271	chr6:88082029	C6orf164	chr6:88032306-88109459:+	-0.52	-4.99	2.7E-6	Depressive episodes in bipolar disorder	
THYM	cis	1	rs2432195	chr5:56120413	C5orf35	chr5:56205103-56213010:+	0.75	9.44	2.59E-15	Type 2 diabetes	
THYM	cis	1	rs2447196	chr15:43893818	ADAL	chr15:43622872-43646094:+	0.49	4.25	4.9E-5	Tumor biomarkers	
THYM	cis	1	rs2447208	chr15:43933895	ADAL	chr15:43622872-43646094:+	-0.53	-4.45	2.33E-5	Tumor biomarkers	
THYM	cis	1	rs2447208	chr15:43933895	CATSPER2	chr15:43922774-43959900:-	-0.65	-4.98	2.88E-6	Tumor biomarkers	
THYM	cis	1	rs2447211	chr15:43936351	ADAL	chr15:43622872-43646094:+	-0.51	-4.38	3.06E-5	Tumor biomarkers	
THYM	cis	1	rs2448704	chr6:49453672	CENPQ	chr6:49431096-49460820:+	0.3	5.69	1.37E-7	Homocysteine levels	
THYM	cis	1	rs2448707	chr6:49446951	CENPQ	chr6:49431096-49460820:+	0.24	4.35	3.42E-5	Folate pathway vitamin levels	
THYM	cis	1	rs2448707	chr6:49446951	MUT	chr6:49398994-49431031:-	-0.28	-4.29	4.25E-5	Folate pathway vitamin levels	
THYM	cis	1	rs2460422	chr7:65601505	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs2462569	chr7:65474846	CCT6P1	chr7:65216092-65228661:+	-0.6	-4.98	2.86E-6	Diabetic kidney disease	
THYM	cis	1	rs2462756	chr11:93758301	HEPHL1	chr11:93754378-93847374:+	-0.94	-4.25	4.93E-5	Obesity-related traits	
THYM	cis	1	rs2463820	chr11:62112290	ASRGL1	chr11:62104774-62160885:+	0.55	5.39	5.18E-7	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs2463821	chr11:62111662	ASRGL1	chr11:62104774-62160885:+	0.55	5.39	5.18E-7	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs2463822	chr11:62103420	ASRGL1	chr11:62104774-62160885:+	0.55	5.44	4.17E-7	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs2463825	chr11:62094493	ASRGL1	chr11:62104774-62160885:+	0.56	5.84	7.37E-8	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs2465120	chr7:65620974	CCT6P1	chr7:65216092-65228661:+	0.65	5.41	4.64E-7	Diabetic kidney disease	
THYM	cis	1	rs2486447	chr1:46545724	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs2501962	chr6:49453636	CENPQ	chr6:49431096-49460820:+	0.25	4.46	2.28E-5	Folate pathway vitamin levels	
THYM	cis	1	rs2501963	chr6:49454281	CENPQ	chr6:49431096-49460820:+	0.25	4.48	2.1E-5	Folate pathway vitamin levels	
THYM	cis	1	rs2513052	chr11:62108248	ASRGL1	chr11:62104774-62160885:+	0.56	5.84	7.18E-8	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs2513071	chr11:62098387	ASRGL1	chr11:62104774-62160885:+	0.56	5.84	7.37E-8	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs2513074	chr11:62100880	ASRGL1	chr11:62104774-62160885:+	0.56	5.84	7.37E-8	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs2513076	chr11:62103711	ASRGL1	chr11:62104774-62160885:+	0.56	5.84	7.37E-8	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs2513744	chr11:62077785	ASRGL1	chr11:62104774-62160885:+	0.51	5.15	1.41E-6	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs2513747	chr11:62098735	ASRGL1	chr11:62104774-62160885:+	0.56	5.84	7.37E-8	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs2513749	chr11:62105391	ASRGL1	chr11:62104774-62160885:+	0.56	5.84	7.18E-8	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs2524005	chr6:29899677	ZFP57	chr6:29640171-29648887:-	0.83	5.37	5.52E-7	Bipolar disorder and schizophrenia	
THYM	cis	1	rs252716	chr5:110425063	TSLP	chr5:110405778-110413722:+	0.44	4.19	6.18E-5	Eosinophilic esophagitis	
THYM	cis	1	rs252887	chr5:56166188	C5orf35	chr5:56205103-56213010:+	0.75	9.04	1.84E-14	Type 2 diabetes	
THYM	cis	1	rs252898	chr5:56188931	C5orf35	chr5:56205103-56213010:+	0.76	9.51	1.87E-15	Type 2 diabetes	
THYM	cis	1	rs252902	chr5:56116085	C5orf35	chr5:56205103-56213010:+	0.74	8.92	3.44E-14	Type 2 diabetes	
THYM	cis	1	rs252904	chr5:56118733	C5orf35	chr5:56205103-56213010:+	0.74	8.98	2.55E-14	Type 2 diabetes	
THYM	cis	1	rs252909	chr5:56121131	C5orf35	chr5:56205103-56213010:+	0.74	8.92	3.44E-14	Type 2 diabetes	
THYM	cis	1	rs252910	chr5:56192983	C5orf35	chr5:56205103-56213010:+	0.77	9.52	1.72E-15	Type 2 diabetes	
THYM	cis	1	rs252915	chr5:56121754	C5orf35	chr5:56205103-56213010:+	-0.74	-8.92	3.44E-14	Type 2 diabetes	
THYM	cis	1	rs252916	chr5:56121788	C5orf35	chr5:56205103-56213010:+	0.75	9.44	2.59E-15	Type 2 diabetes	
THYM	cis	1	rs252919	chr5:56124111	C5orf35	chr5:56205103-56213010:+	0.74	8.92	3.44E-14	Type 2 diabetes	
THYM	cis	1	rs252921	chr5:56137787	C5orf35	chr5:56205103-56213010:+	0.77	9.57	1.35E-15	Type 2 diabetes	
THYM	cis	1	rs252922	chr5:56136343	C5orf35	chr5:56205103-56213010:+	0.77	9.57	1.35E-15	Type 2 diabetes	
THYM	cis	1	rs2533288	chr7:66056711	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Diabetic kidney disease	
THYM	cis	1	rs2541161	chr9:131884802	CRAT	chr9:131857075-131873070:-	-0.42	-4.98	2.82E-6	Blood metabolite ratios	
THYM	cis	1	rs2541164	chr9:131876908	CRAT	chr9:131857075-131873070:-	0.47	5.4	4.92E-7	Blood metabolite ratios	
THYM	cis	1	rs2548664	chr5:56133555	C5orf35	chr5:56205103-56213010:+	0.74	8.92	3.44E-14	Type 2 diabetes	
THYM	cis	1	rs2548665	chr5:56131805	C5orf35	chr5:56205103-56213010:+	0.74	8.92	3.44E-14	Type 2 diabetes	
THYM	cis	1	rs2564921	chr3:53125585	RFT1	chr3:53122503-53164470:-	0.44	4.91	3.78E-6	Height	
THYM	cis	1	rs2564940	chr3:53107569	RFT1	chr3:53122503-53164470:-	-0.44	-5	2.58E-6	Height	
THYM	cis	1	rs2572910	chr8:143770135	PSCA	chr8:143761875-143764142:+	0.42	4.21	5.89E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs2581782	chr3:53122257	RFT1	chr3:53122503-53164470:-	-0.44	-4.93	3.42E-6	Height	
THYM	cis	1	rs2581783	chr3:53122258	RFT1	chr3:53122503-53164470:-	-0.44	-4.93	3.42E-6	Height	
THYM	cis	1	rs2581786	chr3:53126143	RFT1	chr3:53122503-53164470:-	-0.44	-4.91	3.78E-6	Height	
THYM	cis	1	rs2581787	chr3:53127677	RFT1	chr3:53122503-53164470:-	-0.42	-4.59	1.35E-5	Height	
THYM	cis	1	rs2581800	chr3:53109352	RFT1	chr3:53122503-53164470:-	-0.4	-4.44	2.41E-5	Height	
THYM	cis	1	rs2585179	chr8:143774193	PSCA	chr8:143761875-143764142:+	0.42	4.21	5.86E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs2614811	chr15:43913487	ADAL	chr15:43622872-43646094:+	-0.5	-4.35	3.42E-5	Tumor biomarkers	
THYM	cis	1	rs2625667	chr3:41900951	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs2625668	chr3:41905930	ULK4	chr3:41288091-42003660:-	1	11.02	1.12E-18	Diastolic blood pressure	
THYM	cis	1	rs2625984	chr3:129339101	TMCC1	chr3:129366637-129612403:-	-0.31	-4.29	4.36E-5	Waist-to-hip ratio adjusted for body mass index	
THYM	cis	1	rs2629540	chr10:126426148	METTL10	chr10:126447406-126480439:-	0.4	4.43	2.54E-5	Cocaine dependence	
THYM	cis	1	rs2637678	chr6:116787378	FAM26F	chr6:116782556-116784933:+	0.47	4.89	4.17E-6	Ulcerative colitis	
THYM	cis	1	rs2659903	chr7:66180931	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Gout	
THYM	cis	1	rs2659911	chr7:66158420	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Gout	
THYM	cis	1	rs2659913	chr7:66157336	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Gout	
THYM	cis	1	rs2683695	chr3:41914928	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs2683696	chr3:41914898	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs2707828	chr7:66171377	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Gout	
THYM	cis	1	rs2707830	chr7:66167645	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Gout	
THYM	cis	1	rs2707831	chr7:66062511	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Diabetic kidney disease	
THYM	cis	1	rs2707832	chr7:66136549	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Gout	
THYM	cis	1	rs2707838	chr7:66159201	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Gout	
THYM	cis	1	rs2707840	chr7:66158015	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Gout	
THYM	cis	1	rs2707844	chr7:66059509	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Diabetic kidney disease	
THYM	cis	1	rs2717562	chr8:143776668	PSCA	chr8:143761875-143764142:+	0.42	4.21	5.89E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs2734839	chr11:113286490	TTC12	chr11:113185251-113244016:+	-0.31	-4.37	3.15E-5	Information processing speed	
THYM	cis	1	rs2736345	chr8:11352485	BLK	chr8:11351521-11422107:+	-0.39	-4.9	3.99E-6	Systemic lupus erythematosus	
THYM	cis	1	rs2742234	chr10:43612609	CSGALNACT2	chr10:43633934-43680747:+	0.33	4.71	8.36E-6	Hirschsprung disease	
THYM	cis	1	rs27529	chr5:96126308	ERAP1	chr5:96096515-96149837:-	-0.33	-4.3	4.15E-5	Ankylosing spondylitis	
THYM	cis	1	rs2757042	chr6:167371234	RNASET2	chr6:167343008-167412795:-	0.44	7.05	2.87E-10	Crohn's disease	
THYM	cis	1	rs2757047	chr6:167374489	RNASET2	chr6:167343008-167412795:-	0.47	7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs2767342	chr1:117469637	SLC22A15	chr1:116519119-116612672:+	-0.56	-4.27	4.6E-5	Erectile dysfunction and prostate cancer treatment	
THYM	cis	1	rs2768630	chr9:131866388	CRAT	chr9:131857075-131873070:-	-0.47	-5.42	4.57E-7	Blood metabolite ratios	
THYM	cis	1	rs2769347	chr6:167371737	RNASET2	chr6:167343008-167412795:-	0.46	7.38	6.04E-11	Crohn's disease	
THYM	cis	1	rs2769352	chr6:167378619	RNASET2	chr6:167343008-167412795:-	0.45	7.53	2.89E-11	Crohn's disease	
THYM	cis	1	rs2769354	chr6:167379771	RNASET2	chr6:167343008-167412795:-	0.47	7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs2786119	chr1:197329535	CFHR1	chr1:196748292-196801316:+	-0.55	-4.13	7.79E-5	Asthma	
THYM	cis	1	rs2806862	chr1:117467173	SLC22A15	chr1:116519119-116612672:+	0.58	4.55	1.58E-5	Erectile dysfunction and prostate cancer treatment	
THYM	cis	1	rs2806863	chr1:117469513	SLC22A15	chr1:116519119-116612672:+	-0.59	-4.39	2.96E-5	Erectile dysfunction and prostate cancer treatment	
THYM	cis	1	rs2806864	chr1:117469781	SLC22A15	chr1:116519119-116612672:+	-0.59	-4.39	2.96E-5	Erectile dysfunction and prostate cancer treatment	
THYM	cis	1	rs2811434	chr3:129339615	TMCC1	chr3:129366637-129612403:-	0.31	4.24	5.18E-5	Waist-to-hip ratio adjusted for body mass index	
THYM	cis	1	rs2811435	chr3:129339470	TMCC1	chr3:129366637-129612403:-	0.31	4.26	4.74E-5	Waist-to-hip ratio adjusted for body mass index	
THYM	cis	1	rs2811437	chr3:129339045	TMCC1	chr3:129366637-129612403:-	-0.31	-4.29	4.36E-5	Waist-to-hip ratio adjusted for body mass index	
THYM	cis	1	rs2812972	chr6:86669880	SNHG5	chr6:86386726-86388451:-	-0.57	-7.62	1.9E-11	Response to antipsychotic treatment	
THYM	cis	1	rs2816815	chr6:86691656	SNHG5	chr6:86386726-86388451:-	-0.57	-7.62	1.9E-11	Response to antipsychotic treatment	
THYM	cis	1	rs2816821	chr6:86657084	SNHG5	chr6:86386726-86388451:-	-0.57	-7.62	1.9E-11	Response to antipsychotic treatment	
THYM	cis	1	rs28365850	chr14:35591316	KIAA0391	chr14:35591776-35786673:+	0.34	4.33	3.71E-5	Atopic dermatitis	
THYM	cis	1	rs28365850	chr14:35591316	PPP2R3C	chr14:35554679-35591679:-	0.27	4.94	3.36E-6	Atopic dermatitis	
THYM	cis	1	rs2836974	chr21:40663181	PSMG1	chr21:40547390-40555440:-	-0.37	-4.57	1.49E-5	Cognitive function	
THYM	cis	1	rs28399702	chr14:35625217	PPP2R3C	chr14:35554679-35591679:-	0.24	4.67	1.0E-5	Atopic dermatitis	
THYM	cis	1	rs28409322	chr3:134252385	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs28409322	chr3:134252385	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs28505517	chr16:4608099	NMRAL1	chr16:4511696-4526307:-	-0.5	-5.61	1.96E-7	Obesity-related traits	
THYM	cis	1	rs2862961	chr11:43656535	HSD17B12	chr11:43702143-43878160:+	0.57	5.83	7.53E-8	Forced vital capacity	
THYM	cis	1	rs2862963	chr11:43640115	HSD17B12	chr11:43702143-43878160:+	0.57	5.83	7.53E-8	Forced vital capacity	
THYM	cis	1	rs2862996	chr11:43653833	HSD17B12	chr11:43702143-43878160:+	-0.57	-5.83	7.53E-8	Forced vital capacity	
THYM	cis	1	rs28664971	chr17:28437410	EFCAB5	chr17:28256874-28435469:+	0.33	4.51	1.84E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs28667788	chr9:91560954	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs28702390	chr3:41889920	ULK4	chr3:41288091-42003660:-	0.96	9.51	1.88E-15	Diastolic blood pressure	
THYM	cis	1	rs28733681	chr3:41863444	ULK4	chr3:41288091-42003660:-	1	10.81	3.16E-18	Diastolic blood pressure	
THYM	cis	1	rs2874121	chr17:61731024	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.41	2.72E-5	Body mass index	
THYM	cis	1	rs28755797	chr3:41774446	ULK4	chr3:41288091-42003660:-	0.98	9.58	1.33E-15	Diastolic blood pressure	
THYM	cis	1	rs28824259	chr3:48425675	TREX1	chr3:48501186-48509043:+	-0.28	-4.38	3.02E-5	Longevity	
THYM	cis	1	rs28852385	chr9:91559244	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs2885510	chr3:48418226	TREX1	chr3:48501186-48509043:+	0.28	4.49	2.0E-5	Longevity	
THYM	cis	1	rs2887797	chr3:134202506	ANAPC13	chr3:134196547-134204865:-	0.56	7.74	1.08E-11	Height	
THYM	cis	1	rs2887797	chr3:134202506	CEP63	chr3:134204575-134293852:+	0.39	5.72	1.23E-7	Height	
THYM	cis	1	rs2901438	chr2:73665656	ALMS1P	chr2:73872046-73912692:+	0.58	4.7	8.77E-6	Metabolite levels	
THYM	cis	1	rs2920283	chr8:143757037	PSCA	chr8:143761875-143764142:+	0.44	4.23	5.48E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs2920292	chr8:143765699	PSCA	chr8:143761875-143764142:+	0.43	4.3	4.13E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs2920293	chr8:143765414	PSCA	chr8:143761875-143764142:+	0.44	4.3	4.12E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs2920294	chr8:143765326	PSCA	chr8:143761875-143764142:+	0.43	4.3	4.13E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs2920295	chr8:143764937	PSCA	chr8:143761875-143764142:+	0.43	4.3	4.13E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs2920296	chr8:143763109	PSCA	chr8:143761875-143764142:+	0.43	4.29	4.22E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs2920297	chr8:143763083	PSCA	chr8:143761875-143764142:+	0.43	4.29	4.22E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs2920298	chr8:143763043	PSCA	chr8:143761875-143764142:+	0.43	4.29	4.22E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs2920781	chr15:43924682	ADAL	chr15:43622872-43646094:+	-0.51	-4.38	3.06E-5	Tumor biomarkers	
THYM	cis	1	rs2927072	chr15:43922398	ADAL	chr15:43622872-43646094:+	-0.51	-4.38	3.06E-5	Tumor biomarkers	
THYM	cis	1	rs2951851	chr8:6693495	XKR5	chr8:6666043-6693037:-	-0.45	-5.03	2.27E-6	IgA nephropathy	
THYM	cis	1	rs2961102	chr7:65424658	CCT6P1	chr7:65216092-65228661:+	0.64	5.29	7.77E-7	Diabetic kidney disease	
THYM	cis	1	rs2976392	chr8:143762932	PSCA	chr8:143761875-143764142:+	0.43	4.29	4.22E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs2976394	chr8:143763622	PSCA	chr8:143761875-143764142:+	0.43	4.29	4.22E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs2976396	chr8:143764001	PSCA	chr8:143761875-143764142:+	-0.43	-4.29	4.22E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs2976398	chr8:143764879	PSCA	chr8:143761875-143764142:+	0.43	4.3	4.13E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs2977993	chr9:131608786	ENDOG	chr9:131580779-131584954:+	0.22	4.41	2.76E-5	Schizophrenia	
THYM	cis	1	rs2978894	chr8:6693629	XKR5	chr8:6666043-6693037:-	-0.42	-4.52	1.76E-5	IgA nephropathy	
THYM	cis	1	rs2978982	chr8:143763490	PSCA	chr8:143761875-143764142:+	0.43	4.29	4.22E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
THYM	cis	1	rs2985697	chr14:50092902	RPL36AL	chr14:50085407-50087349:-	0.26	4.26	4.89E-5	Carotid intima media thickness	
THYM	cis	1	rs2993259	chr1:46001550	CCDC163P	chr1:45960581-45965646:-	-0.82	-13.83	1.73E-24	Homocysteine levels	
THYM	cis	1	rs30378	chr5:96121994	ERAP1	chr5:96096515-96149837:-	-0.32	-4.13	7.77E-5	Ankylosing spondylitis	
THYM	cis	1	rs30379	chr5:96122260	ERAP1	chr5:96096515-96149837:-	-0.32	-4.13	7.77E-5	Ankylosing spondylitis	
THYM	cis	1	rs30380	chr5:96122281	ERAP1	chr5:96096515-96149837:-	-0.32	-4.13	7.77E-5	Ankylosing spondylitis	
THYM	cis	1	rs3088162	chr20:23607752	CST9	chr20:23583049-23586610:-	-0.5	-4.66	1.04E-5	Chronic kidney disease	
THYM	cis	1	rs3099459	chr5:56137170	C5orf35	chr5:56205103-56213010:+	0.75	9.03	1.94E-14	Type 2 diabetes	
THYM	cis	1	rs3101443	chr15:43912372	ADAL	chr15:43622872-43646094:+	-0.5	-4.35	3.42E-5	Tumor biomarkers	
THYM	cis	1	rs3118625	chr9:131873256	CRAT	chr9:131857075-131873070:-	-0.47	-5.46	3.79E-7	Blood metabolite ratios	
THYM	cis	1	rs3118632	chr9:131901284	CRAT	chr9:131857075-131873070:-	-0.42	-4.98	2.82E-6	Blood metabolite ratios	
THYM	cis	1	rs3124498	chr9:131865493	CRAT	chr9:131857075-131873070:-	-0.48	-5.25	9.3E-7	Blood metabolite ratios	
THYM	cis	1	rs3124499	chr9:131868991	CRAT	chr9:131857075-131873070:-	-0.48	-5.25	9.3E-7	Blood metabolite ratios	
THYM	cis	1	rs3124510	chr9:131899690	CRAT	chr9:131857075-131873070:-	-0.42	-4.98	2.82E-6	Blood metabolite ratios	
THYM	cis	1	rs3124511	chr9:131901458	CRAT	chr9:131857075-131873070:-	-0.47	-5.4	4.92E-7	Blood metabolite ratios	
THYM	cis	1	rs3124512	chr9:131903881	CRAT	chr9:131857075-131873070:-	-0.45	-5.28	8.1E-7	Blood metabolite ratios	
THYM	cis	1	rs3124513	chr9:131904593	CRAT	chr9:131857075-131873070:-	-0.42	-4.98	2.82E-6	Blood metabolite ratios	
THYM	cis	1	rs3124514	chr9:131904608	CRAT	chr9:131857075-131873070:-	-0.42	-4.98	2.82E-6	Blood metabolite ratios	
THYM	cis	1	rs313798	chr7:65493031	CCT6P1	chr7:65216092-65228661:+	0.65	5.41	4.64E-7	Diabetic kidney disease	
THYM	cis	1	rs313799	chr7:65494330	CCT6P1	chr7:65216092-65228661:+	0.63	5.32	6.9E-7	Diabetic kidney disease	
THYM	cis	1	rs313802	chr7:65516373	CCT6P1	chr7:65216092-65228661:+	0.67	5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs313803	chr7:65514731	CCT6P1	chr7:65216092-65228661:+	0.67	5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs313807	chr7:65499481	CCT6P1	chr7:65216092-65228661:+	0.63	5.32	6.9E-7	Diabetic kidney disease	
THYM	cis	1	rs313809	chr7:65499983	CCT6P1	chr7:65216092-65228661:+	0.67	5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs313813	chr7:65503500	CCT6P1	chr7:65216092-65228661:+	0.63	5.21	1.09E-6	Diabetic kidney disease	
THYM	cis	1	rs313814	chr7:65503293	CCT6P1	chr7:65216092-65228661:+	0.67	5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs313820	chr7:65574466	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs313824	chr7:65581207	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs313831	chr7:65551226	CCT6P1	chr7:65216092-65228661:+	0.65	5.41	4.64E-7	Diabetic kidney disease	
THYM	cis	1	rs313832	chr7:65550891	CCT6P1	chr7:65216092-65228661:+	0.65	5.41	4.64E-7	Diabetic kidney disease	
THYM	cis	1	rs316304	chr7:65616894	CCT6P1	chr7:65216092-65228661:+	0.65	5.41	4.64E-7	Diabetic kidney disease	
THYM	cis	1	rs316307	chr7:65570171	CCT6P1	chr7:65216092-65228661:+	0.65	5.41	4.64E-7	Diabetic kidney disease	
THYM	cis	1	rs316312	chr7:65596491	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs316313	chr7:65593548	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs316315	chr7:65591205	CCT6P1	chr7:65216092-65228661:+	-0.53	-5.37	5.57E-7	Diabetic kidney disease	
THYM	cis	1	rs316317	chr7:65613637	CCT6P1	chr7:65216092-65228661:+	0.65	5.41	4.64E-7	Diabetic kidney disease	
THYM	cis	1	rs316318	chr7:65612904	CCT6P1	chr7:65216092-65228661:+	0.65	5.41	4.64E-7	Diabetic kidney disease	
THYM	cis	1	rs316321	chr7:65611613	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs316322	chr7:65611233	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs316325	chr7:65609518	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs316326	chr7:65609453	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs316327	chr7:65609201	CCT6P1	chr7:65216092-65228661:+	-0.64	-5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs316329	chr7:65608416	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs316330	chr7:65605372	CCT6P1	chr7:65216092-65228661:+	0.59	4.33	3.73E-5	Diabetic kidney disease	
THYM	cis	1	rs316331	chr7:65604622	CCT6P1	chr7:65216092-65228661:+	-0.64	-5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs316332	chr7:65604299	CCT6P1	chr7:65216092-65228661:+	0.63	5.27	8.65E-7	Diabetic kidney disease	
THYM	cis	1	rs316334	chr7:65602126	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs3204270	chr17:79682051	ARL16	chr17:79648234-79650954:-	-0.51	-5	2.6E-6	Dental caries	
THYM	cis	1	rs3204270	chr17:79682051	SLC25A10	chr17:79670407-79688041:+	0.53	5.17	1.28E-6	Dental caries	
THYM	cis	1	rs3213762	chr17:38178627	GSDMA	chr17:38119226-38134019:+	-0.89	-9.51	1.83E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THYM	cis	1	rs3214041	chr3:48454468	TREX1	chr3:48501186-48509043:+	-0.29	-4.44	2.44E-5	Longevity	
THYM	cis	1	rs33322	chr5:56175226	C5orf35	chr5:56205103-56213010:+	0.75	9.04	1.84E-14	Type 2 diabetes	
THYM	cis	1	rs33325	chr5:56142547	C5orf35	chr5:56205103-56213010:+	0.77	9.59	1.25E-15	Type 2 diabetes	
THYM	cis	1	rs33326	chr5:56142601	C5orf35	chr5:56205103-56213010:+	0.75	9.04	1.84E-14	Type 2 diabetes	
THYM	cis	1	rs33988592	chr3:121415610	IQCB1	chr3:121488610-121553926:-	0.45	4.25	5.03E-5	Cognitive performance	
THYM	cis	1	rs33993216	chr10:17204139	CUBN	chr10:16865966-17171816:-	0.31	4.8	5.85E-6	Homocysteine levels	
THYM	cis	1	rs33999310	chr3:52883332	ITIH4	chr3:52847007-52866554:-	-0.52	-4.62	1.18E-5	Immune reponse to smallpox (secreted IL-2)	
THYM	cis	1	rs34055941	chr9:131895076	CRAT	chr9:131857075-131873070:-	0.42	4.98	2.82E-6	Blood metabolite ratios	
THYM	cis	1	rs34086988	chr3:121352745	IQCB1	chr3:121488610-121553926:-	0.47	4.28	4.46E-5	Cognitive performance	
THYM	cis	1	rs34102169	chr1:46424864	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs34106666	chr6:86676258	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs34136756	chr7:65381256	CCT6P1	chr7:65216092-65228661:+	0.68	4.97	3.0E-6	Diabetic kidney disease	
THYM	cis	1	rs34192067	chr7:65887657	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Diabetic kidney disease	
THYM	cis	1	rs34193460	chr7:65393110	CCT6P1	chr7:65216092-65228661:+	0.7	5.13	1.51E-6	Diabetic kidney disease	
THYM	cis	1	rs34281561	chr6:86701872	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs34374560	chr20:23609462	CST9	chr20:23583049-23586610:-	-0.51	-4.73	7.71E-6	Chronic kidney disease	
THYM	cis	1	rs344081	chr3:156555984	LEKR1	chr3:156544076-156763918:+	-0.72	-4.3	4.1E-5	Bone mineral density	
THYM	cis	1	rs344088	chr3:156561361	LEKR1	chr3:156544076-156763918:+	-0.72	-4.3	4.1E-5	Bone mineral density	
THYM	cis	1	rs344090	chr3:156563140	LEKR1	chr3:156544076-156763918:+	-0.72	-4.3	4.1E-5	Bone mineral density	
THYM	cis	1	rs34434809	chr10:17187634	CUBN	chr10:16865966-17171816:-	0.32	4.95	3.16E-6	Homocysteine levels	
THYM	cis	1	rs34500464	chr10:17191996	CUBN	chr10:16865966-17171816:-	0.3	4.68	9.61E-6	Homocysteine levels	
THYM	cis	1	rs34529418	chr7:65403209	CCT6P1	chr7:65216092-65228661:+	0.67	4.9	3.88E-6	Diabetic kidney disease	
THYM	cis	1	rs34530577	chr3:53103796	RFT1	chr3:53122503-53164470:-	-0.44	-4.96	3.05E-6	Height	
THYM	cis	1	rs34544259	chr21:43834854	TMPRSS3	chr21:43791996-43816200:-	0.5	4.75	7.26E-6	Type 1 diabetes	
THYM	cis	1	rs34558323	chr10:17184228	CUBN	chr10:16865966-17171816:-	0.3	4.6	1.29E-5	Homocysteine levels	
THYM	cis	1	rs34560516	chr7:65404092	CCT6P1	chr7:65216092-65228661:+	0.64	5.29	7.77E-7	Diabetic kidney disease	
THYM	cis	1	rs34577383	chr7:65385726	CCT6P1	chr7:65216092-65228661:+	0.67	4.9	3.88E-6	Diabetic kidney disease	
THYM	cis	1	rs34581302	chr6:86705948	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs34622557	chr6:86630852	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs34629498	chr19:23060720	ZNF492	chr19:22817126-22850472:+	-0.52	-5.7	1.32E-7	Bronchopulmonary dysplasia	
THYM	cis	1	rs34637256	chr7:65360131	CCT6P1	chr7:65216092-65228661:+	0.65	4.84	4.96E-6	Diabetic kidney disease	
THYM	cis	1	rs34702770	chr7:65344823	CCT6P1	chr7:65216092-65228661:+	0.65	4.84	4.96E-6	Diabetic kidney disease	
THYM	cis	1	rs34703416	chr7:65300642	CCT6P1	chr7:65216092-65228661:+	0.65	4.87	4.36E-6	Diabetic kidney disease	
THYM	cis	1	rs34812189	chr6:56806727	BEND6	chr6:56819773-56892138:+	-0.53	-4.93	3.45E-6	Menarche (age at onset)	
THYM	cis	1	rs34815098	chr7:65292254	CCT6P1	chr7:65216092-65228661:+	0.64	4.78	6.3E-6	Diabetic kidney disease	
THYM	cis	1	rs34852683	chr6:86702330	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs34897231	chr20:23620268	CST9	chr20:23583049-23586610:-	-0.48	-4.46	2.25E-5	Chronic kidney disease	
THYM	cis	1	rs34897410	chr2:239182123	LOC151174	chr2:239133754-239140318:-	0.89	4.51	1.84E-5	Irritable bowel syndrome	
THYM	cis	1	rs34933526	chr7:65383199	CCT6P1	chr7:65216092-65228661:+	0.68	4.97	3.0E-6	Diabetic kidney disease	
THYM	cis	1	rs34945223	chr18:77575871	KCNG2	chr18:77623668-77659815:+	0.55	4.38	3.1E-5	Schizophrenia	
THYM	cis	1	rs34970380	chr7:65431493	CCT6P1	chr7:65216092-65228661:+	0.65	5.32	6.97E-7	Diabetic kidney disease	
THYM	cis	1	rs34974928	chr7:65364006	CCT6P1	chr7:65216092-65228661:+	0.64	4.78	6.3E-6	Diabetic kidney disease	
THYM	cis	1	rs35046236	chr7:65408613	CCT6P1	chr7:65216092-65228661:+	0.62	5.13	1.51E-6	Diabetic kidney disease	
THYM	cis	1	rs35058610	chr7:65390925	CCT6P1	chr7:65216092-65228661:+	0.68	4.97	3.0E-6	Diabetic kidney disease	
THYM	cis	1	rs35060985	chr11:43693110	HSD17B12	chr11:43702143-43878160:+	-0.63	-7.38	6.01E-11	Forced vital capacity	
THYM	cis	1	rs35062783	chr10:17202869	CUBN	chr10:16865966-17171816:-	0.31	4.8	5.85E-6	Homocysteine levels	
THYM	cis	1	rs35209719	chr1:212401677	NEK2	chr1:211836115-211848967:-	-0.16	-4.42	2.59E-5	Intelligence (childhood)	
THYM	cis	1	rs35283677	chr7:65359233	CCT6P1	chr7:65216092-65228661:+	0.68	5.01	2.55E-6	Diabetic kidney disease	
THYM	cis	1	rs35332070	chr19:23034266	ZNF492	chr19:22817126-22850472:+	-0.5	-5.66	1.61E-7	Bronchopulmonary dysplasia	
THYM	cis	1	rs35341640	chr17:18818228	FAM18B	chr17:18684582-18710026:+	0.26	4.53	1.73E-5	Pancreatic cancer	
THYM	cis	1	rs35385043	chr6:86648546	SNHG5	chr6:86386726-86388451:-	-0.57	-7.62	1.9E-11	Response to antipsychotic treatment	
THYM	cis	1	rs35391607	chr7:65360829	CCT6P1	chr7:65216092-65228661:+	0.64	4.78	6.3E-6	Diabetic kidney disease	
THYM	cis	1	rs35396113	chr7:65495461	CCT6P1	chr7:65216092-65228661:+	0.67	5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs35419329	chr6:86702291	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs35421653	chr7:65363429	CCT6P1	chr7:65216092-65228661:+	0.68	5.01	2.55E-6	Diabetic kidney disease	
THYM	cis	1	rs35432774	chr7:65393019	CCT6P1	chr7:65216092-65228661:+	0.67	4.9	3.88E-6	Diabetic kidney disease	
THYM	cis	1	rs35435780	chr17:79579602	TSPAN10	chr17:79609349-79615778:+	0.63	6.68	1.61E-9	Eye color traits	
THYM	cis	1	rs35454259	chr6:27254475	LOC100270746	chr6:26987146-26988085:-	0.48	4.64	1.13E-5	Schizophrenia	
THYM	cis	1	rs35488434	chr20:23620401	CST9	chr20:23583049-23586610:-	-0.48	-4.46	2.25E-5	Chronic kidney disease	
THYM	cis	1	rs35526714	chr12:56634639	RPS26	chr12:56435686-56438005:+	-0.94	-4.54	1.66E-5	Psoriasis vulgaris	
THYM	cis	1	rs35542501	chr7:65431215	CCT6P1	chr7:65216092-65228661:+	0.62	5.1	1.73E-6	Diabetic kidney disease	
THYM	cis	1	rs35608327	chr15:90369204	AP3S2	chr15:90373832-90456222:-	-0.42	-4.66	1.02E-5	Type 2 diabetes	
THYM	cis	1	rs35630951	chr10:17215649	CUBN	chr10:16865966-17171816:-	0.31	4.72	8.18E-6	Homocysteine levels	
THYM	cis	1	rs35641543	chr2:54347313	RTN4	chr2:55199329-55277734:-	-0.5	-4.14	7.39E-5	Sudden cardiac arrest	
THYM	cis	1	rs35648651	chr2:239133843	LOC151174	chr2:239133754-239140318:-	0.94	4.73	7.74E-6	Irritable bowel syndrome	
THYM	cis	1	rs35718987	chr3:134272783	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs35718987	chr3:134272783	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs35723648	chr3:74627121	CNTN3	chr3:74311722-74570343:-	0.47	4.8	5.86E-6	Economic and political preferences	
THYM	cis	1	rs35735127	chr7:65300423	CCT6P1	chr7:65216092-65228661:+	0.64	4.78	6.3E-6	Diabetic kidney disease	
THYM	cis	1	rs35736167	chr15:75332002	PPCDC	chr15:75315927-75343066:+	0.27	4.85	4.8E-6	Blood trace element (Zn levels)	
THYM	cis	1	rs35760725	chr6:86648985	SNHG5	chr6:86386726-86388451:-	-0.57	-7.62	1.9E-11	Response to antipsychotic treatment	
THYM	cis	1	rs35761942	chr6:86629504	SNHG5	chr6:86386726-86388451:-	-0.61	-7.35	6.78E-11	Response to antipsychotic treatment	
THYM	cis	1	rs35797755	chr6:86706554	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs35820085	chr7:65442758	CCT6P1	chr7:65216092-65228661:+	0.65	5.32	6.97E-7	Diabetic kidney disease	
THYM	cis	1	rs35825738	chr7:65318027	CCT6P1	chr7:65216092-65228661:+	0.64	4.78	6.3E-6	Diabetic kidney disease	
THYM	cis	1	rs35988617	chr3:121432902	IQCB1	chr3:121488610-121553926:-	0.45	4.25	5.03E-5	Cognitive performance	
THYM	cis	1	rs36033484	chr7:65390558	CCT6P1	chr7:65216092-65228661:+	0.7	5.13	1.51E-6	Diabetic kidney disease	
THYM	cis	1	rs36068983	chr7:65408991	CCT6P1	chr7:65216092-65228661:+	0.62	5.13	1.51E-6	Diabetic kidney disease	
THYM	cis	1	rs36096931	chr6:86693134	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs36216559	chr2:262335	SH3YL1	chr2:218138-264810:-	-0.33	-4.86	4.59E-6	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs364283	chr6:167383750	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs364451	chr6:167384756	RNASET2	chr6:167343008-167412795:-	-0.45	-7.53	2.89E-11	Crohn's disease	
THYM	cis	1	rs365189	chr6:167384545	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs3731593	chr2:227773924	RHBDD1	chr2:227700773-227861591:+	-0.31	-4.5	1.93E-5	Pulmonary function	
THYM	cis	1	rs3731714	chr2:202060820	PPIL3	chr2:201735680-201753999:-	0.48	4.36	3.36E-5	Trans fatty acid levels	
THYM	cis	1	rs3732276	chr2:242343404	SEPT2	chr2:242254723-242293439:+	0.43	5.77	1.01E-7	Chronic lymphocytic leukemia	
THYM	cis	1	rs3732408	chr3:121421179	IQCB1	chr3:121488610-121553926:-	0.45	4.25	5.03E-5	Cognitive performance	
THYM	cis	1	rs3734618	chr6:39284184	KCNK17	chr6:39266778-39282237:-	-0.47	-4.73	7.83E-6	Type 2 diabetes	
THYM	cis	1	rs3738848	chr2:73761881	ALMS1P	chr2:73872046-73912692:+	0.58	4.7	8.77E-6	Metabolite levels	
THYM	cis	1	rs3739843	chr9:131882961	CRAT	chr9:131857075-131873070:-	0.38	4.61	1.24E-5	Blood metabolite ratios	
THYM	cis	1	rs3739847	chr9:131911574	CRAT	chr9:131857075-131873070:-	-0.42	-4.98	2.82E-6	Blood metabolite ratios	
THYM	cis	1	rs3742500	chr14:24611978	FAM158A	chr14:24608175-24610797:-	-0.3	-9.36	3.95E-15	IgG glycosylation	
THYM	cis	1	rs3745937	chr19:42071289	CEACAM21	chr19:42055886-42093196:+	0.69	9.09	1.46E-14	Schizophrenia	
THYM	cis	1	rs3752950	chr10:17203356	CUBN	chr10:16865966-17171816:-	0.31	4.8	5.85E-6	Homocysteine levels	
THYM	cis	1	rs3760891	chr19:33599708	GPATCH1	chr19:33571786-33621318:+	0.37	4.33	3.69E-5	Bone properties (heel)	
THYM	cis	1	rs3761378	chr21:43832918	TMPRSS3	chr21:43791996-43816200:-	-0.5	-4.73	7.78E-6	Type 1 diabetes	
THYM	cis	1	rs3761959	chr1:157669278	FCRL3	chr1:157646278-157670775:-	0.3	4.26	4.85E-5	Type 1 diabetes autoantibodies	
THYM	cis	1	rs376551	chr6:167384923	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs376574	chr6:167389956	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs3770752	chr2:37576136	CEBPZ	chr2:37428778-37458740:-	0.42	4.2	6.08E-5	Schizophrenia	
THYM	cis	1	rs3772128	chr3:121345094	IQCB1	chr3:121488610-121553926:-	0.48	4.47	2.2E-5	Cognitive performance	
THYM	cis	1	rs3772130	chr3:121344140	IQCB1	chr3:121488610-121553926:-	0.48	4.47	2.2E-5	Cognitive performance	
THYM	cis	1	rs3774372	chr3:41877414	ULK4	chr3:41288091-42003660:-	0.94	9.49	2.06E-15	Diastolic blood pressure	
THYM	cis	1	rs3774808	chr3:48481647	TREX1	chr3:48501186-48509043:+	-0.28	-4.23	5.28E-5	Longevity	
THYM	cis	1	rs3782130	chr12:58161898	FAM119B	chr12:58166383-58176323:+	0.42	5.62	1.9E-7	Multiple sclerosis	
THYM	cis	1	rs3782130	chr12:58161898	TSFM	chr12:58176536-58191367:+	-0.27	-4.75	7.08E-6	Multiple sclerosis	
THYM	cis	1	rs3786933	chr19:33602881	GPATCH1	chr19:33571786-33621318:+	0.37	4.33	3.69E-5	Bone properties (heel)	
THYM	cis	1	rs3787498	chr20:23616781	CST9	chr20:23583049-23586610:-	-0.48	-4.51	1.87E-5	Chronic kidney disease	
THYM	cis	1	rs3787499	chr20:23616807	CST9	chr20:23583049-23586610:-	-0.48	-4.51	1.87E-5	Chronic kidney disease	
THYM	cis	1	rs3791220	chr2:227066	SH3YL1	chr2:218138-264810:-	-0.31	-4.56	1.52E-5	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs3791221	chr2:226933	SH3YL1	chr2:218138-264810:-	-0.31	-4.56	1.52E-5	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs3791223	chr2:222336	SH3YL1	chr2:218138-264810:-	-0.3	-4.42	2.59E-5	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs3791224	chr2:221981	SH3YL1	chr2:218138-264810:-	-0.32	-4.62	1.2E-5	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs3796689	chr4:185649866	MLF1IP	chr4:185615220-185655286:-	-0.35	-8.02	2.79E-12	Kawasaki disease	
THYM	cis	1	rs3800316	chr6:27256102	LOC100270746	chr6:26987146-26988085:-	0.4	5.14	1.46E-6	Schizophrenia	
THYM	cis	1	rs3805108	chr3:183691650	ABCC5	chr3:183637726-183735727:-	0.48	4.28	4.53E-5	Anterior chamber depth	
THYM	cis	1	rs3806988	chr6:49431569	CENPQ	chr6:49431096-49460820:+	-0.24	-4.4	2.83E-5	Folate pathway vitamin levels	
THYM	cis	1	rs3813227	chr2:73651967	ALMS1P	chr2:73872046-73912692:+	-0.58	-4.7	8.77E-6	Metabolite levels	
THYM	cis	1	rs3814492	chr9:131873222	CRAT	chr9:131857075-131873070:-	0.38	4.59	1.35E-5	Blood metabolite ratios	
THYM	cis	1	rs3817181	chr17:61776538	TCAM1P	chr17:61934376-61941738:+	-0.55	-4.23	5.47E-5	Body mass index	
THYM	cis	1	rs3820928	chr2:227773466	RHBDD1	chr2:227700773-227861591:+	-0.31	-4.56	1.54E-5	Pulmonary function	
THYM	cis	1	rs3823114	chr6:49431720	CENPQ	chr6:49431096-49460820:+	-0.25	-4.38	3.04E-5	Folate pathway vitamin levels	
THYM	cis	1	rs3823114	chr6:49431720	MUT	chr6:49398994-49431031:-	0.28	4.22	5.59E-5	Folate pathway vitamin levels	
THYM	cis	1	rs3825079	chr12:58203354	FAM119B	chr12:58166383-58176323:+	0.42	5.72	1.22E-7	Multiple sclerosis	
THYM	cis	1	rs3825079	chr12:58203354	TSFM	chr12:58176536-58191367:+	-0.29	-5.12	1.6E-6	Multiple sclerosis	
THYM	cis	1	rs3826331	chr17:38150492	GSDMA	chr17:38119226-38134019:+	0.89	9.76	5.45E-16	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THYM	cis	1	rs3827142	chr20:23617007	CST9	chr20:23583049-23586610:-	-0.48	-4.51	1.87E-5	Chronic kidney disease	
THYM	cis	1	rs3827143	chr20:23619617	CST9	chr20:23583049-23586610:-	-0.48	-4.46	2.25E-5	Chronic kidney disease	
THYM	cis	1	rs3828165	chr2:220889	SH3YL1	chr2:218138-264810:-	-0.3	-4.42	2.59E-5	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs383402	chr7:65586653	CCT6P1	chr7:65216092-65228661:+	-0.64	-5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs3846055	chr3:134203973	ANAPC13	chr3:134196547-134204865:-	0.57	7.8	7.93E-12	Height	
THYM	cis	1	rs3846055	chr3:134203973	CEP63	chr3:134204575-134293852:+	0.39	5.71	1.31E-7	Height	
THYM	cis	1	rs3846056	chr3:134227292	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs3846056	chr3:134227292	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs385113	chr6:167403971	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs385863	chr6:167386615	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs386548	chr6:167385533	RNASET2	chr6:167343008-167412795:-	0.45	7.46	4.07E-11	Crohn's disease	
THYM	cis	1	rs387676	chr7:65598220	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs3885839	chr7:65290403	CCT6P1	chr7:65216092-65228661:+	0.68	5.01	2.55E-6	Diabetic kidney disease	
THYM	cis	1	rs3890604	chr3:41760625	ULK4	chr3:41288091-42003660:-	1.03	11.64	5.41E-20	Diastolic blood pressure	
THYM	cis	1	rs389946	chr6:167407268	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs389956	chr6:167407254	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs3932818	chr3:134206069	ANAPC13	chr3:134196547-134204865:-	0.57	7.72	1.16E-11	Height	
THYM	cis	1	rs3932818	chr3:134206069	CEP63	chr3:134204575-134293852:+	0.41	5.95	4.4E-8	Height	
THYM	cis	1	rs3934103	chr3:41977214	ULK4	chr3:41288091-42003660:-	-0.99	-10.55	1.1E-17	Diastolic blood pressure	
THYM	cis	1	rs3935543	chr17:79579874	TSPAN10	chr17:79609349-79615778:+	0.63	6.68	1.61E-9	Eye color traits	
THYM	cis	1	rs393558	chr6:167397750	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs393727	chr6:167398632	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs394522	chr6:167398071	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs3960018	chr15:90383307	AP3S2	chr15:90373832-90456222:-	-0.43	-4.89	4.09E-6	Type 2 diabetes	
THYM	cis	1	rs397713	chr6:167386714	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs398278	chr6:167388169	RNASET2	chr6:167343008-167412795:-	-0.45	-7.53	2.89E-11	Crohn's disease	
THYM	cis	1	rs400063	chr6:167386592	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs400176	chr6:167406238	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs400837	chr6:167411008	RNASET2	chr6:167343008-167412795:-	-0.46	-7.49	3.6E-11	Crohn's disease	
THYM	cis	1	rs402418	chr7:65509469	CCT6P1	chr7:65216092-65228661:+	0.67	5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs402749	chr6:167386104	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs404222	chr6:167402150	RNASET2	chr6:167343008-167412795:-	-0.45	-7.53	2.89E-11	Crohn's disease	
THYM	cis	1	rs405553	chr6:167395058	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs406095	chr6:167409087	RNASET2	chr6:167343008-167412795:-	-0.46	-7.49	3.6E-11	Crohn's disease	
THYM	cis	1	rs406900	chr6:88085447	C6orf164	chr6:88032306-88109459:+	-0.5	-4.99	2.68E-6	Depressive episodes in bipolar disorder	
THYM	cis	1	rs4073846	chr1:46462881	CCDC163P	chr1:45960581-45965646:-	0.49	6	3.55E-8	Body mass index	
THYM	cis	1	rs4074170	chr17:28381141	EFCAB5	chr17:28256874-28435469:+	-0.31	-4.25	5.04E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs4074915	chr17:79579230	TSPAN10	chr17:79609349-79615778:+	-0.63	-6.68	1.61E-9	Eye color traits	
THYM	cis	1	rs4074916	chr17:79579248	TSPAN10	chr17:79609349-79615778:+	-0.63	-6.68	1.61E-9	Eye color traits	
THYM	cis	1	rs407515	chr6:167407544	RNASET2	chr6:167343008-167412795:-	-0.46	-7.49	3.6E-11	Crohn's disease	
THYM	cis	1	rs4075623	chr17:28386526	EFCAB5	chr17:28256874-28435469:+	-0.31	-4.25	5.04E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs4076006	chr1:46438076	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs408040	chr6:167398903	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs408080	chr6:167392522	RNASET2	chr6:167343008-167412795:-	-0.45	-7.53	2.89E-11	Crohn's disease	
THYM	cis	1	rs408087	chr6:167398952	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs408918	chr6:167399282	RNASET2	chr6:167343008-167412795:-	-0.47	-7.78	8.78E-12	Crohn's disease	
THYM	cis	1	rs409035	chr20:5943649	MCM8	chr20:5931298-5975829:+	-0.22	-4.5	1.96E-5	HIV-1 viral setpoint	
THYM	cis	1	rs409356	chr6:167405226	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs410128	chr7:65603173	CCT6P1	chr7:65216092-65228661:+	0.6	4.91	3.81E-6	Diabetic kidney disease	
THYM	cis	1	rs4129956	chr4:302008	ZNF718	chr4:53272-156488:+	0.67	7.27	1.03E-10	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs413232	chr6:167400972	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs4134386	chr1:46395089	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs414013	chr6:88085866	C6orf164	chr6:88032306-88109459:+	-0.5	-4.99	2.68E-6	Depressive episodes in bipolar disorder	
THYM	cis	1	rs4145008	chr7:65647511	CCT6P1	chr7:65216092-65228661:+	-0.67	-5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs4148571	chr3:183720576	ABCC5	chr3:183637726-183735727:-	0.5	4.38	3.08E-5	Anterior chamber depth	
THYM	cis	1	rs4148575	chr3:183702275	ABCC5	chr3:183637726-183735727:-	0.48	4.28	4.53E-5	Anterior chamber depth	
THYM	cis	1	rs4149468	chr7:65825690	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Diabetic kidney disease	
THYM	cis	1	rs415842	chr6:167406681	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs415890	chr6:167406633	RNASET2	chr6:167343008-167412795:-	0.47	7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs416131	chr6:167406544	RNASET2	chr6:167343008-167412795:-	0.47	7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs419603	chr7:65597341	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs421214	chr6:167396629	RNASET2	chr6:167343008-167412795:-	-0.47	-7.91	4.62E-12	Crohn's disease	
THYM	cis	1	rs422094	chr6:167397033	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs422164	chr7:65586605	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs422562	chr6:167406318	RNASET2	chr6:167343008-167412795:-	-0.46	-7.5	3.29E-11	Crohn's disease	
THYM	cis	1	rs422694	chr6:167406074	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs422780	chr6:167406209	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs4237643	chr11:43648368	HSD17B12	chr11:43702143-43878160:+	0.57	5.83	7.53E-8	Forced vital capacity	
THYM	cis	1	rs4239227	chr17:28389103	EFCAB5	chr17:28256874-28435469:+	-0.31	-4.25	5.04E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs42648	chr7:89977760	GTPBP10	chr7:89969690-90016650:+	0.29	4.76	7.02E-6	Homocysteine levels	
THYM	cis	1	rs42649	chr7:89977789	GTPBP10	chr7:89969690-90016650:+	0.29	5.03	2.31E-6	Homocysteine levels	
THYM	cis	1	rs42656	chr7:89981636	GTPBP10	chr7:89969690-90016650:+	0.29	4.76	7.02E-6	Homocysteine levels	
THYM	cis	1	rs42658	chr7:89981915	GTPBP10	chr7:89969690-90016650:+	0.26	4.39	2.95E-5	Homocysteine levels	
THYM	cis	1	rs4267943	chr6:49439805	CENPQ	chr6:49431096-49460820:+	0.24	4.17	6.68E-5	Folate pathway vitamin levels	
THYM	cis	1	rs4267943	chr6:49439805	MUT	chr6:49398994-49431031:-	-0.29	-4.38	3.0E-5	Folate pathway vitamin levels	
THYM	cis	1	rs427044	chr7:65508545	CCT6P1	chr7:65216092-65228661:+	0.67	5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs4282209	chr4:76919536	NAAA	chr4:76831809-76862166:-	-0.45	-4.79	6.23E-6	Longevity	
THYM	cis	1	rs429083	chr6:167383972	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs4294134	chr7:135293128	PL-5283	chr7:135347221-135378160:+	0.35	4.87	4.51E-6	Paget's disease	
THYM	cis	1	rs430097	chr6:167405073	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs430293	chr6:167404958	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs430477	chr6:167389851	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs4309773	chr3:134277301	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs4309773	chr3:134277301	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs431076	chr7:65600320	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.1E-7	Diabetic kidney disease	
THYM	cis	1	rs431318	chr7:65511597	CCT6P1	chr7:65216092-65228661:+	0.67	5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs43184	chr5:56141777	C5orf35	chr5:56205103-56213010:+	0.75	9.04	1.84E-14	Type 2 diabetes	
THYM	cis	1	rs4323544	chr9:123647377	LOC253039	chr9:123605320-123616644:+	-0.62	-5.56	2.51E-7	Rheumatoid arthritis	
THYM	cis	1	rs4328498	chr17:28344276	EFCAB5	chr17:28256874-28435469:+	-0.31	-4.27	4.62E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs4334685	chr3:134304335	ANAPC13	chr3:134196547-134204865:-	0.55	7.48	3.7E-11	Height	
THYM	cis	1	rs4334685	chr3:134304335	CEP63	chr3:134204575-134293852:+	0.43	6.36	7.09E-9	Height	
THYM	cis	1	rs4350617	chr17:28423088	EFCAB5	chr17:28256874-28435469:+	0.31	4.23	5.4E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs4362041	chr1:212400469	NEK2	chr1:211836115-211848967:-	-0.17	-4.53	1.74E-5	Intelligence (childhood)	
THYM	cis	1	rs436707	chr6:167388843	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs4367113	chr3:134287975	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs4367113	chr3:134287975	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs4368544	chr3:134300014	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.1	1.9E-12	Height	
THYM	cis	1	rs4368544	chr3:134300014	CEP63	chr3:134204575-134293852:+	-0.41	-5.93	4.96E-8	Height	
THYM	cis	1	rs4372836	chr2:28973883	TRMT61B	chr2:29072690-29093175:-	-0.5	-4.16	6.98E-5	Body mass index	
THYM	cis	1	rs4376778	chr1:46288846	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	6.8E-8	Body mass index	
THYM	cis	1	rs437889	chr7:65509234	CCT6P1	chr7:65216092-65228661:+	0.67	5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs439237	chr6:167391392	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs439295	chr3:156572455	LEKR1	chr3:156544076-156763918:+	-0.72	-4.3	4.1E-5	Bone mineral density	
THYM	cis	1	rs439553	chr6:167391212	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs4408846	chr3:41753679	ULK4	chr3:41288091-42003660:-	0.99	10.12	9.3E-17	Diastolic blood pressure	
THYM	cis	1	rs4417907	chr3:134291363	ANAPC13	chr3:134196547-134204865:-	0.58	8.05	2.33E-12	Height	
THYM	cis	1	rs4417907	chr3:134291363	CEP63	chr3:134204575-134293852:+	0.4	5.81	8.19E-8	Height	
THYM	cis	1	rs4423809	chr3:134300107	ANAPC13	chr3:134196547-134204865:-	-0.57	-7.63	1.8E-11	Height	
THYM	cis	1	rs4423809	chr3:134300107	CEP63	chr3:134204575-134293852:+	-0.42	-6.1	2.28E-8	Height	
THYM	cis	1	rs444988	chr6:167389674	RNASET2	chr6:167343008-167412795:-	-0.45	-7.53	2.89E-11	Crohn's disease	
THYM	cis	1	rs4452748	chr7:50625056	FIGNL1	chr7:50511834-50518088:-	0.3	4.64	1.09E-5	Malaria	
THYM	cis	1	rs4465649	chr17:28394747	EFCAB5	chr17:28256874-28435469:+	-0.31	-4.25	5.04E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs4465650	chr17:28396721	EFCAB5	chr17:28256874-28435469:+	0.31	4.26	4.84E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs4469291	chr6:49440614	CENPQ	chr6:49431096-49460820:+	-0.24	-4.28	4.54E-5	Folate pathway vitamin levels	
THYM	cis	1	rs4469291	chr6:49440614	MUT	chr6:49398994-49431031:-	0.28	4.39	2.9E-5	Folate pathway vitamin levels	
THYM	cis	1	rs448060	chr6:167382622	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs4490383	chr3:48484683	TREX1	chr3:48501186-48509043:+	-0.29	-4.28	4.47E-5	Longevity	
THYM	cis	1	rs4497901	chr2:239969	SH3YL1	chr2:218138-264810:-	-0.32	-4.66	1.02E-5	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs4498009	chr3:134198008	ANAPC13	chr3:134196547-134204865:-	0.58	7.97	3.55E-12	Height	
THYM	cis	1	rs4498009	chr3:134198008	CEP63	chr3:134204575-134293852:+	0.4	5.69	1.38E-7	Height	
THYM	cis	1	rs451396	chr7:65484074	CCT6P1	chr7:65216092-65228661:+	0.65	5.41	4.64E-7	Diabetic kidney disease	
THYM	cis	1	rs4533340	chr17:28277951	EFCAB5	chr17:28256874-28435469:+	0.32	4.3	4.2E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs4535272	chr3:134299916	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.05	2.38E-12	Height	
THYM	cis	1	rs4535272	chr3:134299916	CEP63	chr3:134204575-134293852:+	-0.43	-6.17	1.7E-8	Height	
THYM	cis	1	rs454422	chr20:5943693	MCM8	chr20:5931298-5975829:+	-0.22	-4.5	1.96E-5	HIV-1 viral setpoint	
THYM	cis	1	rs4545281	chr1:46360054	CCDC163P	chr1:45960581-45965646:-	-0.48	-5.85	6.88E-8	Body mass index	
THYM	cis	1	rs45472399	chr10:17209967	CUBN	chr10:16865966-17171816:-	0.31	4.7	8.68E-6	Homocysteine levels	
THYM	cis	1	rs4548056	chr7:65298873	CCT6P1	chr7:65216092-65228661:+	0.64	4.78	6.3E-6	Diabetic kidney disease	
THYM	cis	1	rs4549034	chr2:28972579	TRMT61B	chr2:29072690-29093175:-	-0.5	-4.16	6.98E-5	Body mass index	
THYM	cis	1	rs4549329	chr4:239785	ZNF718	chr4:53272-156488:+	0.53	5.92	5.01E-8	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs4559448	chr1:76203456	ACADM	chr1:76190043-76229353:+	0.3	4.24	5.21E-5	Blood metabolite levels;Acylcarnitine levels	
THYM	cis	1	rs4560868	chr9:115985499	CDC26	chr9:116029290-116037869:-	0.37	6.02	3.22E-8	Hematology traits	
THYM	cis	1	rs45615636	chr10:17210591	CUBN	chr10:16865966-17171816:-	0.3	4.68	9.61E-6	Homocysteine levels	
THYM	cis	1	rs4572812	chr3:134291177	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs4572812	chr3:134291177	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs4575590	chr17:28361969	EFCAB5	chr17:28256874-28435469:+	-0.31	-4.25	5.04E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs4581755	chr17:28427898	EFCAB5	chr17:28256874-28435469:+	0.31	4.23	5.4E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs4582105	chr4:246342	ZNF718	chr4:53272-156488:+	0.68	7.3	8.88E-11	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs458291	chr7:65520479	CCT6P1	chr7:65216092-65228661:+	0.67	5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs4594164	chr14:35509571	PPP2R3C	chr14:35554679-35591679:-	0.27	5.01	2.49E-6	Atopic dermatitis	
THYM	cis	1	rs4606360	chr1:173699007	SERPINC1	chr1:173872943-173886516:-	0.53	5.47	3.69E-7	Subjective well-being	
THYM	cis	1	rs4619189	chr12:131313797	STX2	chr12:131274149-131323811:-	0.33	5.6	2.1E-7	Plasma plasminogen activator levels	
THYM	cis	1	rs462853	chr7:65558167	CCT6P1	chr7:65216092-65228661:+	0.65	5.41	4.64E-7	Diabetic kidney disease	
THYM	cis	1	rs4646536	chr12:58157988	FAM119B	chr12:58166383-58176323:+	0.42	5.82	7.89E-8	Multiple sclerosis	
THYM	cis	1	rs4646536	chr12:58157988	TSFM	chr12:58176536-58191367:+	-0.26	-4.49	1.97E-5	Multiple sclerosis	
THYM	cis	1	rs4646961	chr1:76217169	ACADM	chr1:76190043-76229353:+	0.3	4.24	5.21E-5	Blood metabolite levels;Acylcarnitine levels	
THYM	cis	1	rs464895	chr7:65527106	CCT6P1	chr7:65216092-65228661:+	0.65	5.41	4.64E-7	Diabetic kidney disease	
THYM	cis	1	rs465359	chr7:65558164	CCT6P1	chr7:65216092-65228661:+	0.65	5.41	4.64E-7	Diabetic kidney disease	
THYM	cis	1	rs4660306	chr1:45978675	CCDC163P	chr1:45960581-45965646:-	0.85	14.54	6.79E-26	Homocysteine levels	
THYM	cis	1	rs4660317	chr1:46326226	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	6.8E-8	Body mass index	
THYM	cis	1	rs4660319	chr1:46341623	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	6.8E-8	Body mass index	
THYM	cis	1	rs4660321	chr1:46366760	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs4660870	chr1:45995231	CCDC163P	chr1:45960581-45965646:-	-0.76	-12.14	4.87E-21	Homocysteine levels	
THYM	cis	1	rs4660898	chr1:46402171	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs4660910	chr1:46548402	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs4663300	chr2:239181491	LOC151174	chr2:239133754-239140318:-	0.89	4.51	1.84E-5	Irritable bowel syndrome	
THYM	cis	1	rs4663865	chr2:239145960	LOC151174	chr2:239133754-239140318:-	-0.93	-4.67	9.96E-6	Irritable bowel syndrome	
THYM	cis	1	rs4663866	chr2:239150815	LOC151174	chr2:239133754-239140318:-	0.93	4.57	1.47E-5	Irritable bowel syndrome	
THYM	cis	1	rs4663867	chr2:239159964	LOC151174	chr2:239133754-239140318:-	0.93	4.57	1.47E-5	Irritable bowel syndrome	
THYM	cis	1	rs4663868	chr2:239161091	LOC151174	chr2:239133754-239140318:-	0.93	4.57	1.47E-5	Irritable bowel syndrome	
THYM	cis	1	rs4666118	chr2:28951698	TRMT61B	chr2:29072690-29093175:-	-0.5	-4.13	7.81E-5	Body mass index	
THYM	cis	1	rs4666119	chr2:28975690	TRMT61B	chr2:29072690-29093175:-	-0.52	-4.34	3.54E-5	Body mass index	
THYM	cis	1	rs466983	chr7:65520496	CCT6P1	chr7:65216092-65228661:+	0.67	5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs4673173	chr2:227769493	RHBDD1	chr2:227700773-227861591:+	-0.31	-4.5	1.92E-5	Pulmonary function	
THYM	cis	1	rs4675115	chr2:227769123	RHBDD1	chr2:227700773-227861591:+	-0.33	-4.92	3.62E-6	Pulmonary function	
THYM	cis	1	rs4675116	chr2:227769607	RHBDD1	chr2:227700773-227861591:+	-0.31	-4.56	1.54E-5	Pulmonary function	
THYM	cis	1	rs4675119	chr2:227774635	RHBDD1	chr2:227700773-227861591:+	-0.31	-4.59	1.34E-5	Pulmonary function	
THYM	cis	1	rs4675120	chr2:227774888	RHBDD1	chr2:227700773-227861591:+	-0.31	-4.54	1.63E-5	Pulmonary function	
THYM	cis	1	rs4687701	chr3:53121276	RFT1	chr3:53122503-53164470:-	0.48	5.18	1.23E-6	Height	
THYM	cis	1	rs469758	chr5:96121715	ERAP1	chr5:96096515-96149837:-	-0.32	-4.13	7.77E-5	Ankylosing spondylitis	
THYM	cis	1	rs4706254	chr6:86602813	SNHG5	chr6:86386726-86388451:-	-0.57	-7.62	1.9E-11	Response to antipsychotic treatment	
THYM	cis	1	rs4707239	chr6:86610717	SNHG5	chr6:86386726-86388451:-	-0.57	-7.62	1.9E-11	Response to antipsychotic treatment	
THYM	cis	1	rs4710147	chr6:167374239	RNASET2	chr6:167343008-167412795:-	0.47	7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs4713	chr9:131910805	CRAT	chr9:131857075-131873070:-	-0.42	-4.98	2.82E-6	Blood metabolite ratios	
THYM	cis	1	rs4715129	chr6:49415043	CENPQ	chr6:49431096-49460820:+	-0.23	-4.24	5.16E-5	Folate pathway vitamin levels	
THYM	cis	1	rs4715129	chr6:49415043	MUT	chr6:49398994-49431031:-	0.28	4.43	2.56E-5	Folate pathway vitamin levels	
THYM	cis	1	rs4715130	chr6:49416825	CENPQ	chr6:49431096-49460820:+	-0.23	-4.18	6.53E-5	Folate pathway vitamin levels	
THYM	cis	1	rs4715130	chr6:49416825	MUT	chr6:49398994-49431031:-	0.28	4.37	3.17E-5	Folate pathway vitamin levels	
THYM	cis	1	rs4718269	chr7:65200778	CCT6P1	chr7:65216092-65228661:+	-0.69	-5.71	1.31E-7	Diabetic kidney disease	
THYM	cis	1	rs4718270	chr7:65202407	CCT6P1	chr7:65216092-65228661:+	0.74	5.74	1.13E-7	Diabetic kidney disease	
THYM	cis	1	rs4718309	chr7:65627764	CCT6P1	chr7:65216092-65228661:+	-0.65	-5.41	4.64E-7	Diabetic kidney disease	
THYM	cis	1	rs4718315	chr7:65648541	CCT6P1	chr7:65216092-65228661:+	-0.67	-5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs4718316	chr7:65648731	CCT6P1	chr7:65216092-65228661:+	-0.67	-5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs4718317	chr7:65648901	CCT6P1	chr7:65216092-65228661:+	-0.67	-5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs4718333	chr7:65772758	CCT6P1	chr7:65216092-65228661:+	-0.64	-5.29	7.77E-7	Diabetic kidney disease	
THYM	cis	1	rs4718334	chr7:65789454	CCT6P1	chr7:65216092-65228661:+	-0.64	-5.22	1.03E-6	Diabetic kidney disease	
THYM	cis	1	rs473073	chr10:131429646	MGMT	chr10:131265454-131565783:+	0.32	4.48	2.06E-5	Response to temozolomide	
THYM	cis	1	rs473771	chr10:131408155	MGMT	chr10:131265454-131565783:+	0.3	4.15	7.2E-5	Response to temozolomide	
THYM	cis	1	rs4750759	chr10:131436603	MGMT	chr10:131265454-131565783:+	-0.29	-4.22	5.52E-5	Response to temozolomide	
THYM	cis	1	rs4752946	chr11:46896908	CKAP5	chr11:46765084-46867843:-	0.25	4.24	5.16E-5	HDL cholesterol	
THYM	cis	1	rs4755726	chr11:43642130	HSD17B12	chr11:43702143-43878160:+	-0.57	-5.83	7.53E-8	Forced vital capacity	
THYM	cis	1	rs4759229	chr12:56474480	RPS26	chr12:56435686-56438005:+	-0.93	-9.89	2.9E-16	Cognitive function	
THYM	cis	1	rs4759523	chr12:131315412	STX2	chr12:131274149-131323811:-	0.35	5.89	5.79E-8	Plasma plasminogen activator levels	
THYM	cis	1	rs4759524	chr12:131315610	STX2	chr12:131274149-131323811:-	0.35	5.89	5.79E-8	Plasma plasminogen activator levels	
THYM	cis	1	rs4759787	chr12:131290180	STX2	chr12:131274149-131323811:-	0.35	5.89	5.79E-8	Plasma plasminogen activator levels	
THYM	cis	1	rs4759793	chr12:131297238	STX2	chr12:131274149-131323811:-	0.35	5.89	5.79E-8	Plasma plasminogen activator levels	
THYM	cis	1	rs4763879	chr12:9910164	CLECL1	chr12:9868457-9885860:-	-0.41	-4.43	2.52E-5	Type 1 diabetes	
THYM	cis	1	rs4769117	chr13:21054724	GJB2	chr13:20761606-20767114:-	-0.36	-4.61	1.23E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
THYM	cis	1	rs4794202	chr17:45930539	SCRN2	chr17:45915049-45918699:-	-0.35	-4.6	1.32E-5	Alzheimer's disease (cognitive decline)	
THYM	cis	1	rs479478	chr10:131428959	MGMT	chr10:131265454-131565783:+	0.32	4.48	2.06E-5	Response to temozolomide	
THYM	cis	1	rs4794823	chr17:38166265	GSDMA	chr17:38119226-38134019:+	-0.87	-9.52	1.73E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THYM	cis	1	rs4794824	chr17:38179290	GSDMA	chr17:38119226-38134019:+	-0.87	-9.12	1.23E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THYM	cis	1	rs4795412	chr17:38150604	GSDMA	chr17:38119226-38134019:+	-0.89	-9.76	5.45E-16	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THYM	cis	1	rs4795415	chr17:38157995	GSDMA	chr17:38119226-38134019:+	-0.89	-9.76	5.45E-16	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THYM	cis	1	rs4795416	chr17:38158133	GSDMA	chr17:38119226-38134019:+	-0.89	-9.76	5.45E-16	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THYM	cis	1	rs4795418	chr17:38164851	GSDMA	chr17:38119226-38134019:+	-0.87	-9.52	1.73E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THYM	cis	1	rs4795525	chr17:28388487	EFCAB5	chr17:28256874-28435469:+	-0.31	-4.25	5.04E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs4803480	chr19:42066279	CEACAM21	chr19:42055886-42093196:+	0.64	8.65	1.29E-13	Schizophrenia	
THYM	cis	1	rs4821544	chr22:37258503	NCF4	chr22:37257030-37274058:+	0.47	7.08	2.51E-10	Atopic dermatitis	
THYM	cis	1	rs4858793	chr3:48415007	TREX1	chr3:48501186-48509043:+	0.31	4.84	4.98E-6	Longevity	
THYM	cis	1	rs4858817	chr3:48416756	TREX1	chr3:48501186-48509043:+	0.28	4.48	2.04E-5	Longevity	
THYM	cis	1	rs4859413	chr4:76898250	NAAA	chr4:76831809-76862166:-	0.46	4.92	3.56E-6	Longevity	
THYM	cis	1	rs4859581	chr4:76906974	NAAA	chr4:76831809-76862166:-	-0.46	-4.92	3.56E-6	Longevity	
THYM	cis	1	rs4859582	chr4:76907213	NAAA	chr4:76831809-76862166:-	-0.46	-4.92	3.56E-6	Longevity	
THYM	cis	1	rs4862406	chr4:185629339	CCDC111	chr4:185570767-185616112:+	-0.34	-4.24	5.14E-5	Kawasaki disease	
THYM	cis	1	rs4862406	chr4:185629339	MLF1IP	chr4:185615220-185655286:-	0.33	7.26	1.08E-10	Kawasaki disease	
THYM	cis	1	rs486301	chr15:43836949	ADAL	chr15:43622872-43646094:+	-0.62	-5.23	1.01E-6	Tumor biomarkers	
THYM	cis	1	rs4869313	chr5:96223880	ERAP2	chr5:96211644-96255398:+	-1.01	-20.41	1.67E-36	Pediatric autoimmune diseases	
THYM	cis	1	rs4886018	chr13:52990717	CKAP2	chr13:53029495-53050763:+	-0.35	-5.4	4.97E-7	Lewy body disease	
THYM	cis	1	rs4886615	chr15:75131661	ULK3	chr15:75128459-75135552:-	-0.42	-5.18	1.25E-6	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
THYM	cis	1	rs4887783	chr16:74700743	RFWD3	chr16:74655298-74700779:-	-0.23	-5.03	2.28E-6	Testicular germ cell tumor	
THYM	cis	1	rs4888262	chr16:74670458	RFWD3	chr16:74655298-74700779:-	-0.23	-5.04	2.24E-6	Testicular germ cell tumor	
THYM	cis	1	rs4888264	chr16:74681632	RFWD3	chr16:74655298-74700779:-	-0.21	-4.54	1.68E-5	Testicular germ cell tumor	
THYM	cis	1	rs4888265	chr16:74683737	RFWD3	chr16:74655298-74700779:-	-0.21	-4.54	1.64E-5	Testicular germ cell tumor	
THYM	cis	1	rs4903201	chr14:74659690	LIN52	chr14:74551656-74667117:+	-0.39	-7.22	1.25E-10	Common traits (Other)	
THYM	cis	1	rs4903202	chr14:74660302	LIN52	chr14:74551656-74667117:+	-0.39	-7.22	1.25E-10	Common traits (Other)	
THYM	cis	1	rs4903203	chr14:74660508	LIN52	chr14:74551656-74667117:+	-0.39	-7.22	1.25E-10	Common traits (Other)	
THYM	cis	1	rs4919429	chr10:101938630	BLOC1S2	chr10:102033713-102046439:-	-0.52	-5.18	1.27E-6	Schizophrenia	
THYM	cis	1	rs4919431	chr10:101944325	BLOC1S2	chr10:102033713-102046439:-	-0.49	-5.28	8.32E-7	Schizophrenia	
THYM	cis	1	rs4919690	chr10:104616500	AS3MT	chr10:104613967-104661653:+	0.39	4.43	2.57E-5	Arsenic metabolism	
THYM	cis	1	rs4932143	chr15:90372067	AP3S2	chr15:90373832-90456222:-	-0.42	-4.71	8.38E-6	Type 2 diabetes	
THYM	cis	1	rs4932148	chr15:90394356	AP3S2	chr15:90373832-90456222:-	-0.37	-4.18	6.51E-5	Type 2 diabetes	
THYM	cis	1	rs494003	chr11:65542298	SNX32	chr11:65601410-65621170:+	0.41	4.48	2.05E-5	Systemic lupus erythematosus	
THYM	cis	1	rs4949674	chr1:76213715	ACADM	chr1:76190043-76229353:+	0.3	4.24	5.21E-5	Blood metabolite levels;Acylcarnitine levels	
THYM	cis	1	rs4949874	chr1:76161889	ACADM	chr1:76190043-76229353:+	0.3	4.24	5.21E-5	Blood metabolite levels;Acylcarnitine levels	
THYM	cis	1	rs4949876	chr1:76173377	ACADM	chr1:76190043-76229353:+	0.3	4.24	5.21E-5	Blood metabolite levels;Acylcarnitine levels	
THYM	cis	1	rs4951261	chr1:205717823	PM20D1	chr1:205797154-205819245:-	0.53	4.83	5.15E-6	Menarche (age at onset)	
THYM	cis	1	rs4955485	chr3:134295843	ANAPC13	chr3:134196547-134204865:-	0.55	7.52	3.08E-11	Height	
THYM	cis	1	rs4955485	chr3:134295843	CEP63	chr3:134204575-134293852:+	0.42	6.29	9.47E-9	Height	
THYM	cis	1	rs4955555	chr3:134286427	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs4955555	chr3:134286427	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs496584	chr15:43831923	ADAL	chr15:43622872-43646094:+	-0.61	-5.06	2.08E-6	Tumor biomarkers	
THYM	cis	1	rs4973991	chr3:41927273	ULK4	chr3:41288091-42003660:-	-1	-11.02	1.12E-18	Diastolic blood pressure	
THYM	cis	1	rs4974483	chr3:134219001	ANAPC13	chr3:134196547-134204865:-	0.56	7.61	1.94E-11	Height	
THYM	cis	1	rs4974483	chr3:134219001	CEP63	chr3:134204575-134293852:+	0.41	6	3.54E-8	Height	
THYM	cis	1	rs4974484	chr3:134219019	ANAPC13	chr3:134196547-134204865:-	0.59	8.13	1.58E-12	Height	
THYM	cis	1	rs4974484	chr3:134219019	CEP63	chr3:134204575-134293852:+	0.41	5.87	6.33E-8	Height	
THYM	cis	1	rs4974493	chr3:134219993	ANAPC13	chr3:134196547-134204865:-	0.58	8.05	2.33E-12	Height	
THYM	cis	1	rs4974493	chr3:134219993	CEP63	chr3:134204575-134293852:+	0.4	5.81	8.19E-8	Height	
THYM	cis	1	rs4974559	chr4:1380848	CRIPAK	chr4:1385340-1389782:+	-0.68	-5.72	1.21E-7	Systolic blood pressure	
THYM	cis	1	rs5030707	chr20:23618656	CST9	chr20:23583049-23586610:-	-0.48	-4.46	2.25E-5	Chronic kidney disease	
THYM	cis	1	rs503660	chr10:131418999	MGMT	chr10:131265454-131565783:+	0.32	4.55	1.59E-5	Response to temozolomide	
THYM	cis	1	rs506274	chr10:131409392	MGMT	chr10:131265454-131565783:+	0.34	4.78	6.26E-6	Response to temozolomide	
THYM	cis	1	rs508303	chr10:131424996	MGMT	chr10:131265454-131565783:+	-0.3	-4.28	4.48E-5	Response to temozolomide	
THYM	cis	1	rs516704	chr10:131419879	MGMT	chr10:131265454-131565783:+	0.32	4.55	1.59E-5	Response to temozolomide	
THYM	cis	1	rs522891	chr10:131430916	MGMT	chr10:131265454-131565783:+	-0.32	-4.48	2.06E-5	Response to temozolomide	
THYM	cis	1	rs530466	chr10:131427717	MGMT	chr10:131265454-131565783:+	0.32	4.62	1.23E-5	Response to temozolomide	
THYM	cis	1	rs531676	chr10:99637578	CRTAC1	chr10:99624758-99790585:-	0.49	4.57	1.49E-5	Metabolic syndrome	
THYM	cis	1	rs538969	chr10:131410608	MGMT	chr10:131265454-131565783:+	0.32	4.48	2.05E-5	Response to temozolomide	
THYM	cis	1	rs548390	chr10:131417427	MGMT	chr10:131265454-131565783:+	0.32	4.55	1.59E-5	Response to temozolomide	
THYM	cis	1	rs553371	chr10:131413676	MGMT	chr10:131265454-131565783:+	0.32	4.55	1.59E-5	Response to temozolomide	
THYM	cis	1	rs554792	chr10:131423181	MGMT	chr10:131265454-131565783:+	0.32	4.55	1.59E-5	Response to temozolomide	
THYM	cis	1	rs55645543	chr4:122607178	ANXA5	chr4:122589153-122618147:-	-0.74	-4.93	3.49E-6	Age at smoking initiation in chronic obstructive pulmonary disease	
THYM	cis	1	rs55749163	chr6:18104645	NHLRC1	chr6:18120718-18122851:-	-1.06	-4.38	3.09E-5	Thiopurine S-methyltransferase activity	
THYM	cis	1	rs55753056	chr2:243929	SH3YL1	chr2:218138-264810:-	-0.32	-4.67	9.89E-6	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs55762838	chr19:50727179	NAPSB	chr19:50837059-50848005:-	-0.32	-4.59	1.37E-5	Disc degeneration (lumbar)	
THYM	cis	1	rs55879323	chr1:152168740	HRNR	chr1:152184558-152196669:-	0.55	5.95	4.53E-8	Inflammatory skin disease	
THYM	cis	1	rs55895244	chr7:65387678	CCT6P1	chr7:65216092-65228661:+	0.66	4.82	5.38E-6	Diabetic kidney disease	
THYM	cis	1	rs55913793	chr3:134285968	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs55913793	chr3:134285968	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs55936726	chr2:258210	SH3YL1	chr2:218138-264810:-	-0.33	-4.86	4.59E-6	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs55946380	chr2:268293	SH3YL1	chr2:218138-264810:-	-0.33	-4.86	4.59E-6	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs55971458	chr17:28427016	EFCAB5	chr17:28256874-28435469:+	0.31	4.23	5.4E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs56015036	chr10:17226767	CUBN	chr10:16865966-17171816:-	0.31	4.8	5.85E-6	Homocysteine levels	
THYM	cis	1	rs56016656	chr7:65383481	CCT6P1	chr7:65216092-65228661:+	0.7	5.13	1.51E-6	Diabetic kidney disease	
THYM	cis	1	rs56043407	chr17:2166078	SRR	chr17:2207248-2228553:+	-0.53	-5.51	3.02E-7	Esophageal cancer (squamous cell)	
THYM	cis	1	rs56121764	chr3:41883975	ULK4	chr3:41288091-42003660:-	0.96	9.51	1.88E-15	Diastolic blood pressure	
THYM	cis	1	rs56154726	chr2:73721767	ALMS1P	chr2:73872046-73912692:+	0.59	4.59	1.34E-5	Metabolite levels	
THYM	cis	1	rs56157536	chr10:50610008	PGBD3	chr10:50723247-50747584:-	-0.69	-4.23	5.4E-5	Inflammatory biomarkers	
THYM	cis	1	rs56158380	chr3:41885588	ULK4	chr3:41288091-42003660:-	0.96	9.51	1.88E-15	Diastolic blood pressure	
THYM	cis	1	rs56167434	chr2:282137	SH3YL1	chr2:218138-264810:-	-0.34	-4.91	3.83E-6	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs56207540	chr3:41976627	ULK4	chr3:41288091-42003660:-	1.09	7.15	1.75E-10	Diastolic blood pressure	
THYM	cis	1	rs56261853	chr9:91563353	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs56280226	chr17:28429575	EFCAB5	chr17:28256874-28435469:+	0.31	4.23	5.4E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs56291018	chr7:65390339	CCT6P1	chr7:65216092-65228661:+	0.7	5.13	1.51E-6	Diabetic kidney disease	
THYM	cis	1	rs56314138	chr3:121356656	IQCB1	chr3:121488610-121553926:-	0.48	4.47	2.2E-5	Cognitive performance	
THYM	cis	1	rs56321614	chr2:268191	SH3YL1	chr2:218138-264810:-	-0.33	-4.86	4.59E-6	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs56354891	chr19:50727510	NAPSB	chr19:50837059-50848005:-	-0.32	-4.59	1.37E-5	Disc degeneration (lumbar)	
THYM	cis	1	rs56357623	chr14:77697393	NGB	chr14:77731834-77737655:-	-0.42	-4.23	5.33E-5	Obsessive-compulsive symptoms	
THYM	cis	1	rs56394211	chr10:17186447	CUBN	chr10:16865966-17171816:-	0.31	4.76	6.83E-6	Homocysteine levels	
THYM	cis	1	rs565974	chr10:131423274	MGMT	chr10:131265454-131565783:+	0.32	4.55	1.59E-5	Response to temozolomide	
THYM	cis	1	rs56672945	chr2:73622663	ALMS1P	chr2:73872046-73912692:+	0.62	4.72	8.01E-6	Metabolite levels	
THYM	cis	1	rs56763150	chr6:24482999	ALDH5A1	chr6:24495197-24537434:+	0.33	4.16	7.04E-5	Hematological and biochemical traits	
THYM	cis	1	rs56763150	chr6:24482999	GPLD1	chr6:24428405-24489850:-	0.56	5.51	3.04E-7	Hematological and biochemical traits	
THYM	cis	1	rs567700	chr10:131423126	MGMT	chr10:131265454-131565783:+	0.32	4.55	1.59E-5	Response to temozolomide	
THYM	cis	1	rs56775891	chr18:77575613	KCNG2	chr18:77623668-77659815:+	0.59	4.5	1.9E-5	Schizophrenia	
THYM	cis	1	rs56776628	chr3:41866856	ULK4	chr3:41288091-42003660:-	1	10.81	3.16E-18	Diastolic blood pressure	
THYM	cis	1	rs568617	chr11:65653242	CTSW	chr11:65647284-65651212:+	-0.59	-7.12	2.04E-10	Crohn's disease	
THYM	cis	1	rs568617	chr11:65653242	SNX32	chr11:65601410-65621170:+	0.55	5.17	1.29E-6	Crohn's disease	
THYM	cis	1	rs56922390	chr17:38157021	GSDMA	chr17:38119226-38134019:+	-0.89	-9.76	5.45E-16	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THYM	cis	1	rs569235	chr10:131411620	MGMT	chr10:131265454-131565783:+	0.3	4.15	7.2E-5	Response to temozolomide	
THYM	cis	1	rs56985706	chr7:65394562	CCT6P1	chr7:65216092-65228661:+	0.67	4.9	3.88E-6	Diabetic kidney disease	
THYM	cis	1	rs57057549	chr7:65405738	CCT6P1	chr7:65216092-65228661:+	0.64	5.29	7.77E-7	Diabetic kidney disease	
THYM	cis	1	rs57075379	chr14:35577801	KIAA0391	chr14:35591776-35786673:+	0.32	4.14	7.59E-5	Atopic dermatitis	
THYM	cis	1	rs57075379	chr14:35577801	PPP2R3C	chr14:35554679-35591679:-	0.27	4.99	2.76E-6	Atopic dermatitis	
THYM	cis	1	rs57411618	chr17:28273052	EFCAB5	chr17:28256874-28435469:+	0.32	4.3	4.2E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs57479675	chr3:41798038	ULK4	chr3:41288091-42003660:-	1	10.7	5.35E-18	Diastolic blood pressure	
THYM	cis	1	rs5751255	chr22:42648408	CYP2D6	chr22:42522502-42526883:-	-0.69	-7.37	6.15E-11	Cognitive function	
THYM	cis	1	rs57542652	chr2:228088	SH3YL1	chr2:218138-264810:-	-0.3	-4.19	6.3E-5	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs5758659	chr22:42622003	CYP2D6	chr22:42522502-42526883:-	-0.72	-7.77	9.19E-12	Cognitive function	
THYM	cis	1	rs5758660	chr22:42623718	CYP2D6	chr22:42522502-42526883:-	-0.72	-7.76	9.45E-12	Cognitive function	
THYM	cis	1	rs5758677	chr22:42643039	CYP2D6	chr22:42522502-42526883:-	-0.69	-7.37	6.15E-11	Cognitive function	
THYM	cis	1	rs578056	chr11:65514874	SNX32	chr11:65601410-65621170:+	0.41	4.48	2.05E-5	Systemic lupus erythematosus	
THYM	cis	1	rs57961801	chr9:91563458	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs580016	chr12:120933977	PRKAB1	chr12:120105757-120119428:+	0.45	4.3	4.12E-5	Type 1 diabetes nephropathy	
THYM	cis	1	rs58062456	chr7:65394852	CCT6P1	chr7:65216092-65228661:+	0.67	4.9	3.88E-6	Diabetic kidney disease	
THYM	cis	1	rs580745	chr10:131414401	MGMT	chr10:131265454-131565783:+	0.32	4.55	1.59E-5	Response to temozolomide	
THYM	cis	1	rs58130263	chr11:62194100	ASRGL1	chr11:62104774-62160885:+	-0.29	-4.41	2.74E-5	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs583583	chr1:147083114	ACP6	chr1:147119168-147142634:-	0.51	5.47	3.58E-7	Schizophrenia (negative symptoms)	
THYM	cis	1	rs58461606	chr2:267367	SH3YL1	chr2:218138-264810:-	-0.33	-4.86	4.59E-6	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs58479700	chr6:24483199	ALDH5A1	chr6:24495197-24537434:+	0.33	4.16	7.04E-5	Hematological and biochemical traits	
THYM	cis	1	rs58479700	chr6:24483199	GPLD1	chr6:24428405-24489850:-	0.56	5.51	3.04E-7	Hematological and biochemical traits	
THYM	cis	1	rs58603761	chr2:73726605	ALMS1P	chr2:73872046-73912692:+	0.57	4.59	1.33E-5	Metabolite levels	
THYM	cis	1	rs58669269	chr7:65951953	CCT6P1	chr7:65216092-65228661:+	0.6	4.86	4.72E-6	Diabetic kidney disease	
THYM	cis	1	rs59019708	chr9:91563305	C9orf47	chr9:91605778-91611055:+	-0.26	-4.68	9.7E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs59226697	chr22:25870037	CRYBB2	chr22:25615612-25627836:+	1.03	5.96	4.2E-8	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs59274738	chr17:28437635	EFCAB5	chr17:28256874-28435469:+	0.31	4.23	5.4E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs59794892	chr7:65415873	CCT6P1	chr7:65216092-65228661:+	0.62	5.07	1.95E-6	Diabetic kidney disease	
THYM	cis	1	rs59904960	chr2:227761269	RHBDD1	chr2:227700773-227861591:+	-0.33	-4.97	3.01E-6	Pulmonary function	
THYM	cis	1	rs59925331	chr17:38169273	GSDMA	chr17:38119226-38134019:+	-0.87	-9.52	1.73E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THYM	cis	1	rs59937473	chr2:271797	SH3YL1	chr2:218138-264810:-	-0.33	-4.86	4.59E-6	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs5996946	chr22:25875988	CRYBB2	chr22:25615612-25627836:+	1.12	7.51	3.14E-11	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs59980797	chr10:45049599	ZNF22	chr10:45496273-45500776:+	0.46	4.66	1.04E-5	Estradiol plasma levels (breast cancer)	
THYM	cis	1	rs6004654	chr22:25855204	CRYBB2	chr22:25615612-25627836:+	1.09	7.04	2.94E-10	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs6004655	chr22:25855629	CRYBB2	chr22:25615612-25627836:+	1.09	7.13	1.92E-10	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs6004657	chr22:25855714	CRYBB2	chr22:25615612-25627836:+	1.07	7.06	2.73E-10	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs6004658	chr22:25856231	CRYBB2	chr22:25615612-25627836:+	1.09	7.04	2.94E-10	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs6004659	chr22:25856411	CRYBB2	chr22:25615612-25627836:+	1.07	7.06	2.73E-10	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs6004662	chr22:25862124	CRYBB2	chr22:25615612-25627836:+	1.09	7.11	2.16E-10	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs6004667	chr22:25874464	CRYBB2	chr22:25615612-25627836:+	-1.04	-6.8	9.17E-10	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs6004668	chr22:25874502	CRYBB2	chr22:25615612-25627836:+	-1.1	-7.33	7.64E-11	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs6004669	chr22:25875803	CRYBB2	chr22:25615612-25627836:+	1.1	7.33	7.64E-11	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs6004671	chr22:25879474	CRYBB2	chr22:25615612-25627836:+	1.12	7.51	3.14E-11	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs6004672	chr22:25881013	CRYBB2	chr22:25615612-25627836:+	1.12	7.51	3.14E-11	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs6004673	chr22:25885353	CRYBB2	chr22:25615612-25627836:+	1.03	6.92	5.32E-10	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs6004675	chr22:25889385	CRYBB2	chr22:25615612-25627836:+	1.08	7.35	6.97E-11	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs60149603	chr2:285421	SH3YL1	chr2:218138-264810:-	-0.33	-4.86	4.7E-6	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs60251819	chr6:24468648	GPLD1	chr6:24428405-24489850:-	0.45	4.67	9.97E-6	Hematological and biochemical traits	
THYM	cis	1	rs60326618	chr7:66166358	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Gout	
THYM	cis	1	rs6036476	chr20:23610308	CST9	chr20:23583049-23586610:-	-0.51	-4.73	7.71E-6	Chronic kidney disease	
THYM	cis	1	rs6036478	chr20:23611359	CST9	chr20:23583049-23586610:-	-0.51	-4.73	7.71E-6	Chronic kidney disease	
THYM	cis	1	rs60425110	chr15:75333000	PPCDC	chr15:75315927-75343066:+	0.27	4.85	4.8E-6	Blood trace element (Zn levels)	
THYM	cis	1	rs60484953	chr2:221560	SH3YL1	chr2:218138-264810:-	-0.31	-4.44	2.41E-5	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs6048956	chr20:23609301	CST9	chr20:23583049-23586610:-	-0.51	-4.73	7.71E-6	Chronic kidney disease	
THYM	cis	1	rs60512868	chr3:48483445	TREX1	chr3:48501186-48509043:+	-0.29	-4.33	3.75E-5	Longevity	
THYM	cis	1	rs6053816	chr20:5970750	MCM8	chr20:5931298-5975829:+	-0.2	-4.21	5.84E-5	HIV-1 viral setpoint	
THYM	cis	1	rs60683927	chr7:65394768	CCT6P1	chr7:65216092-65228661:+	0.67	4.9	3.88E-6	Diabetic kidney disease	
THYM	cis	1	rs60693825	chr14:35514456	KIAA0391	chr14:35591776-35786673:+	0.32	4.18	6.43E-5	Atopic dermatitis	
THYM	cis	1	rs60693825	chr14:35514456	PPP2R3C	chr14:35554679-35591679:-	0.27	5.03	2.32E-6	Atopic dermatitis	
THYM	cis	1	rs60710459	chr2:48687857	FOXN2	chr2:48541795-48606434:+	0.27	4.21	5.77E-5	Schizophrenia	
THYM	cis	1	rs6073966	chr20:44570192	TP53RK	chr20:45313005-45318276:-	-0.44	-4.47	2.13E-5	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
THYM	cis	1	rs60843830	chr2:286756	SH3YL1	chr2:218138-264810:-	-0.32	-4.63	1.14E-5	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs60844734	chr2:73623205	ALMS1P	chr2:73872046-73912692:+	0.62	4.72	8.01E-6	Metabolite levels	
THYM	cis	1	rs60982898	chr6:49385806	CENPQ	chr6:49431096-49460820:+	-0.24	-4.37	3.16E-5	Folate pathway vitamin levels	
THYM	cis	1	rs60982898	chr6:49385806	MUT	chr6:49398994-49431031:-	0.27	4.32	3.89E-5	Folate pathway vitamin levels	
THYM	cis	1	rs61037750	chr11:43681372	HSD17B12	chr11:43702143-43878160:+	-0.6	-5.98	3.95E-8	Forced vital capacity	
THYM	cis	1	rs61067328	chr2:227761256	RHBDD1	chr2:227700773-227861591:+	-0.33	-4.97	3.01E-6	Pulmonary function	
THYM	cis	1	rs61102033	chr1:46382441	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs6114206	chr20:23611789	CST9	chr20:23583049-23586610:-	-0.51	-4.73	7.71E-6	Chronic kidney disease	
THYM	cis	1	rs6114208	chr20:23621734	CST9	chr20:23583049-23586610:-	-0.48	-4.49	2.03E-5	Chronic kidney disease	
THYM	cis	1	rs6114209	chr20:23622266	CST9	chr20:23583049-23586610:-	-0.49	-4.44	2.39E-5	Chronic kidney disease	
THYM	cis	1	rs61280878	chr6:24468741	GPLD1	chr6:24428405-24489850:-	0.45	4.67	9.97E-6	Hematological and biochemical traits	
THYM	cis	1	rs6151429	chr22:51063477	ARSA	chr22:51063450-51066607:-	-0.96	-6.33	8.09E-9	Blood metabolite levels	
THYM	cis	1	rs61517255	chr10:17208918	CUBN	chr10:16865966-17171816:-	0.3	4.68	9.61E-6	Homocysteine levels	
THYM	cis	1	rs61524473	chr15:45646283	SPATA5L1	chr15:45694519-45713614:+	0.41	4.68	9.47E-6	Metabolite levels (small molecules and protein measures)	
THYM	cis	1	rs61744385	chr3:41756986	ULK4	chr3:41288091-42003660:-	0.96	9.94	2.21E-16	Diastolic blood pressure	
THYM	cis	1	rs61744388	chr3:41756965	ULK4	chr3:41288091-42003660:-	0.96	9.94	2.21E-16	Diastolic blood pressure	
THYM	cis	1	rs61783200	chr1:46297403	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	6.8E-8	Body mass index	
THYM	cis	1	rs61783220	chr1:46335312	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	6.8E-8	Body mass index	
THYM	cis	1	rs61792114	chr4:289139	ZNF718	chr4:53272-156488:+	0.5	5.62	1.88E-7	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs61792116	chr4:301077	ZNF718	chr4:53272-156488:+	0.65	6.82	8.42E-10	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs61794996	chr4:209328	ZNF718	chr4:53272-156488:+	0.66	6.92	5.22E-10	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs61794997	chr4:222103	ZNF718	chr4:53272-156488:+	0.68	7.3	8.88E-11	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs61795001	chr4:242057	ZNF718	chr4:53272-156488:+	0.68	7.3	8.88E-11	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs61795002	chr4:242797	ZNF718	chr4:53272-156488:+	0.68	7.3	8.88E-11	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs61795006	chr4:253601	ZNF718	chr4:53272-156488:+	0.53	5.92	5.01E-8	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs61795007	chr4:255264	ZNF718	chr4:53272-156488:+	0.53	5.92	5.01E-8	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs61826828	chr1:174015261	RC3H1	chr1:173900354-173962210:-	-0.37	-4.24	5.27E-5	Schizophrenia	
THYM	cis	1	rs62070312	chr17:28438877	EFCAB5	chr17:28256874-28435469:+	0.31	4.23	5.4E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs62114501	chr2:231741	SH3YL1	chr2:218138-264810:-	-0.31	-4.56	1.52E-5	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs62114505	chr2:242426	SH3YL1	chr2:218138-264810:-	-0.32	-4.67	9.89E-6	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs62114544	chr2:269679	SH3YL1	chr2:218138-264810:-	-0.33	-4.86	4.59E-6	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs62114548	chr2:274672	SH3YL1	chr2:218138-264810:-	-0.34	-4.89	4.06E-6	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs62120832	chr19:23064264	ZNF492	chr19:22817126-22850472:+	-0.52	-5.7	1.32E-7	Bronchopulmonary dysplasia	
THYM	cis	1	rs62151652	chr2:73700131	ALMS1P	chr2:73872046-73912692:+	0.59	4.56	1.53E-5	Metabolite levels	
THYM	cis	1	rs62268732	chr3:121370455	IQCB1	chr3:121488610-121553926:-	0.45	4.18	6.42E-5	Cognitive performance	
THYM	cis	1	rs62269547	chr3:134214042	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs62269547	chr3:134214042	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs62271513	chr3:134298412	ANAPC13	chr3:134196547-134204865:-	-0.57	-7.67	1.5E-11	Height	
THYM	cis	1	rs62271513	chr3:134298412	CEP63	chr3:134204575-134293852:+	-0.41	-6.04	2.96E-8	Height	
THYM	cis	1	rs62271514	chr3:134298554	ANAPC13	chr3:134196547-134204865:-	-0.57	-7.67	1.5E-11	Height	
THYM	cis	1	rs62271514	chr3:134298554	CEP63	chr3:134204575-134293852:+	-0.41	-6.04	2.96E-8	Height	
THYM	cis	1	rs62271515	chr3:134300507	ANAPC13	chr3:134196547-134204865:-	0.55	7.48	3.7E-11	Height	
THYM	cis	1	rs62271515	chr3:134300507	CEP63	chr3:134204575-134293852:+	0.43	6.36	7.09E-9	Height	
THYM	cis	1	rs641018	chr11:65655393	CTSW	chr11:65647284-65651212:+	-0.59	-7.12	2.04E-10	Crohn's disease	
THYM	cis	1	rs641018	chr11:65655393	SNX32	chr11:65601410-65621170:+	0.55	5.17	1.29E-6	Crohn's disease	
THYM	cis	1	rs6429567	chr1:45956700	CCDC163P	chr1:45960581-45965646:-	-0.86	-14.78	2.3E-26	Homocysteine levels	
THYM	cis	1	rs6429569	chr1:46001330	CCDC163P	chr1:45960581-45965646:-	-0.76	-11.88	1.72E-20	Homocysteine levels	
THYM	cis	1	rs6429582	chr1:46321843	CCDC163P	chr1:45960581-45965646:-	0.49	5.69	1.38E-7	Body mass index	
THYM	cis	1	rs6439484	chr3:134249899	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs6439484	chr3:134249899	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs6439487	chr3:134260860	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs6439487	chr3:134260860	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs6441104	chr3:156681441	LEKR1	chr3:156544076-156763918:+	-0.78	-4.18	6.6E-5	Bone mineral density	
THYM	cis	1	rs6442117	chr3:48419897	TREX1	chr3:48501186-48509043:+	0.28	4.49	2.0E-5	Longevity	
THYM	cis	1	rs6442118	chr3:48440047	TREX1	chr3:48501186-48509043:+	-0.28	-4.38	3.02E-5	Longevity	
THYM	cis	1	rs6442119	chr3:48440178	TREX1	chr3:48501186-48509043:+	-0.28	-4.36	3.32E-5	Longevity	
THYM	cis	1	rs6442120	chr3:48464503	TREX1	chr3:48501186-48509043:+	-0.28	-4.23	5.28E-5	Longevity	
THYM	cis	1	rs6442123	chr3:48500286	TREX1	chr3:48501186-48509043:+	-0.29	-4.28	4.47E-5	Longevity	
THYM	cis	1	rs6443924	chr3:183679532	ABCC5	chr3:183637726-183735727:-	0.48	4.28	4.53E-5	Anterior chamber depth	
THYM	cis	1	rs6443926	chr3:183706630	ABCC5	chr3:183637726-183735727:-	0.48	4.28	4.53E-5	Anterior chamber depth	
THYM	cis	1	rs6443927	chr3:183718864	ABCC5	chr3:183637726-183735727:-	0.5	4.38	3.08E-5	Anterior chamber depth	
THYM	cis	1	rs6450408	chr5:56098146	C5orf35	chr5:56205103-56213010:+	0.74	8.92	3.44E-14	Type 2 diabetes	
THYM	cis	1	rs6450409	chr5:56101399	C5orf35	chr5:56205103-56213010:+	0.74	9.25	6.53E-15	Type 2 diabetes	
THYM	cis	1	rs6454513	chr6:86720049	SNHG5	chr6:86386726-86388451:-	0.57	7.62	1.9E-11	Response to antipsychotic treatment	
THYM	cis	1	rs6456617	chr6:24480769	GPLD1	chr6:24428405-24489850:-	0.56	5.18	1.24E-6	Hematological and biochemical traits	
THYM	cis	1	rs6458685	chr6:49379536	CENPQ	chr6:49431096-49460820:+	-0.3	-5.65	1.67E-7	Homocysteine levels	
THYM	cis	1	rs6458688	chr6:49406056	CENPQ	chr6:49431096-49460820:+	-0.29	-5.57	2.36E-7	Homocysteine levels	
THYM	cis	1	rs6458690	chr6:49411619	CENPQ	chr6:49431096-49460820:+	-0.24	-4.48	2.1E-5	Folate pathway vitamin levels	
THYM	cis	1	rs6458694	chr6:49445306	CENPQ	chr6:49431096-49460820:+	-0.24	-4.35	3.42E-5	Folate pathway vitamin levels	
THYM	cis	1	rs6458694	chr6:49445306	MUT	chr6:49398994-49431031:-	0.28	4.29	4.25E-5	Folate pathway vitamin levels	
THYM	cis	1	rs6460260	chr7:65215455	CCT6P1	chr7:65216092-65228661:+	-0.76	-5.86	6.67E-8	Diabetic kidney disease	
THYM	cis	1	rs6460261	chr7:65215580	CCT6P1	chr7:65216092-65228661:+	-0.76	-5.86	6.67E-8	Diabetic kidney disease	
THYM	cis	1	rs6460274	chr7:65628484	CCT6P1	chr7:65216092-65228661:+	-0.65	-5.41	4.64E-7	Diabetic kidney disease	
THYM	cis	1	rs646867	chr1:25709258	RHCE	chr1:25688741-25756683:-	0.42	5.05	2.09E-6	Erythrocyte sedimentation rate	
THYM	cis	1	rs646867	chr1:25709258	RHD	chr1:25598981-25656935:+	-0.46	-4.29	4.26E-5	Erythrocyte sedimentation rate	
THYM	cis	1	rs6477694	chr9:111932342	AKAP2	chr9:112810976-112934789:+	-0.2	-4.42	2.59E-5	Body mass index	
THYM	cis	1	rs6478484	chr9:123652380	LOC253039	chr9:123605320-123616644:+	-0.62	-5.56	2.51E-7	Rheumatoid arthritis	
THYM	cis	1	rs6478486	chr9:123655329	LOC253039	chr9:123605320-123616644:+	-0.62	-5.56	2.51E-7	Rheumatoid arthritis	
THYM	cis	1	rs6478867	chr9:131903923	CRAT	chr9:131857075-131873070:-	-0.43	-5.07	1.99E-6	Blood metabolite ratios	
THYM	cis	1	rs6485438	chr11:43686618	HSD17B12	chr11:43702143-43878160:+	-0.6	-6.8	9.28E-10	Forced vital capacity	
THYM	cis	1	rs6485443	chr11:43696316	HSD17B12	chr11:43702143-43878160:+	0.65	7.65	1.61E-11	Forced vital capacity	
THYM	cis	1	rs6496609	chr15:90379632	AP3S2	chr15:90373832-90456222:-	-0.43	-4.89	4.09E-6	Type 2 diabetes	
THYM	cis	1	rs6503530	chr17:38161823	GSDMA	chr17:38119226-38134019:+	-0.87	-9.52	1.73E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THYM	cis	1	rs6504167	chr17:61693194	TCAM1P	chr17:61934376-61941738:+	-0.52	-4.3	4.14E-5	Body mass index	
THYM	cis	1	rs6504169	chr17:61709145	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.33	3.63E-5	Body mass index	
THYM	cis	1	rs6504170	chr17:61709168	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.4	2.78E-5	Body mass index	
THYM	cis	1	rs6504171	chr17:61710010	TCAM1P	chr17:61934376-61941738:+	-0.53	-4.38	3.02E-5	Body mass index	
THYM	cis	1	rs6504173	chr17:61735056	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.47	2.2E-5	Body mass index	
THYM	cis	1	rs6505152	chr17:28331466	EFCAB5	chr17:28256874-28435469:+	-0.31	-4.25	5.04E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs6510348	chr19:33601946	GPATCH1	chr19:33571786-33621318:+	0.37	4.33	3.69E-5	Bone properties (heel)	
THYM	cis	1	rs6515375	chr20:23610841	CST9	chr20:23583049-23586610:-	-0.46	-4.25	4.97E-5	Chronic kidney disease	
THYM	cis	1	rs6519611	chr22:25845855	CRYBB2	chr22:25615612-25627836:+	1.09	7.15	1.78E-10	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs6532078	chr4:76920809	NAAA	chr4:76831809-76862166:-	-0.45	-4.79	6.23E-6	Longevity	
THYM	cis	1	rs6540732	chr1:212392486	NEK2	chr1:211836115-211848967:-	0.18	4.87	4.48E-6	Intelligence (childhood)	
THYM	cis	1	rs6540733	chr1:212392953	NEK2	chr1:211836115-211848967:-	-0.17	-4.36	3.27E-5	Intelligence (childhood)	
THYM	cis	1	rs6540735	chr1:212400760	NEK2	chr1:211836115-211848967:-	-0.17	-4.53	1.74E-5	Intelligence (childhood)	
THYM	cis	1	rs6545883	chr2:61772257	AHSA2	chr2:61404553-61414058:+	-0.49	-4.62	1.19E-5	Tuberculosis	
THYM	cis	1	rs6545883	chr2:61772257	C2orf74	chr2:61372243-61391964:+	0.57	5.16	1.38E-6	Tuberculosis	
THYM	cis	1	rs6546835	chr2:73664715	ALMS1P	chr2:73872046-73912692:+	0.58	4.7	8.77E-6	Metabolite levels	
THYM	cis	1	rs6546836	chr2:73677833	ALMS1P	chr2:73872046-73912692:+	0.55	4.29	4.33E-5	Metabolite levels	
THYM	cis	1	rs6546837	chr2:73677898	ALMS1P	chr2:73872046-73912692:+	0.58	4.72	8.0E-6	Metabolite levels	
THYM	cis	1	rs6546838	chr2:73679280	ALMS1P	chr2:73872046-73912692:+	0.58	4.72	8.0E-6	Metabolite levels	
THYM	cis	1	rs6546839	chr2:73680508	ALMS1P	chr2:73872046-73912692:+	0.58	4.72	8.0E-6	Metabolite levels	
THYM	cis	1	rs6547872	chr2:28978074	TRMT61B	chr2:29072690-29093175:-	-0.49	-4.14	7.61E-5	Body mass index	
THYM	cis	1	rs6558296	chr8:145143802	KIAA1875	chr8:145162629-145173218:+	-0.89	-4.75	7.28E-6	Blood metabolite levels	
THYM	cis	1	rs656980	chr11:65656282	CTSW	chr11:65647284-65651212:+	-0.59	-7.12	2.04E-10	Crohn's disease	
THYM	cis	1	rs656980	chr11:65656282	SNX32	chr11:65601410-65621170:+	0.55	5.17	1.29E-6	Crohn's disease	
THYM	cis	1	rs6581155	chr12:58178162	FAM119B	chr12:58166383-58176323:+	0.42	5.8	8.55E-8	Multiple sclerosis	
THYM	cis	1	rs6581155	chr12:58178162	TSFM	chr12:58176536-58191367:+	-0.3	-5.45	4.0E-7	Multiple sclerosis	
THYM	cis	1	rs6584347	chr10:101906963	BLOC1S2	chr10:102033713-102046439:-	-0.45	-4.9	3.89E-6	Schizophrenia	
THYM	cis	1	rs6584349	chr10:101942556	BLOC1S2	chr10:102033713-102046439:-	-0.49	-5.28	8.32E-7	Schizophrenia	
THYM	cis	1	rs6593585	chr1:76140273	ACADM	chr1:76190043-76229353:+	0.3	4.24	5.22E-5	Blood metabolite levels;Acylcarnitine levels	
THYM	cis	1	rs6599170	chr3:41772718	ULK4	chr3:41288091-42003660:-	1.03	11.59	7.14E-20	Diastolic blood pressure	
THYM	cis	1	rs6599175	chr3:41786009	ULK4	chr3:41288091-42003660:-	-1.03	-10.42	2.13E-17	Diastolic blood pressure	
THYM	cis	1	rs6599176	chr3:41788492	ULK4	chr3:41288091-42003660:-	-1.02	-11.47	1.24E-19	Diastolic blood pressure	
THYM	cis	1	rs6599178	chr3:41842129	ULK4	chr3:41288091-42003660:-	1.02	10.9	1.98E-18	Diastolic blood pressure	
THYM	cis	1	rs6599179	chr3:41855284	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs6599318	chr4:243968	ZNF718	chr4:53272-156488:+	0.68	7.3	8.88E-11	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs6650631	chr18:77566535	KCNG2	chr18:77623668-77659815:+	0.52	4.14	7.41E-5	Schizophrenia	
THYM	cis	1	rs66551258	chr9:91560197	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs6656992	chr1:46333068	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	6.8E-8	Body mass index	
THYM	cis	1	rs6657900	chr1:212400866	NEK2	chr1:211836115-211848967:-	-0.17	-4.53	1.74E-5	Intelligence (childhood)	
THYM	cis	1	rs6661910	chr1:46290632	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.86	6.53E-8	Body mass index	
THYM	cis	1	rs6662641	chr1:46571509	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs6667191	chr1:45982844	CCDC163P	chr1:45960581-45965646:-	-0.86	-14.78	2.3E-26	Homocysteine levels	
THYM	cis	1	rs6668284	chr1:46354510	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	7.1E-8	Body mass index	
THYM	cis	1	rs6669236	chr1:227813909	DUSP5P	chr1:228780657-228788159:+	-0.81	-5.13	1.51E-6	Height	
THYM	cis	1	rs6669522	chr1:46397941	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs6672180	chr1:76123973	ACADM	chr1:76190043-76229353:+	0.3	4.16	7.08E-5	Blood metabolite levels;Acylcarnitine levels	
THYM	cis	1	rs6672898	chr1:46290588	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	6.8E-8	Body mass index	
THYM	cis	1	rs6675726	chr1:46560643	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs6675946	chr1:46371774	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs6677007	chr1:46400590	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs6680380	chr1:46300189	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	6.8E-8	Body mass index	
THYM	cis	1	rs6691624	chr1:19987783	NBL1	chr1:19923467-19984945:+	-0.31	-4.22	5.5E-5	Morning vs. evening chronotype	
THYM	cis	1	rs6695809	chr1:46285461	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	6.8E-8	Body mass index	
THYM	cis	1	rs6700597	chr1:46284246	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	6.8E-8	Body mass index	
THYM	cis	1	rs6701614	chr1:46309420	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	6.8E-8	Body mass index	
THYM	cis	1	rs6705489	chr2:73648811	ALMS1P	chr2:73872046-73912692:+	0.61	4.73	7.71E-6	Metabolite levels	
THYM	cis	1	rs6707722	chr2:73654363	ALMS1P	chr2:73872046-73912692:+	0.58	4.7	8.77E-6	Metabolite levels	
THYM	cis	1	rs6707848	chr2:28988083	TRMT61B	chr2:29072690-29093175:-	-0.53	-4.42	2.62E-5	Body mass index	
THYM	cis	1	rs6708328	chr2:24412413	LOC375190	chr2:24299728-24397519:+	-0.33	-4.67	9.95E-6	Venous thromboembolism (SNP x SNP interaction)	
THYM	cis	1	rs6709534	chr2:217334	SH3YL1	chr2:218138-264810:-	-0.29	-4.18	6.49E-5	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs6710438	chr2:73820108	ALMS1P	chr2:73872046-73912692:+	-0.59	-4.56	1.53E-5	Metabolite levels	
THYM	cis	1	rs6711033	chr2:73746643	ALMS1P	chr2:73872046-73912692:+	0.54	4.34	3.62E-5	Metabolite levels	
THYM	cis	1	rs6715819	chr2:73772309	ALMS1P	chr2:73872046-73912692:+	0.55	4.17	6.71E-5	Metabolite levels	
THYM	cis	1	rs6721034	chr2:54347307	RTN4	chr2:55199329-55277734:-	-0.5	-4.14	7.39E-5	Sudden cardiac arrest	
THYM	cis	1	rs6723774	chr2:227770592	RHBDD1	chr2:227700773-227861591:+	0.31	4.5	1.93E-5	Pulmonary function	
THYM	cis	1	rs6724782	chr2:73679990	ALMS1P	chr2:73872046-73912692:+	0.58	4.72	8.0E-6	Metabolite levels	
THYM	cis	1	rs6727897	chr2:69987384	GMCL1	chr2:70056818-70106727:+	0.14	4.99	2.73E-6	Palmitoleic acid (16:1n-7) plasma levels	
THYM	cis	1	rs67308794	chr9:91560222	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs6734408	chr2:239137481	LOC151174	chr2:239133754-239140318:-	0.92	4.63	1.14E-5	Irritable bowel syndrome	
THYM	cis	1	rs6736866	chr2:73661986	ALMS1P	chr2:73872046-73912692:+	0.64	4.83	5.14E-6	Metabolite levels	
THYM	cis	1	rs6740223	chr2:73653332	ALMS1P	chr2:73872046-73912692:+	0.58	4.7	8.77E-6	Metabolite levels	
THYM	cis	1	rs6741269	chr2:239179418	LOC151174	chr2:239133754-239140318:-	0.93	4.57	1.47E-5	Irritable bowel syndrome	
THYM	cis	1	rs6742276	chr2:61768745	AHSA2	chr2:61404553-61414058:+	-0.48	-5.94	4.71E-8	Tuberculosis	
THYM	cis	1	rs6742276	chr2:61768745	C2orf74	chr2:61372243-61391964:+	0.58	7.39	5.81E-11	Tuberculosis	
THYM	cis	1	rs6745368	chr2:73809974	ALMS1P	chr2:73872046-73912692:+	0.59	4.56	1.53E-5	Metabolite levels	
THYM	cis	1	rs67505314	chr10:17240134	CUBN	chr10:16865966-17171816:-	0.3	4.64	1.12E-5	Homocysteine levels	
THYM	cis	1	rs6752707	chr2:227766822	RHBDD1	chr2:227700773-227861591:+	-0.31	-4.56	1.51E-5	Pulmonary function	
THYM	cis	1	rs6753344	chr2:73653138	ALMS1P	chr2:73872046-73912692:+	-0.59	-4.56	1.53E-5	Metabolite levels	
THYM	cis	1	rs67536397	chr7:65947917	CCT6P1	chr7:65216092-65228661:+	0.6	4.86	4.72E-6	Diabetic kidney disease	
THYM	cis	1	rs6755217	chr2:73641285	ALMS1P	chr2:73872046-73912692:+	0.64	4.66	1.02E-5	Metabolite levels	
THYM	cis	1	rs6755241	chr2:73641364	ALMS1P	chr2:73872046-73912692:+	0.62	4.46	2.21E-5	Metabolite levels	
THYM	cis	1	rs67567111	chr20:23619075	CST9	chr20:23583049-23586610:-	-0.48	-4.46	2.25E-5	Chronic kidney disease	
THYM	cis	1	rs6756987	chr2:73687077	ALMS1P	chr2:73872046-73912692:+	0.58	4.72	8.0E-6	Metabolite levels	
THYM	cis	1	rs6759004	chr2:202004676	CFLAR	chr2:201980816-202029001:+	-0.39	-5.7	1.33E-7	Triptolide cytotoxicity	
THYM	cis	1	rs6759004	chr2:202004676	PPIL3	chr2:201735680-201753999:-	-0.86	-8.94	3.12E-14	Triptolide cytotoxicity	
THYM	cis	1	rs6763088	chr3:134254989	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs6763088	chr3:134254989	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs6763093	chr3:134254995	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs6763093	chr3:134254995	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs6763829	chr3:41897046	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs6765505	chr3:134208132	ANAPC13	chr3:134196547-134204865:-	0.58	7.95	3.88E-12	Height	
THYM	cis	1	rs6765505	chr3:134208132	CEP63	chr3:134204575-134293852:+	0.42	6.15	1.86E-8	Height	
THYM	cis	1	rs6766818	chr3:134226159	ANAPC13	chr3:134196547-134204865:-	0.58	8.05	2.33E-12	Height	
THYM	cis	1	rs6766818	chr3:134226159	CEP63	chr3:134204575-134293852:+	0.4	5.81	8.19E-8	Height	
THYM	cis	1	rs6766897	chr3:134191303	ANAPC13	chr3:134196547-134204865:-	0.57	7.6	2.06E-11	Height	
THYM	cis	1	rs6766897	chr3:134191303	CEP63	chr3:134204575-134293852:+	0.41	5.87	6.43E-8	Height	
THYM	cis	1	rs6768128	chr3:41865080	ULK4	chr3:41288091-42003660:-	1	10.81	3.16E-18	Diastolic blood pressure	
THYM	cis	1	rs6768542	chr3:41865474	ULK4	chr3:41288091-42003660:-	1	10.81	3.16E-18	Diastolic blood pressure	
THYM	cis	1	rs6768563	chr3:41865541	ULK4	chr3:41288091-42003660:-	1	10.7	5.29E-18	Diastolic blood pressure	
THYM	cis	1	rs6769885	chr3:134286913	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs6769885	chr3:134286913	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs6770470	chr3:48435123	TREX1	chr3:48501186-48509043:+	-0.28	-4.38	3.06E-5	Longevity	
THYM	cis	1	rs67728539	chr7:65378124	CCT6P1	chr7:65216092-65228661:+	0.64	4.57	1.46E-5	Diabetic kidney disease	
THYM	cis	1	rs6772896	chr3:134203347	ANAPC13	chr3:134196547-134204865:-	0.58	7.97	3.55E-12	Height	
THYM	cis	1	rs6772896	chr3:134203347	CEP63	chr3:134204575-134293852:+	0.4	5.69	1.38E-7	Height	
THYM	cis	1	rs6776700	chr3:48496758	TREX1	chr3:48501186-48509043:+	-0.28	-4.22	5.51E-5	Longevity	
THYM	cis	1	rs677977	chr1:147083744	ACP6	chr1:147119168-147142634:-	-0.52	-5.61	1.97E-7	Schizophrenia (negative symptoms)	
THYM	cis	1	rs6781326	chr3:41777028	ULK4	chr3:41288091-42003660:-	1.03	11.69	4.41E-20	Diastolic blood pressure	
THYM	cis	1	rs6782563	chr3:134295959	ANAPC13	chr3:134196547-134204865:-	-0.57	-7.59	2.17E-11	Height	
THYM	cis	1	rs6782563	chr3:134295959	CEP63	chr3:134204575-134293852:+	-0.42	-6	3.53E-8	Height	
THYM	cis	1	rs6783001	chr3:41862232	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs6784322	chr3:48422235	TREX1	chr3:48501186-48509043:+	-0.28	-4.2	6.07E-5	Longevity	
THYM	cis	1	rs6785027	chr3:134211649	ANAPC13	chr3:134196547-134204865:-	-0.57	-7.89	5.16E-12	Height	
THYM	cis	1	rs6785027	chr3:134211649	CEP63	chr3:134204575-134293852:+	-0.42	-6.17	1.7E-8	Height	
THYM	cis	1	rs6787371	chr3:134254991	ANAPC13	chr3:134196547-134204865:-	0.58	7.96	3.67E-12	Height	
THYM	cis	1	rs6787371	chr3:134254991	CEP63	chr3:134204575-134293852:+	0.4	5.76	1.02E-7	Height	
THYM	cis	1	rs6789260	chr3:41776350	ULK4	chr3:41288091-42003660:-	0.98	9.44	2.56E-15	Diastolic blood pressure	
THYM	cis	1	rs6790466	chr3:134197740	ANAPC13	chr3:134196547-134204865:-	0.58	7.97	3.55E-12	Height	
THYM	cis	1	rs6790466	chr3:134197740	CEP63	chr3:134204575-134293852:+	0.4	5.69	1.38E-7	Height	
THYM	cis	1	rs6790732	chr3:41864872	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs6791806	chr3:41889995	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs67927699	chr2:61187415	C2orf74	chr2:61372243-61391964:+	0.38	4.27	4.62E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THYM	cis	1	rs6793487	chr3:134299426	ANAPC13	chr3:134196547-134204865:-	-0.57	-7.56	2.56E-11	Height	
THYM	cis	1	rs6793487	chr3:134299426	CEP63	chr3:134204575-134293852:+	-0.42	-6.07	2.66E-8	Height	
THYM	cis	1	rs6794875	chr3:48455626	TREX1	chr3:48501186-48509043:+	-0.29	-4.34	3.54E-5	Longevity	
THYM	cis	1	rs6796210	chr3:41851718	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs6796491	chr3:48430465	TREX1	chr3:48501186-48509043:+	-0.28	-4.38	3.02E-5	Longevity	
THYM	cis	1	rs6797165	chr3:41887777	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs6800217	chr3:183685893	ABCC5	chr3:183637726-183735727:-	0.48	4.28	4.53E-5	Anterior chamber depth	
THYM	cis	1	rs6800862	chr3:134228628	ANAPC13	chr3:134196547-134204865:-	0.56	7.61	1.94E-11	Height	
THYM	cis	1	rs6800862	chr3:134228628	CEP63	chr3:134204575-134293852:+	0.41	6	3.54E-8	Height	
THYM	cis	1	rs6801343	chr3:41767234	ULK4	chr3:41288091-42003660:-	1.01	11.12	6.86E-19	Diastolic blood pressure	
THYM	cis	1	rs6801596	chr3:134252114	ANAPC13	chr3:134196547-134204865:-	0.56	7.61	1.94E-11	Height	
THYM	cis	1	rs6801596	chr3:134252114	CEP63	chr3:134204575-134293852:+	0.41	6	3.54E-8	Height	
THYM	cis	1	rs6802340	chr3:41894034	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs6802654	chr3:134217072	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs6802654	chr3:134217072	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs6803560	chr3:41824480	ULK4	chr3:41288091-42003660:-	1.02	11.1	7.68E-19	Diastolic blood pressure	
THYM	cis	1	rs6803652	chr3:41824556	ULK4	chr3:41288091-42003660:-	1.02	11.1	7.68E-19	Diastolic blood pressure	
THYM	cis	1	rs6804242	chr3:183659463	ABCC5	chr3:183637726-183735727:-	0.48	4.22	5.61E-5	Anterior chamber depth	
THYM	cis	1	rs6804770	chr3:134230234	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs6804770	chr3:134230234	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs6804774	chr3:48430617	TREX1	chr3:48501186-48509043:+	-0.28	-4.25	5.0E-5	Longevity	
THYM	cis	1	rs6805880	chr3:41865397	ULK4	chr3:41288091-42003660:-	1	10.81	3.16E-18	Diastolic blood pressure	
THYM	cis	1	rs6805913	chr3:183662924	ABCC5	chr3:183637726-183735727:-	0.48	4.22	5.61E-5	Anterior chamber depth	
THYM	cis	1	rs6806417	chr3:134211446	ANAPC13	chr3:134196547-134204865:-	-0.62	-6.95	4.58E-10	Height	
THYM	cis	1	rs6806417	chr3:134211446	CEP63	chr3:134204575-134293852:+	-0.42	-5	2.66E-6	Height	
THYM	cis	1	rs6807015	chr3:41754514	ULK4	chr3:41288091-42003660:-	0.99	10.12	9.3E-17	Diastolic blood pressure	
THYM	cis	1	rs6810060	chr3:48434748	TREX1	chr3:48501186-48509043:+	-0.28	-4.38	3.06E-5	Longevity	
THYM	cis	1	rs68171315	chr6:86707400	SNHG5	chr6:86386726-86388451:-	-0.57	-6.96	4.28E-10	Response to antipsychotic treatment	
THYM	cis	1	rs68189316	chr7:65409169	CCT6P1	chr7:65216092-65228661:+	0.62	5.13	1.51E-6	Diabetic kidney disease	
THYM	cis	1	rs6827617	chr4:76916146	NAAA	chr4:76831809-76862166:-	-0.45	-4.79	6.23E-6	Longevity	
THYM	cis	1	rs687672	chr11:65649984	CTSW	chr11:65647284-65651212:+	0.58	6.95	4.54E-10	Crohn's disease	
THYM	cis	1	rs687672	chr11:65649984	SNX32	chr11:65601410-65621170:+	-0.54	-5.02	2.4E-6	Crohn's disease	
THYM	cis	1	rs6885541	chr5:56110857	C5orf35	chr5:56205103-56213010:+	0.74	8.92	3.44E-14	Type 2 diabetes	
THYM	cis	1	rs6901703	chr6:24475300	GPLD1	chr6:24428405-24489850:-	-0.46	-4.69	9.22E-6	Hematological and biochemical traits	
THYM	cis	1	rs6902429	chr6:49393500	CENPQ	chr6:49431096-49460820:+	-0.3	-5.65	1.67E-7	Homocysteine levels	
THYM	cis	1	rs6910460	chr6:24471712	GPLD1	chr6:24428405-24489850:-	0.45	4.67	9.97E-6	Hematological and biochemical traits	
THYM	cis	1	rs6911965	chr6:24480295	GPLD1	chr6:24428405-24489850:-	-0.52	-4.97	3.0E-6	Hematological and biochemical traits	
THYM	cis	1	rs6914463	chr6:86653415	SNHG5	chr6:86386726-86388451:-	-0.57	-7.62	1.9E-11	Response to antipsychotic treatment	
THYM	cis	1	rs6915187	chr6:49423547	CENPQ	chr6:49431096-49460820:+	-0.29	-5.57	2.36E-7	Homocysteine levels	
THYM	cis	1	rs6916802	chr6:24465722	GPLD1	chr6:24428405-24489850:-	0.45	4.67	9.97E-6	Hematological and biochemical traits	
THYM	cis	1	rs6916888	chr6:49383804	CENPQ	chr6:49431096-49460820:+	-0.3	-5.65	1.67E-7	Homocysteine levels	
THYM	cis	1	rs6918347	chr6:49406348	CENPQ	chr6:49431096-49460820:+	-0.29	-5.57	2.36E-7	Homocysteine levels	
THYM	cis	1	rs6923124	chr6:49419864	CENPQ	chr6:49431096-49460820:+	-0.25	-4.46	2.21E-5	Folate pathway vitamin levels	
THYM	cis	1	rs6923148	chr6:86767786	SNHG5	chr6:86386726-86388451:-	0.58	7.92	4.5E-12	Response to antipsychotic treatment	
THYM	cis	1	rs6927188	chr6:42912589	GNMT	chr6:42928500-42931617:+	0.36	5.36	5.88E-7	Diabetic kidney disease	
THYM	cis	1	rs6927188	chr6:42912589	PEX6	chr6:42931613-42946981:-	-0.51	-4.78	6.43E-6	Diabetic kidney disease	
THYM	cis	1	rs6928435	chr6:24467366	GPLD1	chr6:24428405-24489850:-	0.45	4.67	9.97E-6	Hematological and biochemical traits	
THYM	cis	1	rs6930076	chr6:88088654	C6orf164	chr6:88032306-88109459:+	-0.5	-4.96	3.14E-6	Depressive episodes in bipolar disorder	
THYM	cis	1	rs6933377	chr6:86705255	SNHG5	chr6:86386726-86388451:-	0.43	4.91	3.72E-6	Response to antipsychotic treatment	
THYM	cis	1	rs6936048	chr6:86702608	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs693824	chr11:65654783	CTSW	chr11:65647284-65651212:+	-0.59	-7.12	2.04E-10	Crohn's disease	
THYM	cis	1	rs693824	chr11:65654783	SNX32	chr11:65601410-65621170:+	0.55	5.17	1.29E-6	Crohn's disease	
THYM	cis	1	rs6940458	chr6:86644992	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs6949812	chr7:65387101	CCT6P1	chr7:65216092-65228661:+	0.68	4.97	3.0E-6	Diabetic kidney disease	
THYM	cis	1	rs6949897	chr7:50621920	FIGNL1	chr7:50511834-50518088:-	-0.3	-4.64	1.09E-5	Malaria	
THYM	cis	1	rs694994	chr11:65653309	CTSW	chr11:65647284-65651212:+	-0.59	-7.12	2.04E-10	Crohn's disease	
THYM	cis	1	rs694994	chr11:65653309	SNX32	chr11:65601410-65621170:+	0.55	5.17	1.29E-6	Crohn's disease	
THYM	cis	1	rs6958289	chr7:65657111	CCT6P1	chr7:65216092-65228661:+	-0.67	-5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs6958420	chr7:65751171	CCT6P1	chr7:65216092-65228661:+	-0.64	-5.29	7.77E-7	Diabetic kidney disease	
THYM	cis	1	rs6959002	chr7:65650496	CCT6P1	chr7:65216092-65228661:+	-0.67	-5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs6964245	chr7:65718717	CCT6P1	chr7:65216092-65228661:+	-0.64	-5.29	7.77E-7	Diabetic kidney disease	
THYM	cis	1	rs6964530	chr7:65718851	CCT6P1	chr7:65216092-65228661:+	-0.64	-5.29	7.77E-7	Diabetic kidney disease	
THYM	cis	1	rs6966322	chr7:65646754	CCT6P1	chr7:65216092-65228661:+	-0.67	-5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs6970243	chr7:65388490	CCT6P1	chr7:65216092-65228661:+	0.68	4.97	3.0E-6	Diabetic kidney disease	
THYM	cis	1	rs6974723	chr7:65637939	CCT6P1	chr7:65216092-65228661:+	-0.67	-5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs7007450	chr8:71640269	XKR9	chr8:71581600-71648176:+	0.84	10.55	1.11E-17	Bone mineral density	
THYM	cis	1	rs7017914	chr8:71591203	XKR9	chr8:71581600-71648176:+	0.84	10.55	1.11E-17	Bone mineral density	
THYM	cis	1	rs7019938	chr9:91564344	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs7020528	chr9:91564761	C9orf47	chr9:91605778-91611055:+	-0.26	-4.42	2.59E-5	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs7020708	chr9:131885131	CRAT	chr9:131857075-131873070:-	0.38	4.61	1.24E-5	Blood metabolite ratios	
THYM	cis	1	rs7021449	chr9:131899312	CRAT	chr9:131857075-131873070:-	0.42	4.98	2.82E-6	Blood metabolite ratios	
THYM	cis	1	rs7021651	chr9:91548799	C9orf47	chr9:91605778-91611055:+	-0.27	-4.75	7.31E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs7022397	chr9:116007677	CDC26	chr9:116029290-116037869:-	-0.36	-5.77	9.96E-8	Hematology traits	
THYM	cis	1	rs7023900	chr9:131891152	CRAT	chr9:131857075-131873070:-	0.42	4.98	2.82E-6	Blood metabolite ratios	
THYM	cis	1	rs7024847	chr9:91565755	C9orf47	chr9:91605778-91611055:+	-0.26	-4.42	2.59E-5	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs7028197	chr9:91555066	C9orf47	chr9:91605778-91611055:+	-0.26	-4.68	9.7E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs7032526	chr9:91564276	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs7032662	chr9:91564355	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs7036114	chr9:131893406	CRAT	chr9:131857075-131873070:-	0.42	4.98	2.82E-6	Blood metabolite ratios	
THYM	cis	1	rs7036236	chr9:131899299	CRAT	chr9:131857075-131873070:-	0.38	4.61	1.24E-5	Blood metabolite ratios	
THYM	cis	1	rs7037140	chr9:123656327	LOC253039	chr9:123605320-123616644:+	-0.62	-5.56	2.51E-7	Rheumatoid arthritis	
THYM	cis	1	rs7037163	chr9:131894340	CRAT	chr9:131857075-131873070:-	0.47	5.4	4.92E-7	Blood metabolite ratios	
THYM	cis	1	rs7037603	chr9:91565874	C9orf47	chr9:91605778-91611055:+	-0.26	-4.45	2.34E-5	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs703842	chr12:58162739	FAM119B	chr12:58166383-58176323:+	-0.41	-5.65	1.64E-7	Multiple sclerosis	
THYM	cis	1	rs703842	chr12:58162739	TSFM	chr12:58176536-58191367:+	0.3	5.39	5.23E-7	Multiple sclerosis	
THYM	cis	1	rs7038769	chr9:116007583	CDC26	chr9:116029290-116037869:-	-0.36	-5.77	9.96E-8	Hematology traits	
THYM	cis	1	rs7038956	chr9:91553712	C9orf47	chr9:91605778-91611055:+	-0.26	-4.68	9.7E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs7044951	chr9:91564637	C9orf47	chr9:91605778-91611055:+	-0.27	-4.69	8.99E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs7047321	chr9:91555547	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs705696	chr12:56480648	RPS26	chr12:56435686-56438005:+	0.96	10.16	7.65E-17	Cognitive function	
THYM	cis	1	rs7072122	chr10:45034672	ZNF22	chr10:45496273-45500776:+	0.64	5.71	1.28E-7	Estradiol plasma levels (breast cancer)	
THYM	cis	1	rs7072216	chr10:100156853	PYROXD2	chr10:100143323-100174978:-	0.78	12.99	8.8E-23	Metabolite levels	
THYM	cis	1	rs7072634	chr10:17240918	CUBN	chr10:16865966-17171816:-	0.31	4.71	8.37E-6	Homocysteine levels	
THYM	cis	1	rs7074999	chr10:50602997	PGBD3	chr10:50723247-50747584:-	-0.69	-4.44	2.45E-5	Inflammatory biomarkers	
THYM	cis	1	rs7082376	chr10:17232223	CUBN	chr10:16865966-17171816:-	0.31	4.71	8.37E-6	Homocysteine levels	
THYM	cis	1	rs7084476	chr10:17211383	CUBN	chr10:16865966-17171816:-	0.31	4.85	4.79E-6	Homocysteine levels	
THYM	cis	1	rs7086617	chr10:45007607	ZNF22	chr10:45496273-45500776:+	0.58	5.32	7.02E-7	Estradiol plasma levels (breast cancer)	
THYM	cis	1	rs709592	chr17:38175553	GSDMA	chr17:38119226-38134019:+	-0.87	-9.35	3.97E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THYM	cis	1	rs7095944	chr10:126302936	METTL10	chr10:126447406-126480439:-	-0.36	-4.48	2.08E-5	Asthma	
THYM	cis	1	rs709607	chr7:65449541	CCT6P1	chr7:65216092-65228661:+	-0.65	-5.31	7.32E-7	Diabetic kidney disease	
THYM	cis	1	rs7096692	chr10:17180828	CUBN	chr10:16865966-17171816:-	0.32	4.99	2.69E-6	Homocysteine levels	
THYM	cis	1	rs7098825	chr10:104628234	SFXN2	chr10:104474298-104498946:+	-0.55	-4.43	2.49E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
THYM	cis	1	rs7100163	chr10:17181177	CUBN	chr10:16865966-17171816:-	0.31	4.72	8.1E-6	Homocysteine levels	
THYM	cis	1	rs7111	chr15:90373873	AP3S2	chr15:90373832-90456222:-	-0.42	-4.83	5.23E-6	Type 2 diabetes	
THYM	cis	1	rs7115737	chr11:43681249	HSD17B12	chr11:43702143-43878160:+	-0.59	-5.94	4.7E-8	Forced vital capacity	
THYM	cis	1	rs713219	chr9:131900920	CRAT	chr9:131857075-131873070:-	0.42	4.98	2.82E-6	Blood metabolite ratios	
THYM	cis	1	rs71327718	chr3:125592857	LOC100125556	chr3:125635444-125648865:+	0.67	4.26	4.8E-5	Metabolite levels (HVA/5-HIAA ratio)	
THYM	cis	1	rs71334202	chr20:23618652	CST9	chr20:23583049-23586610:-	-0.47	-4.35	3.48E-5	Chronic kidney disease	
THYM	cis	1	rs71426508	chr2:239137767	LOC151174	chr2:239133754-239140318:-	1.02	4.78	6.5E-6	Irritable bowel syndrome	
THYM	cis	1	rs71426509	chr2:239175334	LOC151174	chr2:239133754-239140318:-	0.93	4.57	1.47E-5	Irritable bowel syndrome	
THYM	cis	1	rs71426510	chr2:239178909	LOC151174	chr2:239133754-239140318:-	0.93	4.57	1.47E-5	Irritable bowel syndrome	
THYM	cis	1	rs7144423	chr14:35572547	KIAA0391	chr14:35591776-35786673:+	0.37	4.81	5.59E-6	Atopic dermatitis	
THYM	cis	1	rs7144423	chr14:35572547	PPP2R3C	chr14:35554679-35591679:-	0.28	5.24	9.78E-7	Atopic dermatitis	
THYM	cis	1	rs7153160	chr14:74509377	LIN52	chr14:74551656-74667117:+	0.37	6.78	9.95E-10	Common traits (Other)	
THYM	cis	1	rs7153587	chr14:74509660	LIN52	chr14:74551656-74667117:+	0.37	6.78	9.95E-10	Common traits (Other)	
THYM	cis	1	rs7154306	chr14:35540499	KIAA0391	chr14:35591776-35786673:+	0.32	4.16	6.96E-5	Atopic dermatitis	
THYM	cis	1	rs7154306	chr14:35540499	PPP2R3C	chr14:35554679-35591679:-	0.27	5.01	2.56E-6	Atopic dermatitis	
THYM	cis	1	rs7156322	chr14:35544330	KIAA0391	chr14:35591776-35786673:+	0.33	4.32	3.86E-5	Atopic dermatitis	
THYM	cis	1	rs7156322	chr14:35544330	PPP2R3C	chr14:35554679-35591679:-	0.27	5.01	2.52E-6	Atopic dermatitis	
THYM	cis	1	rs7157566	chr14:74649129	LIN52	chr14:74551656-74667117:+	-0.38	-6.85	7.26E-10	Common traits (Other)	
THYM	cis	1	rs7162900	chr15:75368017	PPCDC	chr15:75315927-75343066:+	0.26	4.77	6.63E-6	Blood trace element (Zn levels)	
THYM	cis	1	rs7167285	chr15:75368769	PPCDC	chr15:75315927-75343066:+	0.26	4.74	7.37E-6	Blood trace element (Zn levels)	
THYM	cis	1	rs7168680	chr15:75369212	PPCDC	chr15:75315927-75343066:+	0.26	4.7	8.93E-6	Blood trace element (Zn levels)	
THYM	cis	1	rs7170930	chr15:66580853	TIPIN	chr15:66629008-66649054:-	-0.6	-4.58	1.4E-5	Response to cytadine analogues (cytosine arabinoside)	
THYM	cis	1	rs7175720	chr15:75348962	PPCDC	chr15:75315927-75343066:+	-0.26	-4.57	1.48E-5	Blood trace element (Zn levels)	
THYM	cis	1	rs7191665	chr16:74688948	RFWD3	chr16:74655298-74700779:-	-0.21	-4.51	1.84E-5	Testicular germ cell tumor	
THYM	cis	1	rs7195763	chr16:4649300	NMRAL1	chr16:4511696-4526307:-	-0.42	-4.94	3.3E-6	Obesity-related traits	
THYM	cis	1	rs7201176	chr16:4626881	NMRAL1	chr16:4511696-4526307:-	-0.48	-5.52	2.96E-7	Obesity-related traits	
THYM	cis	1	rs7201320	chr16:74694058	RFWD3	chr16:74655298-74700779:-	-0.22	-4.79	6.03E-6	Testicular germ cell tumor	
THYM	cis	1	rs7206416	chr16:4626724	NMRAL1	chr16:4511696-4526307:-	-0.47	-5.54	2.74E-7	Obesity-related traits	
THYM	cis	1	rs7209180	chr17:79581519	TSPAN10	chr17:79609349-79615778:+	0.63	6.68	1.61E-9	Eye color traits	
THYM	cis	1	rs7209435	chr17:61712964	TCAM1P	chr17:61934376-61941738:+	-0.53	-4.38	3.02E-5	Body mass index	
THYM	cis	1	rs7211213	chr17:61769456	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.4	2.85E-5	Body mass index	
THYM	cis	1	rs7212497	chr17:28335949	EFCAB5	chr17:28256874-28435469:+	-0.31	-4.25	5.04E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs7213129	chr17:79581573	TSPAN10	chr17:79609349-79615778:+	0.63	6.68	1.61E-9	Eye color traits	
THYM	cis	1	rs7214085	chr17:38169095	GSDMA	chr17:38119226-38134019:+	-0.87	-9.52	1.73E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THYM	cis	1	rs7216798	chr17:61740963	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.47	2.2E-5	Body mass index	
THYM	cis	1	rs7221109	chr17:38770286	SMARCE1	chr17:38783976-38804103:-	-0.28	-4.46	2.28E-5	Type 1 diabetes	
THYM	cis	1	rs7222241	chr17:79574714	TSPAN10	chr17:79609349-79615778:+	0.63	6.68	1.61E-9	Eye color traits	
THYM	cis	1	rs7222308	chr17:28277041	EFCAB5	chr17:28256874-28435469:+	0.32	4.3	4.2E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs7223613	chr17:79574803	TSPAN10	chr17:79609349-79615778:+	-0.63	-6.68	1.61E-9	Eye color traits	
THYM	cis	1	rs7223672	chr17:61720565	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.33	3.63E-5	Body mass index	
THYM	cis	1	rs7223786	chr17:28332107	EFCAB5	chr17:28256874-28435469:+	-0.31	-4.25	5.04E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs7246967	chr19:23056346	ZNF492	chr19:22817126-22850472:+	-0.5	-5.66	1.61E-7	Bronchopulmonary dysplasia	
THYM	cis	1	rs725309	chr3:48418708	TREX1	chr3:48501186-48509043:+	0.28	4.49	2.0E-5	Longevity	
THYM	cis	1	rs725310	chr3:48418571	TREX1	chr3:48501186-48509043:+	0.3	4.76	6.81E-6	Longevity	
THYM	cis	1	rs7254758	chr19:33608047	GPATCH1	chr19:33571786-33621318:+	0.37	4.33	3.69E-5	Bone properties (heel)	
THYM	cis	1	rs7255679	chr19:42063981	CEACAM21	chr19:42055886-42093196:+	0.67	8.85	4.68E-14	Schizophrenia	
THYM	cis	1	rs7255968	chr19:33601902	GPATCH1	chr19:33571786-33621318:+	0.37	4.23	5.32E-5	Bone properties (heel)	
THYM	cis	1	rs7257127	chr19:23056699	ZNF492	chr19:22817126-22850472:+	-0.5	-5.66	1.61E-7	Bronchopulmonary dysplasia	
THYM	cis	1	rs72627410	chr2:101427758	PDCL3	chr2:101179418-101193201:+	0.51	4.17	6.67E-5	Creutzfeldt-Jakob disease (variant)	
THYM	cis	1	rs72644213	chr10:81783660	LOC219347	chr10:81805991-81838949:-	0.63	4.28	4.47E-5	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs7270354	chr20:44607661	WFDC3	chr20:44402847-44420547:-	-0.55	-4.16	7.09E-5	Abdominal aortic aneurysm	
THYM	cis	1	rs7278547	chr21:43835827	TMPRSS3	chr21:43791996-43816200:-	0.51	4.61	1.25E-5	Type 1 diabetes	
THYM	cis	1	rs72819593	chr17:2199489	SRR	chr17:2207248-2228553:+	-0.55	-5.52	2.92E-7	Esophageal cancer (squamous cell)	
THYM	cis	1	rs7285549	chr22:25874580	CRYBB2	chr22:25615612-25627836:+	1.12	7.51	3.14E-11	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs72872744	chr2:48704719	FOXN2	chr2:48541795-48606434:+	0.28	4.22	5.49E-5	Schizophrenia	
THYM	cis	1	rs72921498	chr11:62113090	ASRGL1	chr11:62104774-62160885:+	-0.62	-6.56	2.77E-9	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs72921501	chr11:62115622	ASRGL1	chr11:62104774-62160885:+	-0.62	-6.22	1.35E-8	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs72922733	chr11:65520746	SNX32	chr11:65601410-65621170:+	0.43	4.57	1.48E-5	Systemic lupus erythematosus	
THYM	cis	1	rs7301826	chr12:131291101	STX2	chr12:131274149-131323811:-	0.35	5.89	5.79E-8	Plasma plasminogen activator levels	
THYM	cis	1	rs7303433	chr12:23640479	SOX5	chr12:23685232-24715380:-	-0.72	-4.28	4.41E-5	Schizophrenia	
THYM	cis	1	rs73069392	chr3:41787009	ULK4	chr3:41288091-42003660:-	1	10.33	3.31E-17	Diastolic blood pressure	
THYM	cis	1	rs73069394	chr3:41787233	ULK4	chr3:41288091-42003660:-	0.99	11.02	1.12E-18	Diastolic blood pressure	
THYM	cis	1	rs73069396	chr3:41787236	ULK4	chr3:41288091-42003660:-	0.99	11.02	1.12E-18	Diastolic blood pressure	
THYM	cis	1	rs73071329	chr3:41810539	ULK4	chr3:41288091-42003660:-	1.01	10.74	4.29E-18	Diastolic blood pressure	
THYM	cis	1	rs73074358	chr3:48427247	TREX1	chr3:48501186-48509043:+	-0.28	-4.38	3.02E-5	Longevity	
THYM	cis	1	rs73077367	chr3:41851959	ULK4	chr3:41288091-42003660:-	1	10.98	1.34E-18	Diastolic blood pressure	
THYM	cis	1	rs73079316	chr3:41863859	ULK4	chr3:41288091-42003660:-	0.95	9.28	5.58E-15	Diastolic blood pressure	
THYM	cis	1	rs73079321	chr3:41863910	ULK4	chr3:41288091-42003660:-	1	10.81	3.16E-18	Diastolic blood pressure	
THYM	cis	1	rs73081353	chr3:41906448	ULK4	chr3:41288091-42003660:-	0.95	9.28	5.58E-15	Diastolic blood pressure	
THYM	cis	1	rs73081364	chr3:41913616	ULK4	chr3:41288091-42003660:-	0.95	9.28	5.58E-15	Diastolic blood pressure	
THYM	cis	1	rs73116394	chr2:242367915	SEPT2	chr2:242254723-242293439:+	0.44	6.02	3.32E-8	Chronic lymphocytic leukemia	
THYM	cis	1	rs73116396	chr2:242368693	SEPT2	chr2:242254723-242293439:+	0.44	6.02	3.32E-8	Chronic lymphocytic leukemia	
THYM	cis	1	rs73142121	chr7:65311206	CCT6P1	chr7:65216092-65228661:+	0.65	4.84	4.96E-6	Diabetic kidney disease	
THYM	cis	1	rs73142122	chr7:65311298	CCT6P1	chr7:65216092-65228661:+	0.68	5.01	2.55E-6	Diabetic kidney disease	
THYM	cis	1	rs73142162	chr7:65374296	CCT6P1	chr7:65216092-65228661:+	0.68	5.01	2.55E-6	Diabetic kidney disease	
THYM	cis	1	rs73142166	chr7:65375832	CCT6P1	chr7:65216092-65228661:+	0.67	4.78	6.27E-6	Diabetic kidney disease	
THYM	cis	1	rs73150014	chr7:65450919	CCT6P1	chr7:65216092-65228661:+	0.64	5.31	7.19E-7	Diabetic kidney disease	
THYM	cis	1	rs7320606	chr13:21052521	GJB2	chr13:20761606-20767114:-	-0.36	-4.68	9.62E-6	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
THYM	cis	1	rs7329823	chr13:21050127	GJB2	chr13:20761606-20767114:-	-0.36	-4.82	5.51E-6	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
THYM	cis	1	rs73318135	chr20:23618571	CST9	chr20:23583049-23586610:-	-0.47	-4.17	6.74E-5	Chronic kidney disease	
THYM	cis	1	rs73337598	chr17:61732576	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.45	2.32E-5	Body mass index	
THYM	cis	1	rs734801	chr20:23612791	CST9	chr20:23583049-23586610:-	-0.51	-4.71	8.44E-6	Chronic kidney disease	
THYM	cis	1	rs7356093	chr3:134238753	ANAPC13	chr3:134196547-134204865:-	0.58	8.05	2.33E-12	Height	
THYM	cis	1	rs7356093	chr3:134238753	CEP63	chr3:134204575-134293852:+	0.4	5.81	8.19E-8	Height	
THYM	cis	1	rs7366434	chr1:117455553	SLC22A15	chr1:116519119-116612672:+	-0.64	-4.26	4.74E-5	Erectile dysfunction and prostate cancer treatment	
THYM	cis	1	rs7371896	chr3:134249769	ANAPC13	chr3:134196547-134204865:-	0.58	7.96	3.67E-12	Height	
THYM	cis	1	rs7371896	chr3:134249769	CEP63	chr3:134204575-134293852:+	0.4	5.76	1.02E-7	Height	
THYM	cis	1	rs7372217	chr3:41990122	ULK4	chr3:41288091-42003660:-	-1.01	-11.41	1.64E-19	Diastolic blood pressure	
THYM	cis	1	rs73726531	chr6:18103028	NHLRC1	chr6:18120718-18122851:-	-1.06	-4.38	3.09E-5	Thiopurine S-methyltransferase activity	
THYM	cis	1	rs7374158	chr3:134270156	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs7374158	chr3:134270156	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs7374325	chr3:134275601	ANAPC13	chr3:134196547-134204865:-	0.58	8.05	2.33E-12	Height	
THYM	cis	1	rs7374325	chr3:134275601	CEP63	chr3:134204575-134293852:+	0.4	5.81	8.19E-8	Height	
THYM	cis	1	rs73958618	chr2:136500475	DARS	chr2:136664254-136743222:-	0.36	4.14	7.64E-5	Corneal structure	
THYM	cis	1	rs7406003	chr17:79597597	TSPAN10	chr17:79609349-79615778:+	0.63	6.54	3.14E-9	Eye color traits	
THYM	cis	1	rs7412746	chr1:150860471	HORMAD1	chr1:150670542-150693352:-	-0.63	-5.01	2.48E-6	Melanoma	
THYM	cis	1	rs74138428	chr10:45030702	ZNF22	chr10:45496273-45500776:+	0.47	4.67	9.87E-6	Estradiol plasma levels (breast cancer)	
THYM	cis	1	rs7425670	chr2:88522028	THNSL2	chr2:88469835-88486145:+	-0.5	-4.23	5.34E-5	Plasma clusterin levels	
THYM	cis	1	rs7426847	chr3:134267519	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs7426847	chr3:134267519	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs7427492	chr3:134261654	ANAPC13	chr3:134196547-134204865:-	0.58	8.05	2.33E-12	Height	
THYM	cis	1	rs7427492	chr3:134261654	CEP63	chr3:134204575-134293852:+	0.4	5.81	8.19E-8	Height	
THYM	cis	1	rs7428326	chr3:134251184	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs7428326	chr3:134251184	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs74293240	chr6:24483896	ALDH5A1	chr6:24495197-24537434:+	0.33	4.16	7.04E-5	Hematological and biochemical traits	
THYM	cis	1	rs74293240	chr6:24483896	GPLD1	chr6:24428405-24489850:-	0.56	5.51	3.04E-7	Hematological and biochemical traits	
THYM	cis	1	rs7429866	chr3:134236306	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs7429866	chr3:134236306	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs7432268	chr3:134242051	ANAPC13	chr3:134196547-134204865:-	0.58	8.05	2.33E-12	Height	
THYM	cis	1	rs7432268	chr3:134242051	CEP63	chr3:134204575-134293852:+	0.4	5.81	8.19E-8	Height	
THYM	cis	1	rs7433663	chr3:134235790	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs7433663	chr3:134235790	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs7433991	chr3:134312292	ANAPC13	chr3:134196547-134204865:-	0.55	7.48	3.7E-11	Height	
THYM	cis	1	rs7433991	chr3:134312292	CEP63	chr3:134204575-134293852:+	0.43	6.36	7.09E-9	Height	
THYM	cis	1	rs7436021	chr4:76905472	NAAA	chr4:76831809-76862166:-	-0.46	-4.92	3.56E-6	Longevity	
THYM	cis	1	rs74370978	chr6:18114687	NHLRC1	chr6:18120718-18122851:-	-1.06	-4.36	3.24E-5	Thiopurine S-methyltransferase activity	
THYM	cis	1	rs7456042	chr7:65299778	CCT6P1	chr7:65216092-65228661:+	0.65	4.84	4.96E-6	Diabetic kidney disease	
THYM	cis	1	rs746489	chr9:131910093	CRAT	chr9:131857075-131873070:-	0.38	4.61	1.24E-5	Blood metabolite ratios	
THYM	cis	1	rs7481995	chr11:62129312	ASRGL1	chr11:62104774-62160885:+	0.56	5.84	7.18E-8	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs74839329	chr1:100592057	LRRC39	chr1:100614413-100643800:-	0.67	4.21	5.78E-5	Carotid intima media thickness	
THYM	cis	1	rs74984113	chr4:250522	ZNF718	chr4:53272-156488:+	0.68	7.3	8.88E-11	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs7503679	chr17:79583843	TSPAN10	chr17:79609349-79615778:+	0.65	6.74	1.2E-9	Eye color traits	
THYM	cis	1	rs75117781	chr16:4654204	NMRAL1	chr16:4511696-4526307:-	-0.5	-5.61	1.96E-7	Obesity-related traits	
THYM	cis	1	rs7515491	chr1:46355079	CCDC163P	chr1:45960581-45965646:-	-0.47	-5.57	2.32E-7	Body mass index	
THYM	cis	1	rs7518038	chr1:76154430	ACADM	chr1:76190043-76229353:+	0.3	4.17	6.76E-5	Blood metabolite levels;Acylcarnitine levels	
THYM	cis	1	rs75181745	chr2:88520408	THNSL2	chr2:88469835-88486145:+	-0.5	-4.23	5.34E-5	Plasma clusterin levels	
THYM	cis	1	rs7518329	chr1:212398533	NEK2	chr1:211836115-211848967:-	-0.17	-4.33	3.71E-5	Intelligence (childhood)	
THYM	cis	1	rs7522601	chr1:46419021	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs7522705	chr1:45992300	CCDC163P	chr1:45960581-45965646:-	0.76	12.36	1.77E-21	Homocysteine levels	
THYM	cis	1	rs7522948	chr1:156275308	CCT3	chr1:156278752-156308195:-	-0.18	-4.37	3.22E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
THYM	cis	1	rs7524467	chr1:76194054	ACADM	chr1:76190043-76229353:+	0.3	4.24	5.21E-5	Blood metabolite levels;Acylcarnitine levels	
THYM	cis	1	rs7524495	chr1:46266932	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	6.8E-8	Body mass index	
THYM	cis	1	rs75309929	chr2:88524377	THNSL2	chr2:88469835-88486145:+	-0.5	-4.23	5.34E-5	Plasma clusterin levels	
THYM	cis	1	rs7533888	chr1:76160449	ACADM	chr1:76190043-76229353:+	0.3	4.24	5.21E-5	Blood metabolite levels;Acylcarnitine levels	
THYM	cis	1	rs7534467	chr1:45988691	CCDC163P	chr1:45960581-45965646:-	-0.86	-14.78	2.3E-26	Homocysteine levels	
THYM	cis	1	rs7534754	chr1:76185308	ACADM	chr1:76190043-76229353:+	0.3	4.24	5.21E-5	Blood metabolite levels;Acylcarnitine levels	
THYM	cis	1	rs7536557	chr1:45992114	CCDC163P	chr1:45960581-45965646:-	-0.76	-12.27	2.68E-21	Homocysteine levels	
THYM	cis	1	rs75379431	chr6:18128481	NHLRC1	chr6:18120718-18122851:-	-1.1	-4.37	3.12E-5	Thiopurine S-methyltransferase activity	
THYM	cis	1	rs7539932	chr1:46292354	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	6.8E-8	Body mass index	
THYM	cis	1	rs7540325	chr1:46338217	CCDC163P	chr1:45960581-45965646:-	-0.49	-5.85	6.8E-8	Body mass index	
THYM	cis	1	rs75407001	chr6:18120293	NHLRC1	chr6:18120718-18122851:-	-1.06	-4.39	2.95E-5	Thiopurine S-methyltransferase activity	
THYM	cis	1	rs7548962	chr1:76139266	ACADM	chr1:76190043-76229353:+	0.3	4.24	5.22E-5	Blood metabolite levels;Acylcarnitine levels	
THYM	cis	1	rs7550746	chr1:46351719	CCDC163P	chr1:45960581-45965646:-	-0.5	-5.94	4.7E-8	Body mass index	
THYM	cis	1	rs7552404	chr1:76135946	ACADM	chr1:76190043-76229353:+	0.3	4.24	5.21E-5	Blood metabolite levels;Acylcarnitine levels	
THYM	cis	1	rs7556436	chr1:46363880	CCDC163P	chr1:45960581-45965646:-	0.49	6	3.55E-8	Body mass index	
THYM	cis	1	rs7556615	chr1:46461369	CCDC163P	chr1:45960581-45965646:-	-0.47	-5.73	1.15E-7	Body mass index	
THYM	cis	1	rs7558944	chr2:73810909	ALMS1P	chr2:73872046-73912692:+	0.59	4.56	1.53E-5	Metabolite levels	
THYM	cis	1	rs7561378	chr2:227772248	RHBDD1	chr2:227700773-227861591:+	-0.31	-4.56	1.54E-5	Pulmonary function	
THYM	cis	1	rs7564890	chr2:73641853	ALMS1P	chr2:73872046-73912692:+	0.59	4.4	2.8E-5	Metabolite levels	
THYM	cis	1	rs7566279	chr2:281178	SH3YL1	chr2:218138-264810:-	-0.33	-4.86	4.59E-6	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs7571660	chr2:54347384	RTN4	chr2:55199329-55277734:-	-0.51	-4.25	4.97E-5	Sudden cardiac arrest	
THYM	cis	1	rs7572722	chr2:73724675	ALMS1P	chr2:73872046-73912692:+	0.59	4.52	1.75E-5	Metabolite levels	
THYM	cis	1	rs7576245	chr2:73829678	ALMS1P	chr2:73872046-73912692:+	0.58	4.7	8.77E-6	Metabolite levels	
THYM	cis	1	rs7579277	chr2:28996295	TRMT61B	chr2:29072690-29093175:-	-0.49	-4.13	7.78E-5	Body mass index	
THYM	cis	1	rs757978	chr2:242371101	SEPT2	chr2:242254723-242293439:+	0.45	6.26	1.12E-8	Chronic lymphocytic leukemia	
THYM	cis	1	rs7579961	chr2:227776976	RHBDD1	chr2:227700773-227861591:+	-0.31	-4.54	1.63E-5	Pulmonary function	
THYM	cis	1	rs7580825	chr2:73635148	ALMS1P	chr2:73872046-73912692:+	0.61	4.79	6.13E-6	Metabolite levels	
THYM	cis	1	rs75824542	chr14:74523047	LIN52	chr14:74551656-74667117:+	0.38	7.07	2.63E-10	Common traits (Other)	
THYM	cis	1	rs7582606	chr2:73813945	ALMS1P	chr2:73872046-73912692:+	0.59	4.56	1.53E-5	Metabolite levels	
THYM	cis	1	rs7583255	chr2:73797996	ALMS1P	chr2:73872046-73912692:+	0.59	4.53	1.69E-5	Metabolite levels	
THYM	cis	1	rs7584575	chr2:73666402	ALMS1P	chr2:73872046-73912692:+	0.57	4.75	7.32E-6	Metabolite levels	
THYM	cis	1	rs7585004	chr2:73666645	ALMS1P	chr2:73872046-73912692:+	0.58	4.7	8.7E-6	Metabolite levels	
THYM	cis	1	rs7586463	chr2:73798476	ALMS1P	chr2:73872046-73912692:+	0.59	4.53	1.69E-5	Metabolite levels	
THYM	cis	1	rs75889859	chr14:35539054	KIAA0391	chr14:35591776-35786673:+	0.32	4.16	6.96E-5	Atopic dermatitis	
THYM	cis	1	rs75889859	chr14:35539054	PPP2R3C	chr14:35554679-35591679:-	0.27	5.01	2.56E-6	Atopic dermatitis	
THYM	cis	1	rs758970	chr9:129194773	FAM125B	chr9:129089128-129273699:+	0.41	4.18	6.43E-5	Obesity-related traits	
THYM	cis	1	rs7589728	chr2:88518440	THNSL2	chr2:88469835-88486145:+	-0.5	-4.23	5.34E-5	Plasma clusterin levels	
THYM	cis	1	rs7591472	chr2:201889751	PPIL3	chr2:201735680-201753999:-	-0.88	-10.24	5.04E-17	Triptolide cytotoxicity	
THYM	cis	1	rs75919582	chr7:139054919	C7orf55	chr7:139025897-139030539:+	-0.21	-4.54	1.63E-5	Diisocyanate-induced asthma	
THYM	cis	1	rs7592387	chr2:227777095	RHBDD1	chr2:227700773-227861591:+	-0.31	-4.54	1.63E-5	Pulmonary function	
THYM	cis	1	rs7594511	chr2:73681639	ALMS1P	chr2:73872046-73912692:+	0.59	4.56	1.53E-5	Metabolite levels	
THYM	cis	1	rs7595075	chr2:264019	SH3YL1	chr2:218138-264810:-	-0.33	-4.86	4.59E-6	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs7596362	chr2:61204688	C2orf74	chr2:61372243-61391964:+	0.39	4.35	3.4E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THYM	cis	1	rs7597155	chr2:69985435	GMCL1	chr2:70056818-70106727:+	0.14	4.98	2.86E-6	Palmitoleic acid (16:1n-7) plasma levels	
THYM	cis	1	rs7598396	chr2:73652628	ALMS1P	chr2:73872046-73912692:+	0.59	4.56	1.53E-5	Metabolite levels	
THYM	cis	1	rs7598419	chr2:73798223	ALMS1P	chr2:73872046-73912692:+	0.61	4.61	1.27E-5	Metabolite levels	
THYM	cis	1	rs7598876	chr2:28974466	TRMT61B	chr2:29072690-29093175:-	-0.5	-4.16	6.98E-5	Body mass index	
THYM	cis	1	rs7601738	chr2:242375813	SEPT2	chr2:242254723-242293439:+	-0.43	-5.91	5.25E-8	Chronic lymphocytic leukemia	
THYM	cis	1	rs7604682	chr2:73788026	ALMS1P	chr2:73872046-73912692:+	0.57	4.64	1.09E-5	Metabolite levels	
THYM	cis	1	rs760554	chr22:25872592	CRYBB2	chr22:25615612-25627836:+	1.13	7.35	6.76E-11	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs760555	chr22:25872837	CRYBB2	chr22:25615612-25627836:+	1.07	7.43	4.62E-11	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs7605824	chr2:280819	SH3YL1	chr2:218138-264810:-	0.33	4.79	6.07E-6	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs7607014	chr2:73730174	ALMS1P	chr2:73872046-73912692:+	-0.56	-4.47	2.18E-5	Metabolite levels	
THYM	cis	1	rs7608697	chr2:61204641	C2orf74	chr2:61372243-61391964:+	0.37	4.2	5.94E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THYM	cis	1	rs7608910	chr2:61204856	C2orf74	chr2:61372243-61391964:+	-0.37	-4.23	5.43E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
THYM	cis	1	rs7609851	chr3:156638503	LEKR1	chr3:156544076-156763918:+	-0.72	-4.3	4.1E-5	Bone mineral density	
THYM	cis	1	rs7611611	chr3:134307877	ANAPC13	chr3:134196547-134204865:-	0.55	7.48	3.7E-11	Height	
THYM	cis	1	rs7611611	chr3:134307877	CEP63	chr3:134204575-134293852:+	0.43	6.36	7.09E-9	Height	
THYM	cis	1	rs7611828	chr3:134250325	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs7611828	chr3:134250325	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs7615952	chr3:125649403	LOC100125556	chr3:125635444-125648865:+	-0.7	-5.85	6.81E-8	Blood pressure (smoking interaction)	
THYM	cis	1	rs7616044	chr3:125649354	LOC100125556	chr3:125635444-125648865:+	0.72	5.75	1.07E-7	Blood pressure (smoking interaction)	
THYM	cis	1	rs7616844	chr3:41874343	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs7617397	chr3:41959037	ULK4	chr3:41288091-42003660:-	-1.02	-11.59	6.88E-20	Diastolic blood pressure	
THYM	cis	1	rs7619451	chr3:134233238	ANAPC13	chr3:134196547-134204865:-	0.51	5.2	1.16E-6	Height	
THYM	cis	1	rs7620350	chr3:183710053	ABCC5	chr3:183637726-183735727:-	0.48	4.28	4.53E-5	Anterior chamber depth	
THYM	cis	1	rs7622259	chr3:41881351	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs7624372	chr3:41881107	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs7630741	chr3:48419723	TREX1	chr3:48501186-48509043:+	-0.28	-4.25	5.0E-5	Longevity	
THYM	cis	1	rs7630874	chr3:134293291	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs7630874	chr3:134293291	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs7631057	chr3:41817951	ULK4	chr3:41288091-42003660:-	0.96	10.26	4.69E-17	Diastolic blood pressure	
THYM	cis	1	rs7632387	chr3:41853161	ULK4	chr3:41288091-42003660:-	0.94	9.62	1.09E-15	Diastolic blood pressure	
THYM	cis	1	rs7634377	chr3:48421258	TREX1	chr3:48501186-48509043:+	-0.28	-4.25	5.0E-5	Longevity	
THYM	cis	1	rs7635522	chr3:48423656	TREX1	chr3:48501186-48509043:+	-0.28	-4.36	3.35E-5	Longevity	
THYM	cis	1	rs7636044	chr3:48484560	TREX1	chr3:48501186-48509043:+	-0.29	-4.28	4.47E-5	Longevity	
THYM	cis	1	rs7636782	chr3:48421387	TREX1	chr3:48501186-48509043:+	-0.27	-4.18	6.46E-5	Longevity	
THYM	cis	1	rs7637227	chr3:134244155	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs7637227	chr3:134244155	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs7639514	chr3:156576067	LEKR1	chr3:156544076-156763918:+	-0.72	-4.3	4.1E-5	Bone mineral density	
THYM	cis	1	rs7645295	chr3:134307734	ANAPC13	chr3:134196547-134204865:-	0.55	7.47	3.94E-11	Height	
THYM	cis	1	rs7645295	chr3:134307734	CEP63	chr3:134204575-134293852:+	0.43	6.36	7.17E-9	Height	
THYM	cis	1	rs7646144	chr3:41853125	ULK4	chr3:41288091-42003660:-	0.91	9.16	1.01E-14	Diastolic blood pressure	
THYM	cis	1	rs76471037	chr3:41799414	ULK4	chr3:41288091-42003660:-	1	10.7	5.35E-18	Diastolic blood pressure	
THYM	cis	1	rs7648357	chr3:41849670	ULK4	chr3:41288091-42003660:-	1.03	11	1.24E-18	Diastolic blood pressure	
THYM	cis	1	rs7648578	chr3:41858731	ULK4	chr3:41288091-42003660:-	1.02	11.6	6.77E-20	Diastolic blood pressure	
THYM	cis	1	rs7648990	chr3:134244390	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs7648990	chr3:134244390	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs7650227	chr3:41794937	ULK4	chr3:41288091-42003660:-	1.02	11.07	8.86E-19	Diastolic blood pressure	
THYM	cis	1	rs7651407	chr3:48443816	TREX1	chr3:48501186-48509043:+	-0.28	-4.38	3.02E-5	Longevity	
THYM	cis	1	rs7653691	chr3:48419689	TREX1	chr3:48501186-48509043:+	0.28	4.36	3.31E-5	Longevity	
THYM	cis	1	rs76542740	chr15:43891512	ADAL	chr15:43622872-43646094:+	-0.49	-4.35	3.37E-5	Tumor biomarkers	
THYM	cis	1	rs76574179	chr6:18152540	NHLRC1	chr6:18120718-18122851:-	-1	-4.28	4.46E-5	Thiopurine S-methyltransferase activity	
THYM	cis	1	rs7665727	chr4:277057	ZNF718	chr4:53272-156488:+	0.65	7.31	8.46E-11	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs7669892	chr4:309253	ZNF718	chr4:53272-156488:+	-0.34	-4.27	4.55E-5	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs7674560	chr4:263319	ZNF718	chr4:53272-156488:+	0.52	5.98	3.82E-8	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs7686546	chr4:240614	ZNF718	chr4:53272-156488:+	0.68	7.3	8.88E-11	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs76969503	chr6:18143512	NHLRC1	chr6:18120718-18122851:-	-1.05	-4.61	1.24E-5	Thiopurine S-methyltransferase activity	
THYM	cis	1	rs77032929	chr6:18152293	NHLRC1	chr6:18120718-18122851:-	-1.01	-4.34	3.6E-5	Thiopurine S-methyltransferase activity	
THYM	cis	1	rs7705093	chr5:96290647	ERAP2	chr5:96211644-96255398:+	1	17.34	3.46E-31	Birdshot chorioretinopathy	
THYM	cis	1	rs77078697	chr4:252048	ZNF718	chr4:53272-156488:+	0.53	5.92	5.01E-8	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs77134359	chr6:18135341	NHLRC1	chr6:18120718-18122851:-	-1.1	-4.37	3.12E-5	Thiopurine S-methyltransferase activity	
THYM	cis	1	rs77214986	chr16:4603722	NMRAL1	chr16:4511696-4526307:-	-0.43	-5.14	1.5E-6	Obesity-related traits	
THYM	cis	1	rs77234191	chr4:258294	ZNF718	chr4:53272-156488:+	0.68	7.3	8.88E-11	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs77339739	chr6:18135520	NHLRC1	chr6:18120718-18122851:-	-1.1	-4.37	3.12E-5	Thiopurine S-methyltransferase activity	
THYM	cis	1	rs77374467	chr6:24475278	GPLD1	chr6:24428405-24489850:-	0.57	5.22	1.07E-6	Hematological and biochemical traits	
THYM	cis	1	rs774356	chr9:27559721	C9orf72	chr9:27546544-27573842:-	0.41	5.6	2.04E-7	Amyotrophic lateral sclerosis	
THYM	cis	1	rs774359	chr9:27561049	C9orf72	chr9:27546544-27573842:-	0.4	5.45	3.94E-7	Amyotrophic lateral sclerosis	
THYM	cis	1	rs77477310	chr14:35615793	KIAA0391	chr14:35591776-35786673:+	0.35	4.67	9.73E-6	Atopic dermatitis	
THYM	cis	1	rs77477310	chr14:35615793	PPP2R3C	chr14:35554679-35591679:-	0.26	4.92	3.68E-6	Atopic dermatitis	
THYM	cis	1	rs7747824	chr6:86647106	SNHG5	chr6:86386726-86388451:-	-0.58	-7.77	9.26E-12	Response to antipsychotic treatment	
THYM	cis	1	rs7750918	chr6:49430082	MUT	chr6:49398994-49431031:-	0.29	4.41	2.7E-5	Folate pathway vitamin levels	
THYM	cis	1	rs7756203	chr6:86627707	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs7759071	chr6:49433198	CENPQ	chr6:49431096-49460820:+	-0.3	-5.72	1.22E-7	Homocysteine levels	
THYM	cis	1	rs7760207	chr6:86721700	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs77658252	chr12:54156208	COPZ1	chr12:54718911-54745633:+	-0.3	-4.54	1.64E-5	Tanning	
THYM	cis	1	rs7766645	chr6:86622238	SNHG5	chr6:86386726-86388451:-	-0.57	-7.62	1.9E-11	Response to antipsychotic treatment	
THYM	cis	1	rs7771342	chr6:86631936	SNHG5	chr6:86386726-86388451:-	-0.57	-6.89	5.95E-10	Response to antipsychotic treatment	
THYM	cis	1	rs7773076	chr6:18107132	NHLRC1	chr6:18120718-18122851:-	-1.06	-4.36	3.24E-5	Thiopurine S-methyltransferase activity	
THYM	cis	1	rs7774688	chr6:49387292	CENPQ	chr6:49431096-49460820:+	-0.3	-5.65	1.67E-7	Homocysteine levels	
THYM	cis	1	rs7775626	chr6:18144521	NHLRC1	chr6:18120718-18122851:-	-1.05	-4.61	1.24E-5	Thiopurine S-methyltransferase activity	
THYM	cis	1	rs7778911	chr7:65694506	CCT6P1	chr7:65216092-65228661:+	-0.64	-5.29	7.77E-7	Diabetic kidney disease	
THYM	cis	1	rs778679	chr7:65840911	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Diabetic kidney disease	
THYM	cis	1	rs778691	chr7:65873092	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Diabetic kidney disease	
THYM	cis	1	rs778704	chr7:65863467	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Diabetic kidney disease	
THYM	cis	1	rs7787230	chr7:65629099	CCT6P1	chr7:65216092-65228661:+	-0.65	-5.41	4.64E-7	Diabetic kidney disease	
THYM	cis	1	rs778729	chr7:65824419	CCT6P1	chr7:65216092-65228661:+	0.59	4.86	4.58E-6	Diabetic kidney disease	
THYM	cis	1	rs778758	chr2:61782161	AHSA2	chr2:61404553-61414058:+	-0.46	-5.79	9.05E-8	Tuberculosis	
THYM	cis	1	rs778758	chr2:61782161	C2orf74	chr2:61372243-61391964:+	0.58	7.47	3.96E-11	Tuberculosis	
THYM	cis	1	rs778762	chr2:61782921	AHSA2	chr2:61404553-61414058:+	-0.43	-5.3	7.63E-7	Tuberculosis	
THYM	cis	1	rs778762	chr2:61782921	C2orf74	chr2:61372243-61391964:+	0.58	7.45	4.23E-11	Tuberculosis	
THYM	cis	1	rs778763	chr2:61785639	AHSA2	chr2:61404553-61414058:+	-0.43	-5.3	7.63E-7	Tuberculosis	
THYM	cis	1	rs778763	chr2:61785639	C2orf74	chr2:61372243-61391964:+	0.58	7.45	4.23E-11	Tuberculosis	
THYM	cis	1	rs77902909	chr6:24478715	GPLD1	chr6:24428405-24489850:-	0.57	5.22	1.07E-6	Hematological and biochemical traits	
THYM	cis	1	rs7792391	chr7:65773429	CCT6P1	chr7:65216092-65228661:+	-0.64	-5.29	7.77E-7	Diabetic kidney disease	
THYM	cis	1	rs7794661	chr7:65389730	CCT6P1	chr7:65216092-65228661:+	0.68	4.97	3.0E-6	Diabetic kidney disease	
THYM	cis	1	rs7795242	chr7:65390094	CCT6P1	chr7:65216092-65228661:+	0.67	4.9	3.88E-6	Diabetic kidney disease	
THYM	cis	1	rs7804223	chr7:65664559	CCT6P1	chr7:65216092-65228661:+	-0.68	-5.66	1.6E-7	Diabetic kidney disease	
THYM	cis	1	rs78075821	chr1:171724645	VAMP4	chr1:171669298-171711214:-	0.34	4.39	2.94E-5	Hippocampal atrophy	
THYM	cis	1	rs781142	chr7:65438778	CCT6P1	chr7:65216092-65228661:+	0.63	5.29	7.94E-7	Diabetic kidney disease	
THYM	cis	1	rs781149	chr7:65481284	CCT6P1	chr7:65216092-65228661:+	0.61	5.07	1.93E-6	Diabetic kidney disease	
THYM	cis	1	rs781150	chr7:65480973	CCT6P1	chr7:65216092-65228661:+	0.65	5.41	4.64E-7	Diabetic kidney disease	
THYM	cis	1	rs781156	chr7:65479141	CCT6P1	chr7:65216092-65228661:+	0.65	5.41	4.64E-7	Diabetic kidney disease	
THYM	cis	1	rs781157	chr7:65478311	CCT6P1	chr7:65216092-65228661:+	0.6	4.98	2.86E-6	Diabetic kidney disease	
THYM	cis	1	rs78207779	chr14:35506387	PPP2R3C	chr14:35554679-35591679:-	0.26	4.87	4.53E-6	Atopic dermatitis	
THYM	cis	1	rs7822232	chr8:145145687	KIAA1875	chr8:145162629-145173218:+	-0.8	-4.4	2.79E-5	Blood metabolite levels	
THYM	cis	1	rs78343340	chr4:267437	ZNF718	chr4:53272-156488:+	0.65	7.31	8.46E-11	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs78420872	chr6:24464429	GPLD1	chr6:24428405-24489850:-	0.59	5.4	4.83E-7	Hematological and biochemical traits	
THYM	cis	1	rs7849160	chr9:131874552	CRAT	chr9:131857075-131873070:-	0.38	4.61	1.24E-5	Blood metabolite ratios	
THYM	cis	1	rs7849270	chr9:131874641	CRAT	chr9:131857075-131873070:-	0.4	4.91	3.82E-6	Blood metabolite ratios	
THYM	cis	1	rs785464	chr1:46523089	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs785471	chr1:46518677	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs785479	chr1:46492144	CCDC163P	chr1:45960581-45965646:-	-0.49	-6.01	3.36E-8	Body mass index	
THYM	cis	1	rs785481	chr1:46554518	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs785485	chr1:46574424	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs785488	chr1:46576095	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs785489	chr1:46576390	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs785491	chr1:46583418	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs785492	chr1:46583607	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs785494	chr1:46586626	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs785495	chr1:46587887	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs785503	chr1:46595868	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs785520	chr1:46568836	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs7855278	chr9:131921365	CRAT	chr9:131857075-131873070:-	-0.43	-5.24	9.76E-7	Blood metabolite ratios	
THYM	cis	1	rs78631584	chr6:18128201	NHLRC1	chr6:18120718-18122851:-	-1.1	-4.37	3.12E-5	Thiopurine S-methyltransferase activity	
THYM	cis	1	rs7868408	chr9:131917864	CRAT	chr9:131857075-131873070:-	0.38	4.61	1.24E-5	Blood metabolite ratios	
THYM	cis	1	rs7869804	chr9:131913144	CRAT	chr9:131857075-131873070:-	0.38	4.61	1.24E-5	Blood metabolite ratios	
THYM	cis	1	rs78803505	chr7:65382572	CCT6P1	chr7:65216092-65228661:+	0.67	4.9	3.88E-6	Diabetic kidney disease	
THYM	cis	1	rs78808915	chr6:24481312	ALDH5A1	chr6:24495197-24537434:+	0.33	4.16	7.04E-5	Hematological and biochemical traits	
THYM	cis	1	rs78808915	chr6:24481312	GPLD1	chr6:24428405-24489850:-	0.56	5.51	3.04E-7	Hematological and biochemical traits	
THYM	cis	1	rs78846846	chr6:18132495	NHLRC1	chr6:18120718-18122851:-	-1.1	-4.37	3.12E-5	Thiopurine S-methyltransferase activity	
THYM	cis	1	rs7894268	chr10:17199830	CUBN	chr10:16865966-17171816:-	0.31	4.8	5.85E-6	Homocysteine levels	
THYM	cis	1	rs7903456	chr10:88919319	FAM35A	chr10:88854953-88951220:+	-0.42	-4.57	1.46E-5	Renal underexcretion gout;Gout	
THYM	cis	1	rs79050301	chr6:18152190	NHLRC1	chr6:18120718-18122851:-	-1.13	-4.76	6.91E-6	Thiopurine S-methyltransferase activity	
THYM	cis	1	rs7912093	chr10:17203934	CUBN	chr10:16865966-17171816:-	0.31	4.8	5.85E-6	Homocysteine levels	
THYM	cis	1	rs7912631	chr10:101915265	BLOC1S2	chr10:102033713-102046439:-	-0.5	-5.35	6.1E-7	Schizophrenia	
THYM	cis	1	rs7915944	chr10:101942253	BLOC1S2	chr10:102033713-102046439:-	-0.49	-5.28	8.32E-7	Schizophrenia	
THYM	cis	1	rs791856	chr6:86681841	SNHG5	chr6:86386726-86388451:-	0.57	7.62	1.9E-11	Response to antipsychotic treatment	
THYM	cis	1	rs79199019	chr14:35581125	KIAA0391	chr14:35591776-35786673:+	0.32	4.14	7.59E-5	Atopic dermatitis	
THYM	cis	1	rs79199019	chr14:35581125	PPP2R3C	chr14:35554679-35591679:-	0.27	4.99	2.76E-6	Atopic dermatitis	
THYM	cis	1	rs7921162	chr10:17229004	CUBN	chr10:16865966-17171816:-	0.3	4.53	1.71E-5	Homocysteine levels	
THYM	cis	1	rs79325856	chr6:18161232	NHLRC1	chr6:18120718-18122851:-	-1	-4.28	4.46E-5	Thiopurine S-methyltransferase activity	
THYM	cis	1	rs79366248	chr4:266659	ZNF718	chr4:53272-156488:+	0.65	7.31	8.46E-11	Immune response to smallpox vaccine (IL-6)	
THYM	cis	1	rs7937	chr19:41302706	RAB4B	chr19:41281657-41302847:+	-0.2	-4.52	1.76E-5	Post bronchodilator FEV1;Emphysema imaging phenotypes;Chronic obstructive pulmonary disease;Post bronchodilator FEV1/FVC ratio	
THYM	cis	1	rs79436302	chr14:35578797	KIAA0391	chr14:35591776-35786673:+	0.32	4.14	7.59E-5	Atopic dermatitis	
THYM	cis	1	rs79436302	chr14:35578797	PPP2R3C	chr14:35554679-35591679:-	0.27	4.99	2.76E-6	Atopic dermatitis	
THYM	cis	1	rs7944004	chr11:2311152	C11orf21	chr11:2317507-2323143:-	0.36	5.02	2.44E-6	Chronic lymphocytic leukemia	
THYM	cis	1	rs7944436	chr11:62200661	ASRGL1	chr11:62104774-62160885:+	-0.3	-4.15	7.28E-5	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs79548696	chr3:41803385	ULK4	chr3:41288091-42003660:-	0.99	10.49	1.47E-17	Diastolic blood pressure	
THYM	cis	1	rs7968810	chr12:54158993	COPZ1	chr12:54718911-54745633:+	-0.3	-4.79	6.15E-6	Tanning	
THYM	cis	1	rs7968870	chr12:54159249	COPZ1	chr12:54718911-54745633:+	0.29	4.6	1.33E-5	Tanning	
THYM	cis	1	rs7969151	chr12:54159277	COPZ1	chr12:54718911-54745633:+	-0.3	-4.79	6.15E-6	Tanning	
THYM	cis	1	rs79702597	chr14:35558856	KIAA0391	chr14:35591776-35786673:+	0.32	4.16	6.96E-5	Atopic dermatitis	
THYM	cis	1	rs79702597	chr14:35558856	PPP2R3C	chr14:35554679-35591679:-	0.27	5.01	2.56E-6	Atopic dermatitis	
THYM	cis	1	rs79716074	chr2:277003	SH3YL1	chr2:218138-264810:-	-0.33	-4.86	4.59E-6	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs79888893	chr14:35510676	PPP2R3C	chr14:35554679-35591679:-	0.27	5.01	2.49E-6	Atopic dermatitis	
THYM	cis	1	rs7989332	chr13:21050575	GJB2	chr13:20761606-20767114:-	-0.36	-4.82	5.51E-6	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
THYM	cis	1	rs80085676	chr2:242347907	SEPT2	chr2:242254723-242293439:+	0.44	5.87	6.46E-8	Chronic lymphocytic leukemia	
THYM	cis	1	rs8010715	chr14:24609147	FAM158A	chr14:24608175-24610797:-	-0.3	-9.69	7.56E-16	IgG glycosylation	
THYM	cis	1	rs8013540	chr14:35513760	KIAA0391	chr14:35591776-35786673:+	0.32	4.18	6.43E-5	Atopic dermatitis	
THYM	cis	1	rs8013540	chr14:35513760	PPP2R3C	chr14:35554679-35591679:-	0.27	5.03	2.32E-6	Atopic dermatitis	
THYM	cis	1	rs80152842	chr6:18109498	NHLRC1	chr6:18120718-18122851:-	-1.06	-4.36	3.24E-5	Thiopurine S-methyltransferase activity	
THYM	cis	1	rs8028182	chr15:75718669	MAN2C1	chr15:75648135-75660941:-	0.62	7.05	2.87E-10	Sudden cardiac arrest	
THYM	cis	1	rs8031576	chr15:90380214	AP3S2	chr15:90373832-90456222:-	-0.43	-4.89	4.09E-6	Type 2 diabetes	
THYM	cis	1	rs8033837	chr15:75353975	PPCDC	chr15:75315927-75343066:+	0.27	4.81	5.68E-6	Blood trace element (Zn levels)	
THYM	cis	1	rs8036197	chr15:75370232	PPCDC	chr15:75315927-75343066:+	0.26	4.7	8.93E-6	Blood trace element (Zn levels)	
THYM	cis	1	rs8049173	chr16:11436882	C16orf75	chr16:11343506-11445617:+	0.28	4.37	3.13E-5	Vein graft stenosis in coronary artery bypass grafting	
THYM	cis	1	rs8050324	chr16:4613292	NMRAL1	chr16:4511696-4526307:-	-0.5	-5.61	1.96E-7	Obesity-related traits	
THYM	cis	1	rs8050907	chr16:4646878	NMRAL1	chr16:4511696-4526307:-	-0.44	-5.1	1.7E-6	Obesity-related traits	
THYM	cis	1	rs8055427	chr16:11436883	C16orf75	chr16:11343506-11445617:+	0.28	4.37	3.13E-5	Vein graft stenosis in coronary artery bypass grafting	
THYM	cis	1	rs8061699	chr16:4632723	NMRAL1	chr16:4511696-4526307:-	-0.48	-5.55	2.6E-7	Obesity-related traits	
THYM	cis	1	rs8062783	chr16:74691264	RFWD3	chr16:74655298-74700779:-	0.2	4.44	2.42E-5	Testicular germ cell tumor	
THYM	cis	1	rs8064261	chr17:61705212	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.45	2.37E-5	Body mass index	
THYM	cis	1	rs8068603	chr17:61755211	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.47	2.2E-5	Body mass index	
THYM	cis	1	rs8070454	chr17:38160754	GSDMA	chr17:38119226-38134019:+	-0.89	-9.76	5.45E-16	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THYM	cis	1	rs8070650	chr17:61744040	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.41	2.72E-5	Body mass index	
THYM	cis	1	rs8071789	chr17:38006333	ZPBP2	chr17:38024455-38034144:+	0.49	4.21	5.87E-5	Selective IgA deficiency	
THYM	cis	1	rs8074771	chr17:61735865	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.41	2.72E-5	Body mass index	
THYM	cis	1	rs8075257	chr17:61728750	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.44	2.41E-5	Body mass index	
THYM	cis	1	rs8077265	chr17:61732727	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.47	2.2E-5	Body mass index	
THYM	cis	1	rs8078723	chr17:38166879	GSDMA	chr17:38119226-38134019:+	-0.87	-9.52	1.73E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
THYM	cis	1	rs8080211	chr17:61729882	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.18	6.58E-5	Body mass index	
THYM	cis	1	rs8081612	chr17:61724695	TCAM1P	chr17:61934376-61941738:+	0.51	4.28	4.55E-5	Body mass index	
THYM	cis	1	rs809775	chr1:46538040	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs8100392	chr19:33605933	GPATCH1	chr19:33571786-33621318:+	0.37	4.33	3.69E-5	Bone properties (heel)	
THYM	cis	1	rs8110181	chr19:33605939	GPATCH1	chr19:33571786-33621318:+	0.37	4.33	3.69E-5	Bone properties (heel)	
THYM	cis	1	rs8113312	chr19:23061182	ZNF492	chr19:22817126-22850472:+	-0.52	-5.7	1.32E-7	Bronchopulmonary dysplasia	
THYM	cis	1	rs8181644	chr12:58173466	FAM119B	chr12:58166383-58176323:+	0.42	5.82	7.89E-8	Multiple sclerosis	
THYM	cis	1	rs8181644	chr12:58173466	TSFM	chr12:58176536-58191367:+	-0.26	-4.49	1.97E-5	Multiple sclerosis	
THYM	cis	1	rs832551	chr5:56180112	C5orf35	chr5:56205103-56213010:+	0.75	9.04	1.84E-14	Type 2 diabetes	
THYM	cis	1	rs832553	chr5:56114786	C5orf35	chr5:56205103-56213010:+	0.75	9.44	2.59E-15	Type 2 diabetes	
THYM	cis	1	rs832554	chr5:56115036	C5orf35	chr5:56205103-56213010:+	0.75	9.44	2.59E-15	Type 2 diabetes	
THYM	cis	1	rs832565	chr5:56150803	C5orf35	chr5:56205103-56213010:+	0.75	9.04	1.84E-14	Type 2 diabetes	
THYM	cis	1	rs832568	chr5:56153776	C5orf35	chr5:56205103-56213010:+	0.75	9.04	1.84E-14	Type 2 diabetes	
THYM	cis	1	rs832569	chr5:56154584	C5orf35	chr5:56205103-56213010:+	0.75	9.04	1.84E-14	Type 2 diabetes	
THYM	cis	1	rs832578	chr5:56164223	C5orf35	chr5:56205103-56213010:+	0.77	9.59	1.25E-15	Type 2 diabetes	
THYM	cis	1	rs832582	chr5:56177743	C5orf35	chr5:56205103-56213010:+	0.75	9.04	1.84E-14	Type 2 diabetes	
THYM	cis	1	rs832583	chr5:56178217	C5orf35	chr5:56205103-56213010:+	0.75	9.04	1.84E-14	Type 2 diabetes	
THYM	cis	1	rs832584	chr5:56179212	C5orf35	chr5:56205103-56213010:+	-0.75	-9.04	1.84E-14	Type 2 diabetes	
THYM	cis	1	rs844917	chr20:23141655	CD93	chr20:23059994-23066977:-	0.4	4.14	7.5E-5	Liver enzyme levels (alanine transaminase)	
THYM	cis	1	rs854572	chr7:94954696	PON1	chr7:94927671-95025687:-	0.41	6.03	3.14E-8	Paraoxonase activity	
THYM	cis	1	rs8589	chr6:49403282	CENPQ	chr6:49431096-49460820:+	-0.29	-5.57	2.36E-7	Homocysteine levels	
THYM	cis	1	rs860580	chr5:56149429	C5orf35	chr5:56205103-56213010:+	-0.77	-9.59	1.25E-15	Type 2 diabetes	
THYM	cis	1	rs861283	chr5:56184610	C5orf35	chr5:56205103-56213010:+	0.75	9.04	1.84E-14	Type 2 diabetes	
THYM	cis	1	rs863840	chr5:56128999	C5orf35	chr5:56205103-56213010:+	0.75	9.04	1.84E-14	Type 2 diabetes	
THYM	cis	1	rs866222	chr5:56184444	C5orf35	chr5:56205103-56213010:+	0.75	9.04	1.84E-14	Type 2 diabetes	
THYM	cis	1	rs869417	chr3:183689138	ABCC5	chr3:183637726-183735727:-	0.48	4.28	4.53E-5	Anterior chamber depth	
THYM	cis	1	rs871130	chr12:56648777	RPS26	chr12:56435686-56438005:+	0.82	4.27	4.62E-5	Psoriasis vulgaris	
THYM	cis	1	rs873686	chr4:185638876	CCDC111	chr4:185570767-185616112:+	-0.33	-4.18	6.38E-5	Kawasaki disease	
THYM	cis	1	rs873686	chr4:185638876	MLF1IP	chr4:185615220-185655286:-	0.34	7.62	1.89E-11	Kawasaki disease	
THYM	cis	1	rs877636	chr12:56480583	RPS26	chr12:56435686-56438005:+	-0.96	-10.13	8.8E-17	Cognitive function	
THYM	cis	1	rs881375	chr9:123652898	LOC253039	chr9:123605320-123616644:+	-0.62	-5.56	2.51E-7	Rheumatoid arthritis	
THYM	cis	1	rs882803	chr1:45976147	CCDC163P	chr1:45960581-45965646:-	-0.8	-13.18	3.67E-23	Homocysteine levels	
THYM	cis	1	rs884841	chr6:86680300	SNHG5	chr6:86386726-86388451:-	-0.56	-6.75	1.15E-9	Response to antipsychotic treatment	
THYM	cis	1	rs891368	chr3:53123273	RFT1	chr3:53122503-53164470:-	-0.44	-4.93	3.42E-6	Height	
THYM	cis	1	rs898225	chr3:48413179	TREX1	chr3:48501186-48509043:+	0.28	4.42	2.62E-5	Longevity	
THYM	cis	1	rs903121	chr1:212405455	NEK2	chr1:211836115-211848967:-	-0.16	-4.42	2.59E-5	Intelligence (childhood)	
THYM	cis	1	rs905356	chr9:91546375	C9orf47	chr9:91605778-91611055:+	-0.26	-4.7	8.7E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs906134	chr7:65444288	CCT6P1	chr7:65216092-65228661:+	0.65	5.32	6.97E-7	Diabetic kidney disease	
THYM	cis	1	rs911119	chr20:23612737	CST9	chr20:23583049-23586610:-	0.51	4.71	8.44E-6	Chronic kidney disease	
THYM	cis	1	rs917911	chr12:9905851	CLECL1	chr12:9868457-9885860:-	0.46	4.97	3.0E-6	Type 1 diabetes	
THYM	cis	1	rs9213	chr2:218386	SH3YL1	chr2:218138-264810:-	-0.29	-4.18	6.49E-5	Spherical equivalent (joint main effects and education interaction)	
THYM	cis	1	rs921450	chr7:50623260	FIGNL1	chr7:50511834-50518088:-	0.31	4.76	6.88E-6	Malaria	
THYM	cis	1	rs921451	chr7:50623285	FIGNL1	chr7:50511834-50518088:-	-0.3	-4.64	1.09E-5	Malaria	
THYM	cis	1	rs922075	chr3:48489398	TREX1	chr3:48501186-48509043:+	0.28	4.29	4.29E-5	Longevity	
THYM	cis	1	rs922483	chr8:11351912	BLK	chr8:11351521-11422107:+	-0.4	-4.94	3.3E-6	Systemic lupus erythematosus	
THYM	cis	1	rs9283717	chr5:56078659	C5orf35	chr5:56205103-56213010:+	0.74	8.92	3.44E-14	Type 2 diabetes	
THYM	cis	1	rs9288617	chr2:227762815	RHBDD1	chr2:227700773-227861591:+	-0.32	-4.73	7.77E-6	Pulmonary function	
THYM	cis	1	rs9289275	chr3:125648659	LOC100125556	chr3:125635444-125648865:+	0.7	5.51	3.01E-7	Blood pressure (smoking interaction)	
THYM	cis	1	rs9289471	chr3:134230811	ANAPC13	chr3:134196547-134204865:-	0.57	7.9	4.94E-12	Height	
THYM	cis	1	rs9289471	chr3:134230811	CEP63	chr3:134204575-134293852:+	0.41	6.16	1.71E-8	Height	
THYM	cis	1	rs9289475	chr3:134236459	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs9289475	chr3:134236459	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs9289476	chr3:134237103	ANAPC13	chr3:134196547-134204865:-	0.56	7.61	1.94E-11	Height	
THYM	cis	1	rs9289476	chr3:134237103	CEP63	chr3:134204575-134293852:+	0.41	6	3.54E-8	Height	
THYM	cis	1	rs9289478	chr3:134268619	ANAPC13	chr3:134196547-134204865:-	0.56	7.61	1.94E-11	Height	
THYM	cis	1	rs9289478	chr3:134268619	CEP63	chr3:134204575-134293852:+	0.41	6	3.54E-8	Height	
THYM	cis	1	rs9294377	chr6:88084839	C6orf164	chr6:88032306-88109459:+	-0.5	-4.99	2.68E-6	Depressive episodes in bipolar disorder	
THYM	cis	1	rs9296404	chr6:42925803	GNMT	chr6:42928500-42931617:+	-0.45	-8.71	9.36E-14	Plasma homocysteine levels (post-methionine load test)	
THYM	cis	1	rs9296404	chr6:42925803	PEX6	chr6:42931613-42946981:-	0.7	8.63	1.41E-13	Plasma homocysteine levels (post-methionine load test)	
THYM	cis	1	rs9296616	chr6:49414235	CENPQ	chr6:49431096-49460820:+	-0.23	-4.18	6.53E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9296616	chr6:49414235	MUT	chr6:49398994-49431031:-	0.28	4.37	3.17E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9296617	chr6:49428360	CENPQ	chr6:49431096-49460820:+	-0.24	-4.35	3.4E-5	Folate pathway vitamin levels	
THYM	cis	1	rs929843	chr16:70045748	PDXDC2	chr16:70010210-70099851:-	-0.56	-5.28	8.06E-7	Menarche (age at onset)	
THYM	cis	1	rs9307050	chr4:76905649	NAAA	chr4:76831809-76862166:-	-0.46	-4.92	3.56E-6	Longevity	
THYM	cis	1	rs9309473	chr2:73743982	ALMS1P	chr2:73872046-73912692:+	0.58	4.49	2.03E-5	Metabolite levels	
THYM	cis	1	rs9311288	chr3:41804581	ULK4	chr3:41288091-42003660:-	1.02	11.16	5.5E-19	Diastolic blood pressure	
THYM	cis	1	rs9311423	chr3:48420308	TREX1	chr3:48501186-48509043:+	-0.28	-4.25	5.0E-5	Longevity	
THYM	cis	1	rs9314664	chr9:91561808	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs932644	chr6:167404187	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs932833	chr9:131884041	CRAT	chr9:131857075-131873070:-	0.38	4.61	1.24E-5	Blood metabolite ratios	
THYM	cis	1	rs932835	chr9:131887071	CRAT	chr9:131857075-131873070:-	0.42	4.98	2.82E-6	Blood metabolite ratios	
THYM	cis	1	rs934093	chr3:134195885	ANAPC13	chr3:134196547-134204865:-	0.56	7.74	1.08E-11	Height	
THYM	cis	1	rs934093	chr3:134195885	CEP63	chr3:134204575-134293852:+	0.39	5.72	1.23E-7	Height	
THYM	cis	1	rs936228	chr15:75132164	ULK3	chr15:75128459-75135552:-	-0.42	-5.18	1.25E-6	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
THYM	cis	1	rs936229	chr15:75132319	ULK3	chr15:75128459-75135552:-	-0.42	-5.18	1.25E-6	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
THYM	cis	1	rs9362395	chr6:87854341	C6orf163	chr6:88057220-88075180:+	-0.89	-4.8	5.86E-6	Schizophrenia	
THYM	cis	1	rs9362426	chr6:88089874	C6orf164	chr6:88032306-88109459:+	-0.47	-4.71	8.48E-6	Depressive episodes in bipolar disorder	
THYM	cis	1	rs936525	chr19:23056189	ZNF492	chr19:22817126-22850472:+	-0.5	-5.66	1.61E-7	Bronchopulmonary dysplasia	
THYM	cis	1	rs936526	chr19:23055987	ZNF492	chr19:22817126-22850472:+	-0.5	-5.66	1.61E-7	Bronchopulmonary dysplasia	
THYM	cis	1	rs9369898	chr6:49382193	CENPQ	chr6:49431096-49460820:+	-0.3	-5.65	1.67E-7	Homocysteine levels	
THYM	cis	1	rs937108	chr7:65428452	CCT6P1	chr7:65216092-65228661:+	0.62	5.13	1.51E-6	Diabetic kidney disease	
THYM	cis	1	rs9381040	chr6:41154650	LOC221442	chr6:41068773-41108567:+	0.36	5.32	6.89E-7	Alzheimer's disease (late onset)	
THYM	cis	1	rs9381784	chr6:49398115	CENPQ	chr6:49431096-49460820:+	0.3	5.33	6.54E-7	Homocysteine levels	
THYM	cis	1	rs939336	chr3:183685534	ABCC5	chr3:183637726-183735727:-	0.48	4.28	4.53E-5	Anterior chamber depth	
THYM	cis	1	rs939338	chr3:183704068	ABCC5	chr3:183637726-183735727:-	-0.5	-4.43	2.5E-5	Anterior chamber depth	
THYM	cis	1	rs9394931	chr6:42873245	GNMT	chr6:42928500-42931617:+	0.33	5.63	1.81E-7	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
THYM	cis	1	rs9394931	chr6:42873245	PEX6	chr6:42931613-42946981:-	-0.43	-4.43	2.5E-5	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
THYM	cis	1	rs9395493	chr6:49427409	CENPQ	chr6:49431096-49460820:+	-0.29	-5.57	2.36E-7	Homocysteine levels	
THYM	cis	1	rs939558	chr3:41976040	ULK4	chr3:41288091-42003660:-	-1.02	-11.59	6.88E-20	Diastolic blood pressure	
THYM	cis	1	rs9410258	chr9:91545917	C9orf47	chr9:91605778-91611055:+	-0.27	-4.75	7.31E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs9410260	chr9:91549376	C9orf47	chr9:91605778-91611055:+	-0.26	-4.7	8.7E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs9410261	chr9:91551028	C9orf47	chr9:91605778-91611055:+	-0.26	-4.68	9.7E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs9410263	chr9:91554638	C9orf47	chr9:91605778-91611055:+	-0.26	-4.68	9.7E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs9410264	chr9:91554748	C9orf47	chr9:91605778-91611055:+	-0.26	-4.68	9.7E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs9410272	chr9:91556897	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs9410276	chr9:91559409	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs9410277	chr9:91559769	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs9410278	chr9:91560382	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs9410283	chr9:91565027	C9orf47	chr9:91605778-91611055:+	-0.26	-4.42	2.59E-5	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs9410285	chr9:91567537	C9orf47	chr9:91605778-91611055:+	-0.26	-4.41	2.71E-5	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs9410414	chr9:91549857	C9orf47	chr9:91605778-91611055:+	-0.26	-4.7	8.7E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs9410415	chr9:91552207	C9orf47	chr9:91605778-91611055:+	-0.26	-4.68	9.7E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs9410424	chr9:91561741	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs9410426	chr9:91562847	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs9410427	chr9:91562866	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs9410428	chr9:91562881	C9orf47	chr9:91605778-91611055:+	0.26	4.45	2.34E-5	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs9410431	chr9:91564117	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs9410432	chr9:91564233	C9orf47	chr9:91605778-91611055:+	-0.27	-4.71	8.28E-6	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs9410435	chr9:91566201	C9orf47	chr9:91605778-91611055:+	-0.26	-4.41	2.71E-5	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs9410436	chr9:91566370	C9orf47	chr9:91605778-91611055:+	0.26	4.41	2.71E-5	Response to statins (LDL cholesterol change)	
THYM	cis	1	rs941653	chr14:35592538	PPP2R3C	chr14:35554679-35591679:-	0.25	4.67	9.75E-6	Atopic dermatitis	
THYM	cis	1	rs9425766	chr1:173853127	SERPINC1	chr1:173872943-173886516:-	0.55	5.57	2.4E-7	Life satisfaction	
THYM	cis	1	rs9429183	chr1:46524582	CCDC163P	chr1:45960581-45965646:-	-0.49	-6	3.55E-8	Body mass index	
THYM	cis	1	rs9450662	chr6:88088593	C6orf164	chr6:88032306-88109459:+	-0.49	-4.91	3.8E-6	Depressive episodes in bipolar disorder	
THYM	cis	1	rs9457247	chr6:167392174	RNASET2	chr6:167343008-167412795:-	-0.47	-7.83	7.0E-12	Crohn's disease	
THYM	cis	1	rs9463473	chr6:49380121	CENPQ	chr6:49431096-49460820:+	-0.24	-4.37	3.16E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9463473	chr6:49380121	MUT	chr6:49398994-49431031:-	0.27	4.32	3.89E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9463474	chr6:49380199	CENPQ	chr6:49431096-49460820:+	-0.24	-4.37	3.16E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9463474	chr6:49380199	MUT	chr6:49398994-49431031:-	0.27	4.32	3.89E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9463475	chr6:49380899	CENPQ	chr6:49431096-49460820:+	0.24	4.37	3.16E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9463475	chr6:49380899	MUT	chr6:49398994-49431031:-	-0.27	-4.32	3.89E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9463477	chr6:49386446	CENPQ	chr6:49431096-49460820:+	-0.24	-4.37	3.16E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9463477	chr6:49386446	MUT	chr6:49398994-49431031:-	0.27	4.32	3.89E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9463478	chr6:49386564	CENPQ	chr6:49431096-49460820:+	-0.3	-5.65	1.67E-7	Homocysteine levels	
THYM	cis	1	rs9463479	chr6:49393275	CENPQ	chr6:49431096-49460820:+	-0.24	-4.37	3.16E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9463479	chr6:49393275	MUT	chr6:49398994-49431031:-	0.27	4.32	3.89E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9463480	chr6:49400795	CENPQ	chr6:49431096-49460820:+	-0.24	-4.39	2.98E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9463480	chr6:49400795	MUT	chr6:49398994-49431031:-	0.27	4.23	5.4E-5	Folate pathway vitamin levels	
THYM	cis	1	rs946529	chr1:46485548	CCDC163P	chr1:45960581-45965646:-	-0.49	-6.02	3.21E-8	Body mass index	
THYM	cis	1	rs9467176	chr6:24464907	GPLD1	chr6:24428405-24489850:-	-0.45	-4.67	9.97E-6	Hematological and biochemical traits	
THYM	cis	1	rs9467182	chr6:24468654	GPLD1	chr6:24428405-24489850:-	0.45	4.67	9.97E-6	Hematological and biochemical traits	
THYM	cis	1	rs9467190	chr6:24474771	GPLD1	chr6:24428405-24489850:-	0.44	4.56	1.5E-5	Hematological and biochemical traits	
THYM	cis	1	rs9473549	chr6:49380020	CENPQ	chr6:49431096-49460820:+	-0.23	-4.18	6.53E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9473549	chr6:49380020	MUT	chr6:49398994-49431031:-	0.28	4.37	3.17E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9473550	chr6:49385182	CENPQ	chr6:49431096-49460820:+	-0.26	-4.77	6.65E-6	Homocysteine levels	
THYM	cis	1	rs9473552	chr6:49387154	CENPQ	chr6:49431096-49460820:+	-0.24	-4.37	3.16E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9473552	chr6:49387154	MUT	chr6:49398994-49431031:-	0.27	4.32	3.89E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9473553	chr6:49395977	CENPQ	chr6:49431096-49460820:+	-0.24	-4.37	3.16E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9473553	chr6:49395977	MUT	chr6:49398994-49431031:-	0.27	4.32	3.89E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9473555	chr6:49409487	CENPQ	chr6:49431096-49460820:+	-0.24	-4.37	3.16E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9473555	chr6:49409487	MUT	chr6:49398994-49431031:-	0.27	4.32	3.89E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9473560	chr6:49427918	CENPQ	chr6:49431096-49460820:+	-0.24	-4.35	3.4E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9473561	chr6:49428755	CENPQ	chr6:49431096-49460820:+	-0.25	-4.33	3.64E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9473561	chr6:49428755	MUT	chr6:49398994-49431031:-	0.28	4.21	5.84E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9473563	chr6:49453651	CENPQ	chr6:49431096-49460820:+	-0.24	-4.13	7.76E-5	Folate pathway vitamin levels	
THYM	cis	1	rs9473563	chr6:49453651	MUT	chr6:49398994-49431031:-	0.28	4.32	3.85E-5	Folate pathway vitamin levels	
THYM	cis	1	rs951366	chr1:205685352	PM20D1	chr1:205797154-205819245:-	-0.49	-4.44	2.47E-5	Menarche (age at onset)	
THYM	cis	1	rs951677	chr11:62107249	ASRGL1	chr11:62104774-62160885:+	0.55	5.44	4.17E-7	Chronic obstructive pulmonary disease-related biomarkers	
THYM	cis	1	rs9527	chr10:104623578	AS3MT	chr10:104613967-104661653:+	-0.39	-4.25	4.93E-5	Arsenic metabolism	
THYM	cis	1	rs955196	chr6:86729951	SNHG5	chr6:86386726-86388451:-	0.57	6.84	7.81E-10	Response to antipsychotic treatment	
THYM	cis	1	rs955197	chr6:86729675	SNHG5	chr6:86386726-86388451:-	-0.57	-6.96	4.28E-10	Response to antipsychotic treatment	
THYM	cis	1	rs955227	chr6:86651032	SNHG5	chr6:86386726-86388451:-	-0.61	-7.35	6.78E-11	Response to antipsychotic treatment	
THYM	cis	1	rs958550	chr7:65635679	CCT6P1	chr7:65216092-65228661:+	-0.61	-5.15	1.42E-6	Diabetic kidney disease	
THYM	cis	1	rs9624834	chr22:25846015	CRYBB2	chr22:25615612-25627836:+	1.07	7.06	2.73E-10	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs9624835	chr22:25846021	CRYBB2	chr22:25615612-25627836:+	1.07	7.06	2.73E-10	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs9624836	chr22:25846087	CRYBB2	chr22:25615612-25627836:+	1.09	7.04	2.94E-10	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs9647603	chr6:86639341	SNHG5	chr6:86386726-86388451:-	-0.57	-7.62	1.9E-11	Response to antipsychotic treatment	
THYM	cis	1	rs9653557	chr2:73795962	ALMS1P	chr2:73872046-73912692:+	0.59	4.53	1.69E-5	Metabolite levels	
THYM	cis	1	rs9665626	chr10:104300638	SFXN2	chr10:104474298-104498946:+	0.55	4.27	4.61E-5	Schizophrenia	
THYM	cis	1	rs9674872	chr17:79581931	TSPAN10	chr17:79609349-79615778:+	0.63	6.68	1.61E-9	Eye color traits	
THYM	cis	1	rs9689	chr1:25688276	RHCE	chr1:25688741-25756683:-	0.44	5.23	1.01E-6	Erythrocyte sedimentation rate	
THYM	cis	1	rs9697030	chr9:131920181	CRAT	chr9:131857075-131873070:-	0.42	4.98	2.82E-6	Blood metabolite ratios	
THYM	cis	1	rs9747349	chr17:79584297	TSPAN10	chr17:79609349-79615778:+	0.63	6.68	1.61E-9	Eye color traits	
THYM	cis	1	rs9748176	chr17:79584043	TSPAN10	chr17:79609349-79615778:+	0.63	6.69	1.53E-9	Eye color traits	
THYM	cis	1	rs975752	chr10:101906333	BLOC1S2	chr10:102033713-102046439:-	-0.46	-4.99	2.74E-6	Schizophrenia	
THYM	cis	1	rs9769882	chr7:65642925	CCT6P1	chr7:65216092-65228661:+	-0.67	-5.68	1.48E-7	Diabetic kidney disease	
THYM	cis	1	rs9783304	chr11:43660255	HSD17B12	chr11:43702143-43878160:+	0.57	5.83	7.53E-8	Forced vital capacity	
THYM	cis	1	rs978909	chr2:227771389	RHBDD1	chr2:227700773-227861591:+	-0.31	-4.5	1.93E-5	Pulmonary function	
THYM	cis	1	rs9809619	chr3:134280948	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs9809619	chr3:134280948	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs9809843	chr3:48434398	TREX1	chr3:48501186-48509043:+	-0.28	-4.38	3.02E-5	Longevity	
THYM	cis	1	rs9812647	chr3:48448914	TREX1	chr3:48501186-48509043:+	0.3	4.57	1.48E-5	Longevity	
THYM	cis	1	rs9813774	chr3:134227100	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs9813774	chr3:134227100	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs9814567	chr3:134218557	ANAPC13	chr3:134196547-134204865:-	-0.59	-8.13	1.58E-12	Height	
THYM	cis	1	rs9814567	chr3:134218557	CEP63	chr3:134204575-134293852:+	-0.41	-5.87	6.33E-8	Height	
THYM	cis	1	rs9815103	chr3:48414215	TREX1	chr3:48501186-48509043:+	-0.28	-4.38	3.02E-5	Longevity	
THYM	cis	1	rs9815354	chr3:41912651	ULK4	chr3:41288091-42003660:-	0.95	9.28	5.58E-15	Diastolic blood pressure	
THYM	cis	1	rs9817615	chr3:48470756	TREX1	chr3:48501186-48509043:+	-0.29	-4.26	4.8E-5	Longevity	
THYM	cis	1	rs9818169	chr3:41860599	ULK4	chr3:41288091-42003660:-	1	10.81	3.16E-18	Diastolic blood pressure	
THYM	cis	1	rs9819532	chr3:134288644	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs9819532	chr3:134288644	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs9820192	chr3:41889281	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs9823254	chr3:41894768	ULK4	chr3:41288091-42003660:-	0.95	9.28	5.58E-15	Diastolic blood pressure	
THYM	cis	1	rs9824731	chr3:41889698	ULK4	chr3:41288091-42003660:-	0.96	9.51	1.88E-15	Diastolic blood pressure	
THYM	cis	1	rs9825741	chr3:41761828	ULK4	chr3:41288091-42003660:-	-0.96	-10.86	2.38E-18	Diastolic blood pressure	
THYM	cis	1	rs9826058	chr3:41762062	ULK4	chr3:41288091-42003660:-	1.01	11.17	5.4E-19	Diastolic blood pressure	
THYM	cis	1	rs9826195	chr3:48433635	TREX1	chr3:48501186-48509043:+	-0.28	-4.38	3.02E-5	Longevity	
THYM	cis	1	rs9826496	chr3:134224437	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs9826496	chr3:134224437	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs9827987	chr3:134272621	ANAPC13	chr3:134196547-134204865:-	0.58	8.05	2.33E-12	Height	
THYM	cis	1	rs9827987	chr3:134272621	CEP63	chr3:134204575-134293852:+	0.4	5.81	8.19E-8	Height	
THYM	cis	1	rs9828398	chr3:41895893	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs9828815	chr3:134265749	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs9828815	chr3:134265749	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs9829092	chr3:134229866	ANAPC13	chr3:134196547-134204865:-	0.59	8.13	1.58E-12	Height	
THYM	cis	1	rs9829092	chr3:134229866	CEP63	chr3:134204575-134293852:+	0.41	5.87	6.33E-8	Height	
THYM	cis	1	rs9830064	chr3:41881801	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs9830469	chr3:41762535	ULK4	chr3:41288091-42003660:-	1.01	11.17	5.4E-19	Diastolic blood pressure	
THYM	cis	1	rs9832785	chr3:134213070	ANAPC13	chr3:134196547-134204865:-	0.58	8.05	2.33E-12	Height	
THYM	cis	1	rs9832785	chr3:134213070	CEP63	chr3:134204575-134293852:+	0.4	5.81	8.19E-8	Height	
THYM	cis	1	rs9834098	chr3:41833493	ULK4	chr3:41288091-42003660:-	1	10.44	1.92E-17	Diastolic blood pressure	
THYM	cis	1	rs9834755	chr3:134206845	ANAPC13	chr3:134196547-134204865:-	0.58	7.98	3.28E-12	Height	
THYM	cis	1	rs9834755	chr3:134206845	CEP63	chr3:134204575-134293852:+	0.4	5.9	5.49E-8	Height	
THYM	cis	1	rs9835204	chr3:134261342	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs9835204	chr3:134261342	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs9838618	chr3:48487353	TREX1	chr3:48501186-48509043:+	-0.29	-4.36	3.23E-5	Longevity	
THYM	cis	1	rs9838965	chr3:41927938	ULK4	chr3:41288091-42003660:-	-1.02	-11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs9839399	chr3:41928044	ULK4	chr3:41288091-42003660:-	-1.02	-11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs9840037	chr3:41827522	ULK4	chr3:41288091-42003660:-	1	10.44	1.92E-17	Diastolic blood pressure	
THYM	cis	1	rs9840532	chr3:41885697	ULK4	chr3:41288091-42003660:-	0.97	10.79	3.37E-18	Diastolic blood pressure	
THYM	cis	1	rs9841212	chr3:134191938	ANAPC13	chr3:134196547-134204865:-	0.54	7.49	3.5E-11	Height	
THYM	cis	1	rs9841212	chr3:134191938	CEP63	chr3:134204575-134293852:+	0.38	5.62	1.87E-7	Height	
THYM	cis	1	rs984222	chr1:119503843	WARS2	chr1:119573841-119683295:-	-0.56	-6.63	2.0E-9	Waist-to-hip ratio adjusted for body mass index;Waist-hip ratio	
THYM	cis	1	rs9842261	chr3:41822708	ULK4	chr3:41288091-42003660:-	-1.06	-8.02	2.67E-12	Diastolic blood pressure	
THYM	cis	1	rs9842305	chr3:41998412	ULK4	chr3:41288091-42003660:-	-1.01	-11.41	1.64E-19	Diastolic blood pressure	
THYM	cis	1	rs9846634	chr3:41894049	ULK4	chr3:41288091-42003660:-	0.96	9.31	4.92E-15	Diastolic blood pressure	
THYM	cis	1	rs9847006	chr3:41755359	ULK4	chr3:41288091-42003660:-	1.03	11.64	5.41E-20	Diastolic blood pressure	
THYM	cis	1	rs9847975	chr3:41786904	ULK4	chr3:41288091-42003660:-	0.96	9.25	6.63E-15	Diastolic blood pressure	
THYM	cis	1	rs9848754	chr3:41753647	ULK4	chr3:41288091-42003660:-	0.99	9.66	8.87E-16	Diastolic blood pressure	
THYM	cis	1	rs9849509	chr3:48483432	TREX1	chr3:48501186-48509043:+	-0.29	-4.33	3.75E-5	Longevity	
THYM	cis	1	rs9850015	chr3:134269541	ANAPC13	chr3:134196547-134204865:-	0.58	8.05	2.33E-12	Height	
THYM	cis	1	rs9850015	chr3:134269541	CEP63	chr3:134204575-134293852:+	0.4	5.81	8.19E-8	Height	
THYM	cis	1	rs9851441	chr3:134315091	ANAPC13	chr3:134196547-134204865:-	0.55	7.48	3.7E-11	Height	
THYM	cis	1	rs9851441	chr3:134315091	CEP63	chr3:134204575-134293852:+	0.43	6.36	7.09E-9	Height	
THYM	cis	1	rs9852303	chr3:41759525	ULK4	chr3:41288091-42003660:-	1.03	11.64	5.41E-20	Diastolic blood pressure	
THYM	cis	1	rs9854299	chr3:134206728	ANAPC13	chr3:134196547-134204865:-	0.58	7.99	3.12E-12	Height	
THYM	cis	1	rs9854299	chr3:134206728	CEP63	chr3:134204575-134293852:+	0.42	6.11	2.18E-8	Height	
THYM	cis	1	rs9854833	chr3:41775577	ULK4	chr3:41288091-42003660:-	0.98	9.58	1.33E-15	Diastolic blood pressure	
THYM	cis	1	rs9854838	chr3:41805670	ULK4	chr3:41288091-42003660:-	1.02	11.16	5.5E-19	Diastolic blood pressure	
THYM	cis	1	rs9855965	chr3:41860508	ULK4	chr3:41288091-42003660:-	1	10.81	3.16E-18	Diastolic blood pressure	
THYM	cis	1	rs9856088	chr3:41860482	ULK4	chr3:41288091-42003660:-	1	10.81	3.16E-18	Diastolic blood pressure	
THYM	cis	1	rs9856633	chr3:42013850	ULK4	chr3:41288091-42003660:-	1.01	11.41	1.64E-19	Diastolic blood pressure	
THYM	cis	1	rs9856693	chr3:134306913	ANAPC13	chr3:134196547-134204865:-	0.55	7.48	3.7E-11	Height	
THYM	cis	1	rs9856693	chr3:134306913	CEP63	chr3:134204575-134293852:+	0.43	6.36	7.09E-9	Height	
THYM	cis	1	rs9857175	chr3:41822054	ULK4	chr3:41288091-42003660:-	1.02	10.98	1.36E-18	Diastolic blood pressure	
THYM	cis	1	rs9863786	chr3:134247203	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs9863786	chr3:134247203	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs9863915	chr3:41762002	ULK4	chr3:41288091-42003660:-	1.03	11.64	5.41E-20	Diastolic blood pressure	
THYM	cis	1	rs9864217	chr3:41762206	ULK4	chr3:41288091-42003660:-	0.99	9.66	8.87E-16	Diastolic blood pressure	
THYM	cis	1	rs9864346	chr3:134312352	ANAPC13	chr3:134196547-134204865:-	0.57	7.57	2.35E-11	Height	
THYM	cis	1	rs9864346	chr3:134312352	CEP63	chr3:134204575-134293852:+	0.42	6.06	2.7E-8	Height	
THYM	cis	1	rs9864371	chr3:48426766	TREX1	chr3:48501186-48509043:+	-0.28	-4.38	3.02E-5	Longevity	
THYM	cis	1	rs9864439	chr3:134298671	ANAPC13	chr3:134196547-134204865:-	0.55	7.52	3.08E-11	Height	
THYM	cis	1	rs9864439	chr3:134298671	CEP63	chr3:134204575-134293852:+	0.42	6.29	9.47E-9	Height	
THYM	cis	1	rs9865127	chr3:41807448	ULK4	chr3:41288091-42003660:-	1.02	11.16	5.5E-19	Diastolic blood pressure	
THYM	cis	1	rs9865780	chr3:41895802	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs9866092	chr3:41895967	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs9866759	chr3:41758418	ULK4	chr3:41288091-42003660:-	1.03	11.64	5.41E-20	Diastolic blood pressure	
THYM	cis	1	rs9867627	chr3:41795841	ULK4	chr3:41288091-42003660:-	-0.94	-9.12	1.25E-14	Diastolic blood pressure	
THYM	cis	1	rs9869207	chr3:41878661	ULK4	chr3:41288091-42003660:-	1.02	11.47	1.22E-19	Diastolic blood pressure	
THYM	cis	1	rs9869282	chr3:41756064	ULK4	chr3:41288091-42003660:-	1.03	11.64	5.41E-20	Diastolic blood pressure	
THYM	cis	1	rs9869440	chr3:41763155	ULK4	chr3:41288091-42003660:-	1.01	11.17	5.4E-19	Diastolic blood pressure	
THYM	cis	1	rs9869981	chr3:134248801	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs9869981	chr3:134248801	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs9871305	chr3:134213538	ANAPC13	chr3:134196547-134204865:-	0.59	8.13	1.58E-12	Height	
THYM	cis	1	rs9871305	chr3:134213538	CEP63	chr3:134204575-134293852:+	0.41	5.87	6.33E-8	Height	
THYM	cis	1	rs9873207	chr3:41884750	ULK4	chr3:41288091-42003660:-	0.96	9.51	1.88E-15	Diastolic blood pressure	
THYM	cis	1	rs9874513	chr3:41909508	ULK4	chr3:41288091-42003660:-	0.95	9.28	5.58E-15	Diastolic blood pressure	
THYM	cis	1	rs9874975	chr3:41764300	ULK4	chr3:41288091-42003660:-	1.03	11.59	7.14E-20	Diastolic blood pressure	
THYM	cis	1	rs9875083	chr3:41775786	ULK4	chr3:41288091-42003660:-	0.98	9.44	2.56E-15	Diastolic blood pressure	
THYM	cis	1	rs9875107	chr3:41822313	ULK4	chr3:41288091-42003660:-	1	10.63	7.58E-18	Diastolic blood pressure	
THYM	cis	1	rs9876658	chr3:134179453	ANAPC13	chr3:134196547-134204865:-	-0.53	-7.23	1.19E-10	Height	
THYM	cis	1	rs9876658	chr3:134179453	CEP63	chr3:134204575-134293852:+	-0.39	-5.73	1.17E-7	Height	
THYM	cis	1	rs9876781	chr3:48487338	TREX1	chr3:48501186-48509043:+	-0.29	-4.28	4.47E-5	Longevity	
THYM	cis	1	rs9876960	chr3:41985812	ULK4	chr3:41288091-42003660:-	-1.01	-11.41	1.64E-19	Diastolic blood pressure	
THYM	cis	1	rs9879311	chr3:10415343	GHRLOS	chr3:10322637-10335132:+	0.4	4.2	6.0E-5	Schizophrenia	
THYM	cis	1	rs9881491	chr3:48487911	TREX1	chr3:48501186-48509043:+	-0.28	-4.22	5.51E-5	Longevity	
THYM	cis	1	rs9882329	chr3:41767154	ULK4	chr3:41288091-42003660:-	1.03	11.59	7.14E-20	Diastolic blood pressure	
THYM	cis	1	rs9883753	chr3:134247231	ANAPC13	chr3:134196547-134204865:-	0.56	7.61	1.94E-11	Height	
THYM	cis	1	rs9883753	chr3:134247231	CEP63	chr3:134204575-134293852:+	0.41	6	3.54E-8	Height	
THYM	cis	1	rs9883759	chr3:48463618	TREX1	chr3:48501186-48509043:+	-0.28	-4.23	5.28E-5	Longevity	
THYM	cis	1	rs9883927	chr3:48463711	TREX1	chr3:48501186-48509043:+	-0.29	-4.26	4.8E-5	Longevity	
THYM	cis	1	rs9884031	chr3:134256500	ANAPC13	chr3:134196547-134204865:-	0.58	8.01	2.88E-12	Height	
THYM	cis	1	rs9884031	chr3:134256500	CEP63	chr3:134204575-134293852:+	0.41	6.04	2.93E-8	Height	
THYM	cis	1	rs9890205	chr17:28382704	EFCAB5	chr17:28256874-28435469:+	-0.31	-4.25	5.04E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs9890886	chr17:28391076	EFCAB5	chr17:28256874-28435469:+	-0.31	-4.25	5.04E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs9891871	chr17:28370191	EFCAB5	chr17:28256874-28435469:+	-0.31	-4.25	5.04E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs9894429	chr17:79596811	TSPAN10	chr17:79609349-79615778:+	0.63	6.54	3.14E-9	Eye color traits	
THYM	cis	1	rs9896062	chr17:28357047	EFCAB5	chr17:28256874-28435469:+	-0.31	-4.25	5.04E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs9899788	chr17:61756384	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.47	2.2E-5	Body mass index	
THYM	cis	1	rs9901112	chr17:61730617	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.41	2.72E-5	Body mass index	
THYM	cis	1	rs9901507	chr17:61765524	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.47	2.2E-5	Body mass index	
THYM	cis	1	rs9902453	chr17:28349095	EFCAB5	chr17:28256874-28435469:+	-0.31	-4.26	4.84E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs9903897	chr17:61716705	TCAM1P	chr17:61934376-61941738:+	-0.53	-4.38	3.02E-5	Body mass index	
THYM	cis	1	rs9903903	chr17:61762044	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.47	2.2E-5	Body mass index	
THYM	cis	1	rs9906340	chr17:28398977	EFCAB5	chr17:28256874-28435469:+	-0.36	-4.27	4.71E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs9908044	chr17:61747032	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.47	2.2E-5	Body mass index	
THYM	cis	1	rs9909992	chr17:61731931	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.41	2.72E-5	Body mass index	
THYM	cis	1	rs9912201	chr17:61763208	TCAM1P	chr17:61934376-61941738:+	-0.55	-4.23	5.47E-5	Body mass index	
THYM	cis	1	rs9912741	chr17:28359511	EFCAB5	chr17:28256874-28435469:+	-0.31	-4.25	5.04E-5	Coffee consumption (cups per day)	
THYM	cis	1	rs9912904	chr17:61763534	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.41	2.72E-5	Body mass index	
THYM	cis	1	rs9920775	chr15:90368273	AP3S2	chr15:90373832-90456222:-	-0.41	-4.65	1.09E-5	Type 2 diabetes	
THYM	cis	1	rs9921338	chr16:11416839	C16orf75	chr16:11343506-11445617:+	-0.28	-4.33	3.7E-5	Vein graft stenosis in coronary artery bypass grafting	
THYM	cis	1	rs9922925	chr16:4624892	NMRAL1	chr16:4511696-4526307:-	-0.48	-5.52	2.96E-7	Obesity-related traits	
THYM	cis	1	rs9923145	chr16:74686166	RFWD3	chr16:74655298-74700779:-	-0.21	-4.54	1.68E-5	Testicular germ cell tumor	
THYM	cis	1	rs992416	chr17:61745905	TCAM1P	chr17:61934376-61941738:+	-0.54	-4.41	2.72E-5	Body mass index	
THYM	cis	1	rs9929496	chr16:74668473	RFWD3	chr16:74655298-74700779:-	-0.23	-4.89	4.07E-6	Testicular germ cell tumor	
THYM	cis	1	rs9931225	chr16:74699293	RFWD3	chr16:74655298-74700779:-	-0.23	-5.05	2.14E-6	Testicular germ cell tumor	
THYM	cis	1	rs9968172	chr3:134231251	ANAPC13	chr3:134196547-134204865:-	-0.58	-8.1	1.81E-12	Height	
THYM	cis	1	rs9968172	chr3:134231251	CEP63	chr3:134204575-134293852:+	-0.4	-5.85	6.83E-8	Height	
THYM	cis	1	rs9976479	chr21:43836083	TMPRSS3	chr21:43791996-43816200:-	0.49	4.63	1.15E-5	Type 1 diabetes	
THYM	cis	1	rs9976767	chr21:43836390	TMPRSS3	chr21:43791996-43816200:-	-0.49	-4.62	1.18E-5	Type 1 diabetes	
THYM	cis	1	rs997872	chr22:25878614	CRYBB2	chr22:25615612-25627836:+	1.1	7.33	7.64E-11	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs997873	chr22:25878282	CRYBB2	chr22:25615612-25627836:+	1.12	7.51	3.14E-11	Bipolar disorder with mood-incongruent psychosis	
THYM	cis	1	rs998449	chr10:45056696	ZNF22	chr10:45496273-45500776:+	0.57	5.19	1.21E-6	Estradiol plasma levels (breast cancer)	
THYM	cis	1	rs9985356	chr3:134232920	ANAPC13	chr3:134196547-134204865:-	-0.52	-6.96	4.36E-10	Height	
THYM	cis	1	rs9985356	chr3:134232920	CEP63	chr3:134204575-134293852:+	-0.39	-5.72	1.23E-7	Height	
THYM	cis	1	rs9989967	chr3:134238964	ANAPC13	chr3:134196547-134204865:-	0.56	7.61	1.94E-11	Height	
THYM	cis	1	rs9989967	chr3:134238964	CEP63	chr3:134204575-134293852:+	0.41	6	3.54E-8	Height	
THYM	cis	1	rs9990351	chr3:134239191	ANAPC13	chr3:134196547-134204865:-	-0.56	-7.61	1.94E-11	Height	
THYM	cis	1	rs9990351	chr3:134239191	CEP63	chr3:134204575-134293852:+	-0.41	-6	3.54E-8	Height	
THYM	cis	1	rs9995007	chr4:76897791	NAAA	chr4:76831809-76862166:-	-0.46	-4.92	3.56E-6	Longevity	
THYM	trans	1	rs10037055	chr5:176691279	LOC388955	chr2:63849182-63850159:-	-0.58	-8.52	2.33E-13	Migraine without aura	
THYM	trans	1	rs6886255	chr5:176718361	LOC388955	chr2:63849182-63850159:-	0.58	8.51	2.53E-13	Migraine without aura	
